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Abstract 
Antimicrobial peptides (AMPs) have been proposed as antitumor molecules since they 
sometimes displayed selective cytotoxicity towards cancer cells; they have the potential to 
bypass multi-drug resistance, as they exert their bioactivity by interacting with the membranes, 
without a specific target. Trichogin GA IV (TG) belongs to lipopeptaibols, a class of 
antimicrobial peptides characterized by the presence of tetrasubstituted -amino acids in their 
sequence. Differently from other AMPs, lipopeptaibols present a significant resistance to 
enzyme hydrolysis. The purpose of the present Ph.D. thesis is the study of the peptide-
membrane interaction in healthy and cancer cells as the membrane perturbing ability of these 
peptides is most likely at  the basis of the selective cytotoxicity of the peptides. Working in 
physiological condition was of primary importance to untangle the specificity of the different 
peptides for the various cell lines: the membrane properties at physiological temperature are 
indeed among the main determinants of the peptide-membrane interaction. The study has 
been conducted using several techniques. Structural features of TG analogs have been 
quantified to rationally design new analogs with different characteristics. The results of 
cytotoxicity assays on cancer and healthy cells showed that it is possible to tune the toxicity 
of TG towards cells with different membrane composition. Fluorescence microscopy showed 
peptides localization on cell membranes. Electron Paramagnetic Resonance (EPR) 
spectroscopy is a versatile technique that has been widely exploited to determine the affinity 
of spin labeled peptides for model and cell membranes and their orientation in the 
phospholipid bilayer. The obtained results are promising, as we could relate structural 
modification with variations in TG analogs toxicity, an encourage further studies. 
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Riassunto 
I peptide antimicrobici (AMPs) sono stati proposti come possibili molecole antitumorali, 
poiché alcuni studi hanno evidenziato la capacità di alcuni AMPs di attaccare selettivamente 
alcune cellule tumorali; gli AMPs sono promettenti in quanto il loro meccanismo di azione, 
che prevede un attacco aspecifico sulle membrane cellulari, premette di superare lo sviluppo 
di resistenza ai convenzionali farmaci antibiotici ed antitumorali. La Tricogina GA IV (TG) 
appartiene alla famiglia dei lipopeptaibolici, una classe di peptidi antimicrobici, la cui sequenza 
è caratterizzata dalla presenza di -ammino acidi tetrasostituiti. Diversamente da quanto 
osservato per altre classi di AMPs, i lipopeptaibolici sono particolarmente resistenti all’idrolisi 
enzimatica. Lo scopo del presente lavoro di tesi è lo studio dell’interazione peptide-membrana 
nel caso di cellule sane e tumorali. Infatti, la capacità di questi peptidi di perturbare le 
membrane è probabilmente alla base della selettività per le cellule tumorali che alcuni di essi 
hanno mostrato. Di primaria importanza è stato eseguire la maggior parte degli esperimenti 
in condizioni fisiologiche, in quanto le proprietà delle membrane a temperatura fisiologica 
sono tra i principali determinanti dell’interazione peptide-membrana. In questo studio sono 
state utilizzate diverse tecniche. Le caratteristiche strutturali degli analoghi della TG sono 
state quantificate per poter sviluppare un design razionale di nuovi analoghi che presentassero 
caratteristiche strutturali differenti. I risultati di tossicità degli analoghi della TG su cellule 
sane e tumorali hanno evidenziato che è in effetti possibile modulare l’attività di questi peptidi 
verso cellule le cui membrane presentano diversa composizione. Tramite microscopia di 
fluorescenza si è osservato come questi peptidi si localizzino sulle membrane cellulari. La 
Risonanza Paramagnetica Elettronica (EPR) è una tecnica spettroscopia versatile che è stata 
utilizzata per determinare quale fosse l’affinità di peptidi marcati con sonde paramagnetiche 
per diversi sistemi membrano-mimetici e per membrane cellulari; inoltre è stata determinata 
l’orientazione che tali peptidi assumono quando immersi in un doppio strato fosfolipidico. I 
risultati ottenuti sono promettenti ed hanno evidenziato che è possibile correlare modifiche 
strutturali con variazioni nella tossicità degli analoghi della TG. 
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1. Introduction 
1.1 AntiMicrobial Peptides (AMPs) 
Antimicrobial peptides, first discovered in the 1980s, are considered a fundamental part 
of immune system of nearly every living organism, from amoebas to humans. Their role 
is of key importance: they usually display a broad spectrum of activity against bacteria 
and fungi, and sometimes their killing potential is extended to some viruses, parasites 
and cancer cells. The attention on this family of peptides raised since their most 
common mechanism of action is to act on bacterial membranes or other generalized 
targets, in contrast to most antibiotics, that usually target specific proteins. This peculiar 
mode of action makes the development of resistance by gene mutation less likely to 
occur, a feature that makes AMPs promising antibacterial drugs. By now, several 
hundreds of AMPs have been isolated from a large variety of natural sources: plants, 
bacteria, fungi, fish, amphibians and mammals. The main strategy to categorize them is 
by their secondary structure. Indeed, the majority of AMPs adopt a stable secondary 
structure (the most common being helices and -sheets) with an amphipathic character, 
i.e. the hydrophobic and hydrophilic residues are distributed in such a way that, when 
the peptide adopts its secondary conformation, they are placed at opposite sectors of 
the molecule. Due to the great number of peptide families, structures and modes of 
action, a massive work is by now needed to list and describe all the known AMPs and 
countless reviews have been produced in the last twenty years to keep pace with the 
constantly increasing knowledge about peptides. In this introductive paragraph, it will 
be given a brief description of some well studied peptides that are representative of 
different categories to show the great variety of sources, structures and modes of action 
of this class of molecules and to underline the reasons of the interest in the study of 
their bioactivity. Some comprehensive reviews on AMPs, their sources, action 
mechanisms, structures and application for therapeutic purposes are reported in ref [7-
15].   
Probably the most populated category of AMPs is the one of the -helical peptides. An 
example of 3D structures of -helical peptides is given in Figure 1.1. Although there 
are fully hydrophobic peptides, the ones that display the highest selectivity towards 
microbes are the amphipathic ones. One of the most studied -helical peptides is 
alamethicin. It is produced by a fungus of the Trichoderma family, it is mostly 
hydrophobic and forms stable, organized pores on membranes made of oligomeric 
bundles of helices, due to the strategic location of a negatively charged Glu residue in 
its sequence. The fungi of the Trichoderma family also produce other interesting peptides, 
such as ampullosporin and trichogin, the latter being the focus of the present Ph.D. 
thesis. Like alamethicin, they have a helical secondary structure without cationic residues 
in their sequences, and display moderate antibacterial activity. Another famous pore-
forming peptide is gramicidin A, produced by the bacterium Bacillus brevis; this peptide 
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locates transmembrane as a dimer with a central hole through which ions pass, 
destabilizing the physiological concentration gradient. Bacteria can seem unexpected 
sources of AMPs, but examples of peptides produced by bacteria are numerous. As an 
example, Escherichia Coli produces a series of peptides named colicins, with the purpose 
of reducing the competition from other bacterial strains. The bacterium Helicobacter pilori 
produces a protein, named L1, the N-terminal region of which is composed by a cationic 
amphipathic -helical fragment that retains its antibacterial activity, probably against 
competitive bacterial strains. Among the most studied cationic -helical peptides, there 
is magainin, the first peptide that was discovered to be produced by the skin of an 
animal, namely the frog Xenopus laevis. Magainin is probably the most representative 
peptide of the Shai-Matsuzaki-Huang mechanism: it involves the formation of transient, 
disordered pores, often referred as toroidal pores that induce membrane leakage and 
disruption. Magainins have a broad activity spectrum, from bacteria and fungi to tumor 
cells and viruses, and the most active peptides of this family also display a high degree 
of hemolysis. Another milestone in the discovery and study of AMPs is represented by 
cecropins, a family of helical peptides produced in the hemolymph of the moth 
Hyalophora cecropia. Differently from melittins, peptides found in bee venom, cecropins 
are an example of selective toxicity, since they are active against some fungi, Gram-
positive and Gram-negative bacteria, but, at the same concentration, are inactive against 
animal cells. Interestingly, also mammals rely on peptides to defend from external 
pathogens; usually these peptides are called “host-defense” peptides to highlight their 
additional immunomodulatory activity, i.e. they usually have poor antimicrobial activity 
 
Figure 1.1 Examples of 3D structures of -helical peptides. 
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per se, but modulate the response of the immune system (Figure 1.2). One example is 
represented by the large family of the cathelicidins that are produced by phagocytes of 
sheep, bovines, pigs, rabbits and humans. They display a variety of sequences, that is an 
interesting example of the so-called convergent evolution: different evolutionary 
pathways result in similar solutions. The differences in sequence keep the function intact 
while, at the same time, they ensure that peptides from different species are recognized 
as external by other species. For example, sheep cathelicidin SMAP-29 is lytic against 
human erythrocytes, but inactive against sheep erythrocytes. Another example is the pig 
cecropin P1. Its structure and sequence resembles those of insect cecropins, and also 
the activity spectrum is similar. 
All the peptides presented so far share a mostly helical conformation. A discrete 
number of other peptides, instead, present different types of -structures, an example 
of which is reported in Figure 1.3. To form -structures, at least two peptides must 
aggregate with proper geometry; alternatively, a single peptide of sufficient length 
should bend to form new hydrogen bonds that sustain the -sheet. Even in this 
situation, the hydrogen bonds that can be formed could be not enough to grant stability 
to the peptide, therefore it is more common to observe -structures in cyclic peptides: 
the cyclization reduces the entropy loss after the formation of the -structure. Examples 
of cyclic peptides with -structures are protegrins, lactoferricin and gramicidin S. The 
most famous family of peptides with -sheets sectors is the family of defensin. They are 
produced in neutrophils as part of the innate immune system and were found in 
mammals, insects and plants. Their structure is more complex since it comprises both 
 and  secondary domains. In the case of -structured peptides, the determinants of 
the toxicity are usually uncertain; nevertheless, it is usually hypothesized that they act 
against bacteria attacking their membranes as it occurs with -helical peptides.  
 
Figure 1.2 Host defense peptides act by immune modulation or by direct killing. Figure 
from [7]. 
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After this short overview, it is clear that the potential uses of AMPs are promising. New 
peptides are not only discovered from natural sources, but efforts are made for a rational 
design of new synthetic peptides with the desired characteristics. Generally, peptides 
with a positive charge and amphipathic structure are the most explored to promote, at 
the same time, affinity for the lipid bilayers and selectivity towards negatively charged 
membranes. At present, many peptides reached the in vitro stage of study as antibiotic 
or anticancer drugs: among them, there are many of the peptides described before, such 
as some strains of cecropins, magainins, melittins, lactoferricins and human defensins. 
Only few of them were promoted to the in vivo stage of the study: some strains of 
magainins, human defensisn and lactoferricins. The peptide gramicidin S reached the 
clinical use, and nisin is being used as food additive. However, still many shortcomings 
must be addressed before AMPs become widely available as proper drugs. They display 
poor bioavailability, since they are readily degraded in the serum by proteases, limiting 
their pharmacokinetic properties. Moreover, the selectivity is usually a major issue both 
for antimicrobial and for anticancer use. The complexity of the design of new improved 
peptides lies in the fact that size, sequence, percentage of organized secondary structure, 
charge, hydrophobicity and amphipathicity are all features that are closely related to 
each other and influence peptides activity in an often poorly predictable manner.  
 
 
 
 
 
Figure 1.3 Examples of 3D structures of -structured peptides. 
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1.1.1 Mechanism of action of AMPs 
The broad spectrum of activity against pathogens that is usually displayed by AMPs, 
that extends from bacteria and fungi to viruses and cancer cells, is mainly due to their 
particular ability to act against a generalized target, rather than against specific proteins, 
as conventional antibiotics [20]. Indeed, although some AMPs actually attack key 
cellular processes, such as DNA synthesis, protein folding and activity [21-23], the 
majority of -helical AMPs disrupt the cytoplasmic membrane in a number of different 
ways. Moreover, as already mentioned in the last paragraph, even when an AMP attack 
a specific intracellular target, the interaction of the AMP with the cell membrane 
remains of central importance. Usually, AMPs have the common characteristics of being 
positively charged, amphipathic, and with a relevant hydrophobic sector. Then, their 
mechanism of action should involve the binding to the membrane, mainly to negatively 
charged moieties, and subsequently its perturbation and eventually its disruption. 
Countless studies tried to categorize the mechanism of action of membrane disrupting 
peptides. The most common classification divides peptides that follow the barrel-stave 
model and peptides that follow the Shai-Matsuzaki-Huang model. In the barrel-stave 
model [24], peptides aggregate to form an ordered pore, exposing their hydrophobic 
face towards the lipid tails and the hydrophilic face toward the pore itself. One of the 
most famous peptides that act via this mechanism is the peptaibol alamethicin [24,25], 
along with other less famous ones [26,27]. The Shai-Matsuzaki-Huang model includes 
different steps of membrane perturbation [28]: first, peptides bind on the membrane 
surface, sometimes causing membrane thinning; when peptide concentration raises 
AMPs can form disordered toroidal pores that deform the membrane; finally, regardless 
the extent of membrane perturbation, AMPs can disrupt the membrane via 
micellization. The last step of this mechanism has sometimes been called carpet model. 
Along with the increasing number of discovered and studied AMPs, many variations to 
these two models have been proposed. A comprehensive schematic representation of 
the proposed modes of action is reported in Figure 1.4. 
All the proposed mechanism are based on the common characteristic of -helical AMPs 
to have an amphipathic secondary structure that favors the binding to the cell surface. 
AMPs that are long enough to span the thickness of the phospholipid bilayer, usually 
create pores of different geometry. Instead, shorter peptides deform the bilayer causing 
local perturbations in phospholipid packing. A recent review on the toroidal pore 
mechanism [29,30] proposes that even when the peptide concentration is low, a small 
number of peptides could still cause a transient disorganization of phospholipids that 
bend and form a temporary pore. Interestingly, it has been shown [31] that this 
mechanism is particularly fit to explain how AMPs with a polar or charged residue in 
their hydrophobic face work: the presence of a polar residue in the face that is usually 
bound to the lipid portion of the bilayer could pull lipid head groups into the membrane 
interior, inducing pore formation. In this context, the carpet model mentioned above is 
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considered as an extreme extension of the disordered torodial pores. Other -helical 
AMPs are thought to cause leakage of intracellular materials or membrane 
depolarization because their positively charged residues compromise the membrane 
stability by attracting all the negatively charged head groups nearby [32]. Finally, it has 
to be mentioned that also some -helical AMPs act by interfering with the activity of 
some proteins (as clavanin A, that inhibits the  proteins involved in the maintenance of 
the pH gradient across the membrane [33]) or of nucleic acids (as buforin II, that 
intercalates between nucleic acids [34]). The description of AMPs mechanisms focused 
on -helical AMPs. However, AMPs with other secondary structures sometimes share 
the same action mechanisms. For example, the -hairpin structure is common among 
AMPs: peptides in this conformation are able to disrupt the membrane forming pores 
known as -barrels, or forming -sheet aggregates [35]. Other peptides in -sheet 
conformation are, instead, active against intracellular components: they for example 
interfere with proteins involved in the ATP reactions, in the DNA and RNA synthesis, 
or directly in the synthesis of the membrane [22,36]. Moreover, bigger peptides are 
composed of domains in different secondary conformations. As an example, human -
defensin is has a -helical domain and a three-stranded -sheet [37,38].  
 
Figure 1.4 The figure shows the principal proposed mechanisms that helical peptides adopt 
to attack the membrane bilayer. Figure taken from ref [5]. 
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In conclusion, it is important to remark that the great size of studies on peptides and 
their mechanisms of action showed that organisms developed complex pathways to 
defend. An organism that has to defend from an external pathogen is likely to release 
many isoforms of similar AMPs, each one with a different mode of action [39]. 
Alternatively, it has been observed that some peptides, such as magainin, work through 
multiple different mechanisms at the same time [40]: this strategy is actually convenient 
in terms of both efficiency and ability to avoid resistance mechanisms. 
 
1.1.2 Structural parameters accounted for activity and selectivity of -helical 
AMPs 
Many AMPs have a stable secondary structure, the most diffuse being the -helix. It is 
quite evident that the secondary structure is of paramount importance for the bioactivity 
of these peptides. Therefore, many studies tried to describe the influence of different 
structural parameters to the cytolytic effect of peptides. The most investigated 
parameters, are charge, helicity, hydrophobicity, hydrophobic moment, and angles 
subtended by domains of different polarity. Figure 1.5, from ref [1], shows an example 
of the parameters discussed in this paragraph, calculated for one of the most studied 
peptides, magainin. In figure are reported the 3D helical representation of the peptide 
and the helical wheel diagram, where residues with different hydrophobicity are 
differently colored. On the helical wheel are reported , the angle subtended by the 
hydrophilic residues, and , the hydrophobic moment vector. The figure also reports 
the values of all the mentioned parameters: the number of residues (N), the total charge 
(Q), the mean hydrophobicity per residue (H) and the hydrophobicity of the domain 
subtended by the angle 360° -  (Hh), the module of the hydrophobic moment (||), 
and the angle  
Many antibacterial peptides are positively charged, probably to favor the interaction 
with the negatively charged membranes of bacteria. Therefore, charge is the first 
 
Figure 1.5 An example of a peptide in a-helical conformation, for which all the structural 
parameters described in this paragraph are obtained. Figure from [1]. 
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parameter to take in consideration when trying to improve the activity of AMPs. Indeed, 
there are some example of peptides, like -hemolysin and magainin, whose antibacterial 
activity was greatly improved by the substitution of one or more neutral residues with 
positively charged ones [41-43]. Studies on model peptides [44] revealed however that 
it is difficult to find a simple correlation between peptide charge and antimicrobial 
activity. This is due to the fact that an amino-acid substitution influences not only the 
charge, but also other structural parameters. Subsequent studies [45] showed that 
peptide-membrane interaction is balanced by multiple factors, such as electrostatic and 
hydrophobic interactions, helicity and amphipathicity of peptides and how they relate 
to membrane composition.  
Another feature that has been taken in consideration when trying to rationalize AMPs 
behavior is their helicity. It is nearly immediate to relate the activity of a helical peptide 
to the extent of its regular secondary conformation. Helicity is quite difficult to 
quantitatively measure for peptides. A possibility is given by 1H-NMR spectroscopy that 
shows the correlation between nuclei depending on their distance. IR and CD 
spectroscopies give information on peptides secondary structures; however, they 
provide general information on the structure, but cannot account for small local 
perturbation. It is well established that certain amino-acids are helix-inducing, while 
others destabilize the helix [46]. Early studies showed that an enhancement of 
antibacterial activity of analogs of the peptides melittin and cecropin occurred when 
they carried substituents with increased helix inducing power and, viceversa, a loss of 
hemolytic and antimicrobial activity was displayed in analogs with substituents that 
prevented helical folding [47-51]. Proving that these correlations were due to the helicity 
and not to other properties of the substituted amino-acids, another study [52] observed 
the same results substituting some amino-acids with their enantiomers. Moreover, it has 
been observed that helicity plays a more decisive role when permeabilizing neutral 
membranes, while it becomes less important when attacking charged bilayers. A possible 
explanation is the prevalence of the electrostatic forces, when present, over 
hydrophobic interactions. Even encouraged by some positive results, it appears difficult 
to find an unambiguous relation between bioactivity and helicity alone: when studying 
a modified peptide, many other features may change synergically with helicity, such as 
the hydrophobicity of their side chain. 
The hydrophobicity is defined as the ability of a given molecule to move from an aqueous 
to a hydrophobic phase. The overall hydrophobicity of a peptide depends on the 
hydrophobicity of the side chains of its amino-acids, and is independent from the 
secondary structure. Theoretical and experimental attempts to build hydrophobicity 
scales for amino-acids are numerous, and will be discussed diffusely in paragraph 3.4.2, 
along with an original proposal that is part of the present work. It is necessary for a 
peptide to carry hydrophobic residues, as they are needed for the binding and 
subsequent perturbation of the lipid bilayer; at the same time, hydrophilic residues are 
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required to ensure solubility in aqueous media and to prevent peptide aggregation. Some 
studies [53] were able to correlate a change in hydrophobicity with a change in 
antimicrobial properties of peptides, while some other studies [54-56] found no 
correlation between them. These contrasting observations can be explained since to 
modify hydrophobicity it is necessary to modify the primary sequence of peptides, 
leading to the variation of multiple parameters, such as charge, helix inducing effects, 
therefore, the combined effect of all these variations may not be easy to predict. 
Additionally, it has been verified that hydrophobic interactions are more effective on 
neutral membranes [57,58], thus small variations of hydrophobicity on charged peptides 
interacting with membranes with an excess of negative or positive charge may be 
negligible. 
A more interesting parameter is the hydrophobic moment, that will be also exploited in the 
present work along with hydrophobicity (see paragraph 3.4.2). This parameter, strictly 
connected with hydrophobicity, is more informative because it includes different 
features of helical peptides. It is calculated as the vector sum of the hydrophobicity of 
each residue [59], and is strongly dependent on the secondary structure assumed by the 
peptide. It reflects the peptide amphipathicity, therefore it will have a high value if 
hydrophobic residues are located on one side of the helix and hydrophilic residues are 
located on the other side, while it will be very low if residues are randomly organized 
along the helix. It was originally intended as a parameter that could predict the affinity 
of helical protein domains for water or for the hydrophobic protein core, but the same 
principle can be used to describe the interaction between a peptide with a membrane. 
Indeed, it could be hypothesized that helical peptides with a strong amphipathicity are 
more prone to form pores that span the membrane bilayer: the hydrophobic side 
interacts with the lipids, while the hydrophilic side faces the aqueous phase. However, 
experimental evidences are more difficult to interpret, since in many peptides residues 
of different polarity are not regularly distributed along the helix, leading to a non-perfect 
amphipathicity; additionally, a secondary structure must be assumed to perform the 
calculation, therefore the prediction of hydrophobic moment value is inaccurate for 
peptides with disordered domains. Due to these issues, some studies on different 
peptides [60] could not find a correlation between changes in hydrophobic moment and 
lytic activity. As already noted for the other parameters, it is generally difficult to find 
direct correlations between one single parameter and peptides toxicity. A better 
approach is to renounce to compare peptides with very different structures, and instead 
to observe how small variations on a given primary structure affect these structural 
parameters (such as hydrophobicity and hydrophobic moment) and search for a trend 
that links them to peptides bioactivity. Following this method, some studies [49] actually 
found a correlation between a progressive loss of antimicrobial activity and the 
progressive reduction of hydrophobic moment of melittin. 
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A parameter that is, to some extent, linked to the hydrophobicity and hydrophobic 
moment is the angle subtended by domains of different polarity.  It can be calculated as the 
angle, subtended by hydrophilic residues measured looking down along the helical axis. 
Evidently, such an angle can be defined only for regular amphipathic structures, while 
it is impossible to obtain it if the residues are randomly distributed. Some studies [61] 
proposed that peptides with small hydrophilic angle and a high hydrophobicity prefer 
to form transmembrane pores, while peptides with medium hydrophilic angle and 
medium hydrophobicity prefer to lie parallel to the membrane surface. Moreover, it is 
now well established that a large hydrophobic sector is essential for membrane binding. 
It is therefore clear that the structural parameters described in this paragraph are 
essential to understand peptides behavior, although it is usually not easy to find a simple 
correlation between the variation of individual parameters with peptide activity. Even 
one single modification on the primary sequence can alter at the same time charge, 
helicity propensity, hydrophobicity and hydrophobic moment. The rational design of a 
peptide with an optimized balance between hemolytic and antimicrobial activity is still 
a challenge. It is not only essential to rationalize the combined effect of the discussed 
parameters, but also the characteristics of the target membranes must be taken into 
account. 
 
1.1.3 Peptaibols and lipopeptaibols 
Peptaibols are a particular class of antimicrobial peptides that have been isolated from 
the fungal families Trichoderma and Gliocladium [62-64]. The name “peptaibol” derives 
from the fact that they are particularly rich in the C-tetrasubstituted non coded amino 
acid Aib (-aminoisobutyric acid, see Figure 1.6) and they carry an amino-alcohol at the 
C-terminus of the sequence; the first isolated peptaibols all carried a phenilalaninol at 
the C-terminus [65], but other amino-alcohols are now present in peptaibols sequences. 
Moreover, they are acetylated at the N-terminus. These peptides are characterized by a 
microheterogeneity which results in a complex mixture of closely related sequence 
analogs. At present, over 300 different sequences of peptaibols are known [66]. All of 
them are characterized by short (6-10 residues) or medium-length (11-19 residues) 
sequences. One of the most famous peptaibols is alamethicin [67]; other well studied 
long sequenced peptaibols are trichosporins and trichorzianines. Shorter sequenced 
peptaibols include the families of emerimicins, zervamicins and antiamoebins [68]. The 
presence of many Aib residues in the sequences is of particular importance. Aib is the 
simplest tetrasubstituted amino acid, carrying two methyl groups on the C. Since Aib 
is more sterically hindered than the conventional amino acids, only few torsional angles 
are permitted. Figure 1.6 shows the Ramachandran plot for the tripeptide Ac-Ala-Aib-
Ala-OMe; differently from the quite flexible Ala residues, few torsional angles are 
permitted for Aib, located around -60°/-30° and +60°/+30°. Comparing them with the 
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angles corresponding to typical secondary structures of peptides, it can be observed that 
Aib can only assume helical conformations, both  and 310. Since Aib is achiral, the 
handedness of the helix is determined by the other chiral residues in the peptide: L-
amino acids induce right-handed helices, D-amino acid induce left-handed helices. 
There are some structural differences between  and 310 helices (Figure 1.7). In the -
helix, each N-H group of the backbone donates a hydrogen bond to the C=O group 
four residues earlier (i+4i). This helix is sometimes called 3.613 since it has 3.6 residues 
per turn (an angle of 100° for each subsequent residue) and 13 atoms are involved in 
the ring formed by the hydrogen bonds. A more elongated and narrow helix is the 3 10, 
in which each N- H group of the backbone donates a hydrogen bond to the C=O group 
three residues earlier (i+3i). It has exactly 3 residues per turn (an angle of 120° 
between two subsequent residues) and 10 atoms are involved in the ring formed by the 
 
Figure 1.6 In the top left part of the figure is reported a schematic peptide bond with the 
torsion angles and and a 3D representation of Aib. In the top right part it is shown the 
Ramachandran plot where torsion angles and  of peptide typical secondary structures 
are highlighted. In the bottom part, the simulated Ramachandran plot of the tripeptide Ac-
Ala-Aib-Ala-OMe is reported in [18]. 
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hydrogen bonds. The preference of peptaibols for one of these conformation is driven 
by different factors: usually, short peptides with a high Aib content will prefer the 310 
helix, while longer peptides with few Aib prefer the -helix. It has been observed that 
many peptaibols adopt mixed structure, where the central part of the peptide is-
helical, while terminal domains are in 310 conformation [69,70]. A more complicated 
role is also played by the primary sequence, since each side chain has a different helicity 
propensity.  
The interest in peptaibols raised from their peculiar characteristics. First, they share with 
the other AMPs the capability of perturbing cell membranes without binding to specific 
receptors, with the advantage of avoiding the development of specific drug resistance. 
Additionally, the presence of the non-coded amino-acid Aib confers to peptaibols 
resistance to enzymatic degradation [71]: peptide bonds in which the sterically hindered 
Aib is involved cannot be lysed by proteases. Some peptaibols are also promising 
anticancer agents [72]: as an example, trichokonin VI was reported to inhibit the growth 
of hepatocellular carcinoma cells without affecting healthy liver cells [73]. 
A subclass of peptaibols is the family of lipopeptaibols [74]. They are characterized by 
the presence of a fatty acyl moiety at the N-terminus. They were isolated from cultures 
of different species of the fungi Trichoderma. They are usually short sequenced (6-11 
residues) with long fatty acyl moieties (8-15 carbon atoms). They share all the 
characteristics typical of the peptaibols, such as a helical conformation, an abundance 
of Aib residues and an amino-alcohol at the C-terminus. The long saturated chain is 
 
Figure 1.7 3D representations of a -helix and a 310 helix. 
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believed to favor the binding to lipid membranes. Many lipopeptaibols have 
antibacterial activity, for example  trichogin GA IV is toxic against Staphilococcus aureus; 
trichoningins are selectively toxic against Staphilococcus aureus, while they are inactive 
against Escherichia coli. Some peptaibols also displayed other activities: trichopolyns act 
as immunosuppressant and inhibitors of lymphocytes proliferation; the lipopeptaibol 
LP 237s showed cytotoxic activity against a number of cancer cells (leukemia, lung, 
ovarian, colon and breast). Helioferins have a broad activity spectrum against many 
bacteria and fungi; additionally, they inhibit the growth of leukemia cells at 
concentration where they have no hemolytic effect. The first and most studied 
lipopeptaibol is trichogin GA IV, that is the focus of this work and will be described in 
the next paragraph. 
 
1.1.3.1 Trichogin GA IV (TG) 
The first lipopeptaibol discovered is trichogin. It was isolated from the first time in 1992 
from the strain Trichoderma longibrachiatum [68] as a group of peptides with similar 
structure. The main isoform is trichogin GA IV, which primary sequence is as follows: 
1-Oct-Aib-Gly-Leu-Aib-Gly-Gly-Leu-Aib-Gly-Ile-Lol 
TG has an octanoyl chain (1-Oct) at the N-terminus and a Leucinol (Lol) at the C-
terminus. It has three Aib that are able to confer a stable secondary structure even if the 
sequence is short. Indeed, TG conformation has been studied in methanol by 1H and 
13C NMR and by Circular Dichroism. From these results, a predominant right-handed 
-helix was proposed. Subsequent studies on the crystal structure of TG [16] (Figure 
1.8) showed that this peptide, similarly to other short peptaibols rich in Aib, has a 310 
helical conformation for the first 2-3 residues next to the N-terminus, which is also 
partially disordered due to the presence of the flexible octanoyl chain. The remaining 
part of the sequence is in -helical conformation. The central region, containing two 
Gly, is quite flexible and may create a hinge in certain TG analogs. In -helical 
conformation, TG is considered an amphipathic peptide, since all the hydrophobic 
residues are located on one side of the helix, while the four Gly, that are slightly 
hydrophilic, are located on the other face. Amphipathicity seems to be a required feature 
to maintain, and eventually improve, TG ability to perturb phospholipids bilayers, as it 
was observed in a study where amphipathicity was enhanced by substituting the four 
Gly with Ser residues [75].  Studies have been conducted to verify the influence of the 
C- and N-termini on the activity of TG. Antimicrobial and hemolysis tests have been 
run on synthetic TG analogs varying the length of the carbon chain [76]. It was 
discovered that at least six carbon atoms are required for a significant activity, but a too 
long chain results in activity loss as well. C2-TG and C16-TG were almost completely 
inactive against Staphilococcus aureus, while C8-TG was the most active peptide. Similar 
results were obtained for the hemolytic activity. Moreover, it was also observed that 
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moving the octanoyl chain at the C-terminus reduced the activity, while adding an 
octanoyl group both at the C- and at the N-termini improved the activity of TG [77]. 
Recently, also the C-terminal amino alcohol was proved to be essential for the activity 
of TG analogs against bacteria and tumor cells [78]. These considerations highlight the 
close interplay that exists between the constituents of TG: primary sequence 
modifications, octanoyl chain, amino alcohol, secondary structure all contribute to the 
behavior of TG and its analogs. 
Being 11 residues long, TG is not long enough to span the membrane bilayer, as 
alamethicin does. Therefore, many mechanisms of action have been proposed. Initially, 
the X-ray studies showed that the octanoyl chain would lie perpendicular to the helical 
axis [16]: due to this observation, it was proposed that TG could form a barrel-stave 
pore made of TG dimers, in which the octanoyl chains anchored the peptide deep into 
the lipid bilayer, while the C-termini were facing the polar headgroups. This mechanism 
was proposed again more recently [79], adding the proposal that TG dimers acted as 
ion transporters that destabilize the ionic equilibrium of the cell. From EPR and 
fluorescent experiments, others proposed that, being too short, TG acts with a carpet 
like mechanism, thus generally perturbing the membrane [80,81]. A work that analyzed 
the behavior of TG analogs labeled with fluorescent probes proposed a new mechanism, 
according to which TG approached the membrane as a monomer and then aggregates, 
perturbing the membrane with a Shai-Matsuzaki-Huang model, forming pores of small 
dimensions [82]. Shortly after this proposal, another work [83] suggested that TG 
interaction with membranes is concentration dependent: at low concentration, TG lies 
on the membranes surface, while it aggregates and inserts into the bilayer at higher 
concentrations, causing leakage. 
With the purpose of collecting more information on TG’s behavior and elucidate the 
actual mechanism of action, many TG analogs have been synthesized and studied. 
 
Figure 1.8 Crystal structure of Trichogin GA IV: side view and view along the helical axis.  
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Recently, TG analogs lacking one or two Aib were synthesized and their antibacterial 
activities were tested [84]. One or two Aib were substituted with a Leu: Leu amino acids 
are known helix supporting residues, although less effective than Aib, and their 
introduction enhanced the overall amphipathicity. It was observed that all analogs have 
a remarkable resistance to proteolysis and are selectively toxic against Staphilococcus 
aureus, with the only exception of the analog with Leu in position 4 that completely lost 
its toxicity. An analysis of these peptide structures showed that they all maintain a stable 
-helix, except for the non-toxic analog. The latter showed a peculiar conformation, 
with Gly 5 and 6 turned to form a hinge, deducing that an excessive deviation from the 
helical structure hinders TG activity. In the same years, another study analyzed TG 
analogs with different characteristics. Several analogs with one or more Gly substituted 
by Lys were synthesized [2] in order to confer a positive charge to TG and to enhance 
its amphipathicity. It was observed, for all peptides, a stable -helical conformation that 
could partially switch to a 310 helix at decreasing pH values. Peptides with one Lys 
increased their antibacterial activity with respect to the natural TG sequence, but 
increased their hemolytic activity as well. 
From the great variety of mechanisms proposed though years of experimental 
observations, it is clear that elucidating the actual behavior of TG towards membranes 
is still an unfinished challenge. Not only modifications on even only one amino acid in 
the sequence can greatly change its mode of action, but also the model system used to 
carry out the experiments has a great influence on the results. In the present work, we 
will study several analogs of TG in different model membrane environments, and we 
will perform one of the first attempts to observe how TG interacts with viable cells. 
 
The tetrasubstituted nitroxide amino acid TOAC 
Modern spin-label techniques using the spin active 2,2,6,6-tetramethylpiperidine-1oxyl-
4-amino-4-carboxylic acid (TOAC, Figure 1.9) residue have emerged as powerful tools 
for determination of peptides conformation, association to a bilayer, aggregation and 
distance between aggregated peptides. The important advantage of TOAC is that, 
differently from other nitroxides used in biological experiments (presented in paragraph 
1.3.2), it is tightly bound to the peptide backbone and therefore its motion is directly 
related to the motion of the peptide [85,86]. TOAC is of primary importance in the 
study of the Aib-rich family of peptaibols, since it shares with Aib the characteristic of 
being a conformationally constrained C tetrasubstituted amino acid; they both are 
strong helix inducers [85,87] and many peptaibols have been modified substituting 
TOAC in places of the primary sequence occupied by an Aib residue. As an 
confirmation, conformational studies have been conducted on [Leu11-OMe] TG analogs 
singly labeled with TOAC at positions 1, 4 or 8, or doubly labeled at positions 1 and 4, 
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1 and 8, 4 and 8 [88], finding that the helix inducing properties of TOAC are equal or 
better than those of the Aib. Crystallographic studies on several different analogs of 
TG, such as [TOAC4,8, Leu11-OMe] TG, [Fmoc0, TOAC4,8, Leu11-OMe] TG, [Boc-Bpa0, 
TOAC8, Leu11-OMe] TG (see ref [89] for an extensive list) observed that all the studied 
TG analogs start with a 310/-helix, but rapidly switch to a pure a-helix conformation, 
confirming that TOAC is an optimal substituent for Aib. 
A study on singly labeled TG analogs ([TOAC1/4/8, Leu11-OMe] TG) showed that all 
these analogs have membrane permeability properties comparable to those of trichogin 
[80] on liposomes based on phosphatidylcholine. The same study also demonstrated, by 
EPR measurements, that in the absence of a transmembrane potential these analogs lie 
parallel to the surface of the lipid membranes, with the Gly-rich face oriented towards 
the aqueous phase.  
Being an optimal substituent to perform EPR studies, TOAC has been widely exploited 
as a substituent for the peptide studied in this Ph.D. thesis, trichogin GA IV. 
 
  
 
Figure 1.9 The amino acid TOAC 
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1.2 Hallmarks of cancer 
Among diseases, cancer is one of the leading causes of mortality worldwide, with a rate 
of 14 million new cases each year, in a continuous increase [90]. The generic term cancer 
defines a number of different diseases that have the common feature of rapidly creating 
abnormal cells that circumvent the apoptotic system, unlimitedly grow avoiding the 
usual mechanisms that limit cell reproduction in confined spaces, and can invade 
adjoining parts of the body, spreading to other organs. Conventional treatments involve 
the use of radiations and chemotherapeutic drugs, including alkylating agents and 
antimetabolites that bind to specific targets on the membrane surface and then exert 
their mechanism on intracellular components, the most recurring being DNA [91]. 
These therapies need high doses to be successful, and the occurrence of severe side-
effects often impairs the therapeutic advantage. These treatments act non-specifically 
against cells in rapid division, whether cancer cells or normal cells, like those of bone 
 
Figure 1.10 This illustration shows the six principal generalized hallmark capabilities 
originally proposed in [6] to characterize cancer diseases: sustaining proliferative signaling, 
evading growth suppressors, resisting cell death, enabling replicative immortality, inducing 
angiogenesis and activating invasion and metastasis. Moreover, four more hallmarks are 
emerging: deregulating cellular energetics, avoiding immune destruction, genome instability 
and mutation, tumor-promoting inflammation. Drugs that interfere with each of the 
acquired capabilities necessary for tumor growth and progression have been developed and 
are in clinical trials or in some cases approved for clinical use in treating certain forms of 
human cancer. The drugs developed to target each of the characteristics are listed in boxes. 
Figure taken from ref [19]. 
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marrow, digestive tract and hair follicles [92-94]. In addition, the development of 
multidrug resistance is a major issue that further limits the efficacy of existing 
treatments. Resistance can vary between different patients, and involves multiple 
pathways [91,95,96]: for example, cancer cells may develop an efficient transport system 
that ejects the drug from the cytosol before it can exert its function; alternatively, they 
avoid apoptosis by suppressing the mechanism of Cytochrome C release; moreover, 
slight modifications on the active site where the drug executes its inhibition mechanism 
prevent the molecular recognition, inactivating the drug. Recently, several alternative 
and innovative cancer therapies have been developed that display a more specific action 
against cancer cells, reducing the damage to healthy cells and thus undesired side effects. 
Figure 1.10 briefly summarizes the peculiar features that can be expressed by cancer 
cells and treatments currently under development that exploit them [19]. Along with the 
six characteristics of cancer proposed in 2000 [6] (sustaining of proliferative signals; 
evading growth suppression; resistance to cell death; unending replication; enhanced 
angiogenesis; invasion of nearby tissues), four new hallmarks are rising (altered cellular 
energetics; resistance against immune system attack; high propensity to mutations; state 
of persistent inflammation). Drugs that interfere with each of these 10 hallmarks are 
under development (reported in Figure 1.10, boxed near the corresponding feature), 
and some drugs already reached the clinical stage. Although innovative, these treatments 
all share the same characteristic of attacking a specific receptor, thus becoming less 
effective, or even completely inactive, after the occurring of a mutation that modifies 
the moiety target of the drug. Moreover, many of the new drugs must still be used in 
combination with the conventional treatments, reducing the advantages in terms of 
minor side effects. In this context of urgent need of finding molecules that can 
overcome drug resistance and at the same time reduce healthy cell cytotoxicity, peptides 
and peptidomimetics raised attention due to their different mode of action. Indeed, 
many of them attack the cell membrane, disrupting it by the formation of transient pores 
that kill the cell in a short timespan [97,98], which would avoid the development of 
resistance. Therefore, host defense peptides, previously considered only for their 
antimicrobial activity, have been subsequently taken in consideration as anticancer 
agents. Currently, a relatively large group of more than a hundred AMPs has been found 
to have also anticancer activity [99-101]. The majority of them has common 
characteristics: they have low molecular weight (less than 30 amino-acids long), carry 
one or more cationic residues and adopt an amphipathic helical conformation in 
membrane systems [102,103]. These features are usually accounted for the selectivity of 
these peptides for cancer cells with respect to healthy cells, given the increased quantity 
of anionic molecules present on the outer leaflet of the bilayer of the cancer cell 
membrane. 
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1.2.1 Characteristics of the tumor cell membranes 
AMPs are emerging as potential anticancer agents thanks to their peculiar behavior: as 
already described, they mostly attack the cell membrane itself, rather than targeting a 
specific receptor. Thus, it is less likely that the cell can develop resistance to the 
treatment: this leads to the double advantage of the possibility of faster and more 
efficient treatments that at the same time cause less severe side effects. In order to 
design and synthesize more selective peptides, it is essential to understand their exact 
mechanism of interaction and cell destruction. Moreover, it is important to understand 
the characteristics that differentiate healthy cell membranes from tumor cell membranes 
that determine peptides propensity to interact with tumor cells. 
One of the most recurring features that differentiate healthy cells from cancer ones is 
the over expression of negatively charged molecules on the outer leaflet of cancer cells 
membranes. Many AMPs carry positively charged residues, therefore it is 
straightforward to correlate selectivity with promoted electrostatic interactions. Many 
cancer cells display an over-expression of the negatively charged lipid phosphatidilserine 
(PS) [104,105], while healthy cells are mostly zwitterionic, being mainly composed by 
phosphatidilcoline (PC) and sphingomielyn [106]. Actually, PS in healthy cells is more 
abundant in the inner leaflet of the cell membrane; this asymmetry is sustained by ATP-
dependent mechanisms [107], that become less effective in dying cells. Therefore, a high 
quantity of PS on the outer leaflet of healthy cells acts like a marker that activates a 
series of molecular signaling responsible of the induction of apoptosis. Cancer cells, 
however, despite exposing high PS levels, are still able to avoid apoptosis by other 
mechanisms, such as escaping macrophages recognition [108,109]. For this reason, 
positively charged peptides that specifically bind to negatively charged membranes and 
rapidly provoke the lysis are suitable candidates as anticancer agents. Moreover, it is 
worth noting that also mitochondria membrane is rich in negatively charged lipids, the 
most abundant being cardiolipin [101], and some tumor cells displayed high levels of 
PS also on the mitochondrial membrane [105]. Therefore, even peptides that penetrate 
cell membranes without causing significant damage, once in the cytosol could interact 
with the mitochondria, causing apoptosis. Other studies [110,111] pointed out that even 
when the difference in PS content between cancer and healthy cells is not marked, still 
many AMPs are more toxic against cancer cells [112]. So, other sources responsible for 
the overall negative charge have been searched. Indeed, other negatively charged 
molecules are expressed on the surface of tumor cells. One group of them is represented 
 
Figure 1.11 Phosphatidilserine (PS) and cholesterol. 
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by mucins, a family of glycoproteins rich in sialic acid residues that are overexpressed 
in many carcinomas [113,114] and that are correlated with the ability of the tumor cells 
to migrate in other regions of the body. A study pointed out that sialic acid might be a 
target for some anticancer AMPs such as some peptides of the cathelicidin family [115]. 
In contrast, other studies showed that this preference is not a general behavior of AMPs, 
since some peptides of the lactoferrin family do not lose cytotoxic activity after the 
cleavage of sialic acid from the cell membrane [116]. Another source of negative surface 
charges are proteoglycans, a family of membrane proteins rich in residues with 
negatively charged side chains [117,118] that are also susceptible to altered expression 
on some type of cancer cells. The role of this family of molecules as targets of AMPs is 
even more debated than that of mucins, since peptides have been found that are 
inhibited by a high expression of proteoglycans, other are not influenced by their 
presence, and some others seem to increase their activity [119,120]. In conclusion, many 
negatively charged molecules can be expressed or over expressed on cancer cell 
membrane; PS is certainly the most studied and it is generally accepted that it plays an 
important role in selectivity of cationic amphipathic peptides for cancer cells.  
Another characteristic that often differentiates tumor and healthy cells is the membrane 
fluidity. Cancer cells often have altered fluidity: many tumor cells that affect lymph 
nodes, lungs and brain have an increased fluidity [121,122], while cells of other tumors, 
mainly solid tumors, have a decreased fluidity [123]. The rationalization of this feature, 
that could represent a useful characteristic to selectively target tumor cells, is 
complicated by the fact that even in the same cell, membrane fluidity is not uniform. 
Indeed, some studies [124] showed that the increased rigidity displayed by some tumors 
(mainly attacking breast and prostate) is due to the presence on the membrane surface 
of lipid-rafts that are rich in cholesterol. Additionally, cancer cells with increased rigidity 
may have the same total amount of cholesterol with respect to healthy cells; that implies 
that along with lipid rafts rich in cholesterol, other regions are, actually,  poor in 
cholesterol and therefore more fluid. These fluid regions, mainly composed by less 
packed phospholipids, may be more susceptible to the attack of AMPs. Therefore, a 
combined presence of rigid lipid rafts, regions rich in phospholipids, and a high 
percentage of negatively charged PS, may be the ideal membrane composition that 
makes a cancer cell the preferred target of cationic helical AMPs. However, this scenario 
is complicated by other studies that seem to point in the opposite direction [125,126]: 
the high resistance to treatment displayed by some ovarian cancer cells and some 
leukemic cells has been linked to their remarkable rigidity, due to the high quantity of 
cholesterol in their membranes. It is clear, then, that fluidity is an important parameter 
to take into account when interpreting the interaction between cell membranes and 
peptides. However, it is not possible to assume a priori if a higher cholesterol content 
would lead to a more peptide-vulnerable membrane: each case should be analyzed 
individually. 
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Surface charge and fluidity are the two most important characteristics that influence the 
behavior of AMPs towards cell membranes. In addition to them, another common 
difference between cancer and healthy cells is represented by the total surface area. 
Indeed, many cancer cells have an increased total surface area due to the presence of 
microvilli [127]. Microvilli are small membrane protrusions composed of filaments 
linked by proteins and containing principally cytoplasm; usually no intracellular 
organelles. Due to their particular morphology, they are able to greatly increase the 
membrane surface with no increase of volume, thus increasing the ability of the cell to 
absorb nutrients from the extracellular environment. It is believed that AMPs can be 
more effective against cells rich in microvilli since a larger amount of peptides can bind 
to cell surface [127]. Indeed, a study [128] showed that cecropin B is more active against 
tumor cells with increased surface area that against healthy fibroblasts. 
In summary, cancer cell membranes display various differences with respect to healthy 
cells that can be exploited to design selective drugs that do not undergo to the 
development of resistance. The ideal cancer cell to be treated with cationic helical AMPs 
should therefore be rich in lipid rafts alternated with fluid regions rich in phospholipids. 
Fluid regions should be rich in anionic phospholipid such as PS to electrostatically 
attract cationic AMPs. Finally, membranes rich in microvilli would have a greater surface 
area, where an increased number of peptides would be able to bind. 
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1.3 Electron Paramagnetic Resonance applied to the study of biological samples 
Electron Paramagnetic Resonance (EPR) spectroscopy is a powerful tool that can 
provide many information on biological systems, such as peptides and proteins: it can 
determine the secondary, tertiary and quaternary structure of proteins and detect 
changes is aggregation and interactions with membranes; it is possible to describe 
proteins and peptides dynamics and their relative orientation in different systems. In 
this Ph.D. project, EPR spectroscopy has been extensively exploited to collect a variety 
of information on the TG analogs of our interest. In the following paragraphs, an 
overview of EPR theory will be given, along with how this technique is used to study 
biological systems. The following paragraphs, from 1.3.1 to 1.3.4, are adapted from ref 
[4]. 
 
1.3.1 Elements of continuous wave EPR theory 
EPR spectroscopy is based on the interaction between an external magnetic field (B0) 
with a dipole (e) associated to the spin angular momentum of the electron. The dipole 
can orient itself parallel or antiparallel to the magnetic field B0, and an oscillating 
magnetic field (B1) with the proper energy can promote the transition of the electron 
from one orientation to another. The interaction of the dipole e with the external field 
B0 is called Zeeman interaction and its energy is given by: 
𝐸 = − 𝜇𝑒⃗⃗⃗⃗ 𝐵0⃗⃗⃗⃗  Equation 1 
where e is the magnetic moment associated to the electron spin angular momentum, 
𝑆 : 
𝜇𝑒 = −𝑔𝛽𝑒𝑆  Equation 2 
In equation 2,  is the electron Bohr magneton. The g factor is a proportionality factor  
that relates the observed magnetic moment μ of a particle to its angular momentum 
quantum number and for the free electron its value is ge = 2.0023. When the electron is 
located in a molecular system, the g value differs from ge in dependence of the elctron 
distribution in the molecule. 𝑆  is the spin angular momentum and for an electron, that 
has an electron spin quantum number of s=½, it can only assume the value |𝑆| =
√𝑠(𝑠 + 1)ℏ = 3 2⁄ ℏ. Its projection on the axis parallel to the external magnetic field B0, 
conventionally the z axis, can only assume two values, depending on the spin magnetic 
quantum number mS: since Sz=mSħ, then Sz can assume the values of +1/2 or -1/2 (in 
ħ units). Therefore two energy levels can be derived from Equation 1: E = ±(1/2)geB0. 
The energy difference, in ħ units, between these two levels is therefore dependent to 
the external field B0: 
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E = h = geB0 Equation 3 
The dependence of E on B0 is schematized in Figure 1.12. The simplest EPR 
experiment is the cw EPR experiment. It consists in irradiating the sample with an  
oscillating magnetic field with a frequency  that equals the energy gap (Equation 3); 
the strength of the magnetic field is swept to induce a transition of the unpaired electron 
between the two energy levels. The typical EPR signal, shown in Figure 1.12, is collected 
as the first derivative of the actual signal; this allows to improve the signal-to-noise ratio 
and to better observe scarcely resolved signals. In EPR spectroscopy at X band, the 
static field B0 is about 0.3 - 0.8 mT, while the oscillating magnetic field lies in the 
microwave range. The intensity of the EPR signal is proportional to the microwave 
absorption that is dependent on the population difference between the two energy 
levels. The population ratio is given in equation 4, and the population difference, in the 
case of E<<kT, is given in equation 5. 
(N+1/2)/(N-1/2) = exp (-E / kT) Equation 4 
(N-1/2 - N+1/2)/(N-1/2) = E/kT Equation 5 
To increase the difference of population, and therefore to improve the EPR signal, it is 
possible to increase the magnetic field B0 or to lower the temperature T. To restore the 
Boltzmann equilibrium of the populations after the energy absorption, relaxation 
pathways such as the spin-spin relaxation and the spin-lattice relaxation take place. If the 
relaxation pathways are not efficient, the system can reach the saturation (i.e., the two 
energy levels are equally populated and therefore no signal can be measured). Moreover, 
electrons can experience a perturbation of their local environment due to the influence 
of magnetic nuclei. This interaction is called hyperfine interaction and can result in a local 
 
Figure 1.12 Schematic representation of the Zeeman interaction. At the proper resonance 
frequency h, there is the EPR transition (one line represented as the first derivative of the 
signal). 
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enhancement or a local reduction of the external B0. The resonance conditions in 
equation 3 are modified to include the hyperfine interaction A: 
E = h = geB0+ mIA Equation 6 
For a nucleus with nuclear quantum number I (characteristic of a given nuclide), mI can 
assume 2I+1 values. It is then clear that the hyperfine interaction of an electron with a 
nucleus with nuclear spin I leads to the splitting of the electron transition into 2I+1 
transitions, as represented in Figure 1.13 for the case of an hyperfine interaction of an 
electron (S=1/2) with a nucleus with I=1. The hyperfine interaction between an 
electron and a nucleus has two components, an isotropic component and a dipolar one. 
The isotropic splitting, defined as a0, is proportional to the electron spin density on the 
nucleus, and is determined by the electronic wavefunction. The dipolar component is 
dependent on the spatial orientation, with respect to B0, of the vector between the two 
magnetic moments. Being anisotropic, the hyperfine interactions can be described with 
a tensor, A, that in its principal axes system assumes a diagonal form: 
𝑨 = |
𝐴𝑥𝑥 0 0
0 𝐴𝑦𝑦 0
0 0 𝐴𝑧𝑧
| 
Moreover, also the Zeeman interaction of the electron spin with the external field H is 
anisotropic, therefore the g factor, introduced in equation 2, is a tensor that can be 
represented, in its principal axes system, in diagonal form as well: 
𝒈 = |
𝑔𝑥𝑥 0 0
0 𝑔𝑦𝑦 0
0 0 𝑔𝑧𝑧
| 
 
 
Figure 1.13 Schematic representation of the Zeeman and hyperfine interaction of a spin 
(S=1/2) with a nucleus with I=1. The three EPR transitions are represented as the first 
derivative of the signal. 
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1.3.2 Nitroxides 
Rarely biological samples are measurable with EPR spectroscopy at physiological 
temperature, since they do not have paramagnetic centers in their structure. With the 
exception of metalloproteins, biological samples as proteins and peptides must be 
modified with paramagnetic probes. The most commonly used probes are nitroxides, 
that contain an unpaired electron on the p orbital of the N―O bond of a nitroxide 
derivative; they are usually sterically hindered 5- or 6-member rings, and example is 
given in Figure 1.14. Nitroxides have been extensively used to label proteins at a specific 
site (Site Directed Spin Labeling, SDSL). The probe MTSSL (1-oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl) methanethiosulfonate) is covalently linked to a Cys 
residue of the protein. It is also possible to mutate the protein to have Cys residues 
available for the labeling in the desired positions. The MTSSL probe is used to study 
protein partition between membrane and solution, orientation and dynamics of the 
protein in membrane environment and solvent accessibility in different domains of the 
protein. To study peptides, the amino acid TOAC (2,2,6,6-tetramethylpiperidine-1oxyl-
4-amino-4-carboxylic acid) has been often employed, that, differently from MTSSL, 
must be incorporated during the peptide synthesis and represents a direct modification 
on the primary sequence. TOAC is a C-tetrasubstituted, sterically hindered, amino-acid 
that promotes helical formation: thus, its presence could alter the secondary structure 
of the peptide, so its position must be chosen carefully. It is also possible to prepare -
peptides modified with a -amino-acid, like POAC ((3R-4R)-4-amino-1-oxyl-2,2,5,5-
tetramethylpirrolidine-3-carboxylic acid).  
All the nitroxides used as EPR probes, some of which are described above, are based 
on the same principle: the unpaired electron (S=1/2) interacts with the 14N nucleus 
(I=1). The hyperfine interaction between them generates a splitting of the electron 
signal into three transitions (2I+1=3, see equation 6 and Figure 1.13). The magnetically 
active site of these nitroxides is the N—O fragment, the structure of which is reported 
in Figure 1.15. The unpaired electron is localized in a 2p orbital on the N—O group. 
Typical principal values of the hyperfine tensor A for nitroxide spin labels are Axx ≈ Ayy 
≈ 0.7 mT and Azz ≈ 3.5 mT. Since the difference between the x and y component is 
  
Figure 1.14 Three common EPR probes: from left, MTSSL, TOAC, POAC. 
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usually very small, the tensor is assumed to have an axial symmetry. Instead, the g tensor 
has a rhombic symmetry, and typical values of the g tensor for a nitroxide spin label are 
gxx ≈ 2.0085, gyy ≈ 2.0065, gzz ≈ 2.0027. The fact that A and g tensors are anisotropic 
means that EPR spectroscopy is sensitive to changes in orientation of the nitroxide and 
to its rotational motion. 
 
1.3.3 Influence of the orientation on nitroxide cw-EPR spectra 
In absence of motion (on the EPR timescale), the nitroxide label has a defined 
orientation with respect to the magnetic field B0. Both g and A tensors depend on the 
orientation of the molecule, following equations 7 and 8, respectively. 
𝑔(𝜃, 𝜙) = 𝑔𝑥𝑥 sin
2 𝜃 cos2 𝜙 + 𝑔𝑦𝑦 sin
2 𝜃 sin2 𝜙 + 𝑔𝑧𝑧 cos
2 𝜃 Equation 7 
𝐴2(𝜃, 𝜙) = 𝐴𝑥𝑥
2 sin2 𝜃 cos2 𝜙 + 𝐴𝑦𝑦
2 sin2 𝜃 sin2 𝜙 + 𝐴𝑧𝑧
2 cos2 𝜃 Equation 8 
 where  and  determine the orientation, expressed as polar angles, of the principal 
axes of g and A tensors with respect to the B0 direction. This dependency is clear in the 
experimental spectra of Figure 1.16, where it is shown that the splitting of the three 
lines, determined by the hyperfine tensor, is ≈ 7 mT if the spin label z-axis is parallel to 
the magnetic field, while it is reduced to ≈ 1.4 mT if the z-axis is perpendicular to B0. 
The center position of the spectrum is determined by the g tensor; assuming a given g 
value for a spin with the z-axis aligned with B0, at X band the center of spectrum is 
shifted of 0.5 mT downfield if the spin is aligned with the y-axis and 0.9 mT downfield 
if the spin is aligned with the x-axis. If the sample is composed by many molecules, each 
one in a different orientation, the experimental spectrum will be the sum of each 
different contribution. The final intensity at each filed position is proportional to the 
number of spins at that specific orientation, and the resonance field for each orientation 
is given by equation 8. 
 
Figure 1.15 Representation of the principal axes of the N—O fragment. 
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𝐻𝑟𝑒𝑠(𝜃, 𝜙,𝑚𝐼) =
ℎ𝜈
𝛽𝑔(𝜃, 𝜙)
+ 𝑚𝐼𝐴(𝜃, 𝜙) Equation 8 
Figure 1.17 shows how the spectrum changes increasing number of orientations 
distributed as a Gaussian distribution around a given angle. When the spins are 
isotropically distributed, the spectrum assumes the typical powder pattern that is the 
result of the contribution of all the possible orientations. The experimental features 
such as spectral splitting, central g value and linewidth are characteristic of the 
orientational distribution.  
 
 1.3.4 Influence of the dynamics on nitroxide cw EPR spectra 
The sensitivity of the EPR signal to motion is due to the rotation of the molecules that 
modulate the anisotropic magnetic interactions. To understand the lineshape 
modifications due to the molecular motion, we can consider the simple exchange 
 
Figure 1.16 EPR spectra of a nitroxide single molecule that shows the orientational 
sensitivity. The splitting of the spectrum changes when the z-axis of the nitroxide rotates 
with respect to the magnetic field; the center of the spectrum changes when the nitroxide 
rotates about any axis. Figure taken from ref [4]. 
 
 
Figure 1.17 Broadening of the spectra with increasing disorder: a, ±1°; b, ±5°; c, isotropic 
distribution. Figure adapted from ref [4].  
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process between two spins with different resonance frequencies, at increasing exchange 
frequencies, represented in Figure 1.18. Initially, the two spins A and B resonate at 
characteristic frequencies A and B and exchange their positions at a frequency of 
1/ex. If their exchange rate is significantly lower than 0AB, the spectrum will be 
formed by two well defined signals centered at the two frequencies A and B, and the 
linewidths will be only determined by their spin-spin relaxation times, T2. For a very fast 
exchange (1/ex >> AB), the two peaks merge in one peak at a frequency that is the 
average of A and B. For an intermediate situation, the centers of the two EPR signals 
reduce their distance with respect to the slow exchange condition, and their linewidths 
increase, according to equations 10 and 11.  
Δ𝜔𝐴𝐵 = Δ𝜔𝐴𝐵
0 √1 − 8/𝜏𝑒𝑥
2 Δ𝜔𝐴𝐵
0  Equation 10 
1 𝑇2
𝑒𝑓𝑓⁄ = 1 𝑇2
𝐴⁄ + 1 𝑇2
𝐵⁄ + Δ𝜔𝐴𝐵
2 𝜏𝑒𝑥 8⁄  Equation 11 
The reorientation of a nitroxide in a magnetic field is a form of exchange, where the 
exchange time ex becomes the rotational correlation time tR: 1/tR is the exchange 
frequency at which the spin reorientates with respect to the magnetic field. The 
difference of the two resonance frequencies is determined by Zeeman and hyperfine 
interactions; when the molecule rotates in the magnetic field B0, there is an exchange 
between different orientations, and therefore between different resonance frequencies. 
As in the two sites exchange model, in the EPR spectra of a rotating nitroxide the 
lineshape progressively broadens, as shown in Figure 1.19. Nitroxide spin labels bound 
to peptides and small proteins have a motion on the nanosecond timescale that is ideal 
to be studied with cw EPR. For a very slow motion, the typical spectrum of a rigid 
nitroxide (or powder spectrum) is shown. It has to be noted that the broadening of the 
 
Figure 1.18 Effect on the resonance of two spins, with resonance frequencies A and B, 
of the exchange at frequency 1/ex. Figure taken from ref [4]. 
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three lines is not homogeneous, since it depends on the nuclear spin quantum number 
mI relative to the 
14N nucleus; it is therefore minimum for the central component 
(mI=0), intermediate for the low field component (mI=+1) and maximum for the high 
field component (mI=-1). It is not trivial to interpret EPR spectra in different motion 
regimes, however the variety of information that can be obtained encouraged the effort 
in the development of various computational models. Some details on the model used 
to simulate the EPR spectra of nitroxides interacting with lipid membranes in this Ph.D. 
work are reported in Appendix A. 
 
1.3.5 Measurements of solvent accessibility 
One of the more interesting information that can be obtained from EPR experiments 
in spin-labeled proteins or peptides is the degree of solvent accessibility of a given 
position labeled with the nitroxide. Solvent accessibility is a measure of the exposure of 
a given site to a polar (usually water) or apolar (usually the inside of a membrane) 
environment. Accessibility is proportional to the collision rate with diffusible 
paramagnetic reagents (relaxants) that are dissolved in solution of the polar or apolar 
solvent. For example, residues on a solvent-exposed surface or buried in the protein 
interior will experience high- or low-collision rates, respectively.  
The determination of solvent accessibility in SDSL relies on the Heisenberg exchange 
mechanism [129]: an enhancement of the nitroxide relaxation due to collisions with fast-
relaxing paramagnetic species in solution. For the Heisenberg exchange to be 
proportional to the solvent accessibility the process should be in the strong exchange 
limit and be diffusion-controlled, i.e. every collision must induce relaxation, a condition 
that is met with the relaxants that are commonly used such as oxygen, CROX or 
NiEDDA [130]. For a bimolecular encounter between a small nitroxide (N) in solution 
 
Figure 1.19 Sensitivity of the EPR spectra to different motions. Figure adapted from ref. 
[3] 
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and an exchange reagent i, the Heisenberg exchange frequency, Wex, experienced by a 
particular nitroxide is given by 
𝑊𝑒𝑥 = 𝑘𝑒𝑥𝐶𝑖 Equation 12 
where kex is the exchange rate constant and C i is the concentration of the exchange 
reagent i. Defining T1i as the longitudinal relaxation time of the reagent i and c the 
encounter complex lifetime, for exchange reagents with T1i < c, T1e Heisenberg 
exchange leads to equal changes in T1e and T2e of the nitroxide, and 
𝑊𝑒𝑥 = ∆(1/𝑇1𝑒) = ∆(1/𝑇2𝑒) = 𝑘𝑒𝑥𝐶𝑖 Equation 13 
Thus, methods based on measurement of either T2e or T1e may be employed for 
experimental determination of Wex. The most common EPR method for observing spin 
label solvent accessibility is power saturation: the intensity of the central line in the first 
derivative spectrum is observed as a function of the incident microwave power in the 
absence and in the presence of the relaxant. The saturation curves are then fitted with: 
𝐴 = 𝐴0√𝑃 [1 + (√2
𝜀
− 1)(𝑃/𝑃1/2)]
𝜀
⁄  Equation 14 
Where  is a homogeneity factor dependent on the lineshape that can range from 0.5 
for a Lorentzian lineshape to 1.5 for a Gaussian lineshape; A0 is simply a scaling factor; 
P1/2 is the power of the microwave field at which the signal is reduced to half with 
respect to the value it would have in absence of saturation. The change in P1/2 (Pi1/2) 
upon addition of the relaxant i is correlated with the solvent accessibility of the 
nitroxide. For a homogeneous Lorentzian, 
𝑃1/2 = (2
2/3 − 1) (𝛾2Λ2𝑇1𝑒𝑇2𝑒)⁄  Equation 15 
where BP is an instrumental parameter that depends on the Q factor of the used 
cavity and ghis the gyromagnetic ratio. For the common case where Wex << 
1/T2e, T2e may be taken as a constant, and 
Δ𝑃1/2
𝑖 = 𝑃1/2
𝑖 − 𝑃1/2
0 = (22/3 − 1) (𝛾2Λ2)(1/𝑇2𝑒)(1/𝑇1𝑒
𝑖 − 1/𝑇1𝑒
0 ) =⁄  
Equation 16 
= ((2
2
3 − 1)/( 𝛾2Λ2𝑇2𝑒))𝑊𝑒𝑥 
where P1/2 and P
0
1/2 are in the presence and absence of relaxant i, respectively, and T1e 
and T01e are the corresponding relaxation times. Although P1/2 is proportional to Wex, 
it depends on the motion of the nitroxide through T2e and on properties of the resonator 
through . Figure 1.20 shows an example of how the peak-to-peak amplitude of an 
experimental spectrum varies as a function of the microwave power. It can be observed 
that the curve profiles change for samples that have different T1 and in the presence of 
different relaxants. To avoid the dependence of Pi1/2 on experimental factors, the 
dimensionless quantity i is used [131,132]: 
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Π𝑖 =
Δ𝑃1/2
𝑖
Δ𝐻𝑝𝑝
Δ𝐻𝑝𝑝
𝑅𝐸𝐹
𝑃1/2
𝑅𝐸𝐹 = 𝛼𝑊𝑒𝑥 Equation 17 
Division of P1/2 by the nitroxide central linewidth, Hpp, normalizes for the nitroxide 
T2e, and division by the quantity [P1/2
REF/HppREF] normalizes for variations in resonator 
efficiency. In published literature to date, a dilute DPPH (2,2-diphenyl-1-picrylhydrazyl) 
powder in KCl was selected as the reference, and the reported  values depend on this 
choice.  
 
An application of solvent accessibility measurements: membrane immersion depth of a nitroxide 
Measurements of accessibility to a certain relaxant are extensively applied to scan the 
secondary conformation of selected domains of proteins and to determine the 
penetration depth of a nitroxide bound to a peptide in a membrane bilayer. These 
experiments are based on the different solubility of polar and non-polar relaxing agents 
in the aqueous and in the lipid phase of a phospholipid bilayer [17]. Indeed, if a spin 
labeled amino acid has a high frequency collision, i.e. has a high accessibility, with a 
water soluble relaxant, such as NiAA (nickel(II) acetylacetonate) or NiEDDA (nickel(II) 
ethylenediaminediaceate), then that amino acid is facing the aqueous environment. 
Conversely, if the nitroxide has a high accessibility to a nonpolar relaxant, the most used 
being O2, then it can be concluded that the amino acid is facing the hydrophobic lipid 
tails of the bilayer. Additionally, oxygen has a concentration gradient that increases 
towards the center of the bilayer, thereby solutes that are located more deeply in the 
membrane have a higher collision frequency than those located just below the polar 
headgroup region. In the case of a helical peptide, it is possible to obtain information 
  
Figure 1.20 Power saturation curves of 5DPC (1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-
3-phosphocholine) and 14DPC (1-palmitoyl-2-stearoyl-(14-doxyl)-sn-glycero-3-
phosphocholine) in presence of oxygen, NiEDDA and under nitrogen flux (absence of 
relaxants). The peak to peak amplitude of the spectra varies as a function of the microwave 
power and of the accessibility of the relaxants to the nitroxides. 
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Figure 1.21 Scanning of accessibility  of helices labeled in different positions. The 
accessibility profile varies depending on the orientation of the helix with respect to the 
membrane bilayer.  profile of the transmembrane helix is directly proportional to the 
solubility of the two different relaxants (NiEDDA and O2) in water and in hydrophobic 
environment. 
 
Figure 1.22 Schematic representation of a phospholipid bilayer of POPC doped with X-
DPC (1-palmitoyl-2-stearoyl-(X-doxyl)-sn-glycero-3-phosphocholine), labelled at different 
position (yellow circles). It is also represented the concentration at different depths of the 
bilayer of the two used relaxants: O2 (red dots) is more soluble in the lipid phase, NiEDDA 
(green dots) is more soluble in aqueous phase. 
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on its position relatively to a membrane bilayer by labeling the sequence in different 
positions and measuring the accessibility i for all the analogs. Figure 1.21 shows how 
 varies in presence of NiEDDA or in presence of O2 for peptides with different 
orientation in the membrane. To obtain a correlation between accessibilities of a label 
and its actual depth of insertion into the phospholipid bilayer, it is necessary to first 
build the so called “molecular ruler”, using vesicles doped with a phospholipid carrying 
a spin label at different positions of the lipid tails. In this way, the values obtained for 
the reference system (the labeled phospholipids) can be used as a comparison for solutes 
of unknown depth. A schematic representation of the ruler is reported in Figure 1.22. 
The results of the accessibilities to oxygen and NiEDDA are generally combined in the 
dimensionless depth parameter , given in equation 18.  
Φ = 𝑙𝑛
Δ𝑃1/2
𝑂2
Δ𝑃1/2
𝑁𝑖𝐸𝐷𝐷𝐴
 Equation 18 
P1/2 is defined in equation 16. values obtained for the reference system are then 
used as a comparison for solutes of unknown depth. The advantage of is that, being 
a ratio of two experiments, all the dependencies on the experimental setup are canceled 
out and it does not depend on the choice of reference as  does. 
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2. Aim of the work 
In this Ph.D. thesis, the antimicrobial lipopeptaibol trichogin GA IV (TG) and several 
of its analogs are studied. The main goal is to determine, with several techniques, key 
features of peptides structure that  influence peptide behavior towards cancer and 
healthy cell membranes in physiological conditions. 
A series of TG analogs have been designed to vary some key structural parameters of 
the peptide: helicity, hydrophobicity, hydrophobic moment, charge. All peptides were 
synthesized by Solid Phase Peptide Synthesis. Then, the toxicity of all the peptides has 
been tested against three healthy and cancer cell lines, the membranes of which have a 
significantly different composition. 
Peptides secondary structure has been extensively characterized: Circular Dichroism 
spectra have been performed in membrane mimicking environment and in model 
membranes. A hydrophobicity scale has been developed extended to quantify the 
hydrophobicity and hydrophobic moment of the peptides. Through this work, it was 
possible to shed light on the interaction between structure and activity of these TG 
analogs. 
Many experiments have been performed to observe the interaction between peptides 
and membranes. Fluorescence microscopy allowed to directly observe the localization 
of TG analogs on cell membranes. EPR experiments gave information on the binding 
propensity and on the dynamics of spin labeled TG analogs interacting with model 
membranes composed of synthetic phospholipids, with reconstituted cell membranes 
from healthy and cancer cell lines, and, finally, with viable cells. 
Important information on the orientation of spin labeled TG analogs in membranes 
came from the immersion depth measurements that have been performed in model 
membranes and in viable cells. 
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3. Results and discussion 
3.1 Design of TG analogs 
The native sequence of TG is shown in the helical wheel representation in Figure 3.1. 
TG is normally considered a hydrophobic peptide due to the presence of many 
hydrophobic amino-acids and also owing to the lipidic octanoyl chain at the N-terminus. 
It has a slightly amphipathic character since it presents a lipophilic face made of 
hydrophobic residues and a slightly hydrophilic face composed by Gly residues. The 
helix can be divided into three sectors: a slightly hydrophilic sector of ~140° entirely 
made of glycine residues (red), a highly hydrophobic sector of ~130° (blue), and a 
structural/hydrophobic sector (green) of ~90° made of the octanoyl fatty chain and 
three Aib residues that have a helix-promoting function. When designing TG analogs, 
we didn’t alter the hydrophobic sector for two reasons: a strong hydrophobic sector is 
a prerequisite for effective membrane perturbation [1]; the hydrophobic sector of TG 
is the only one that contains chiral amino acids, that are essential to induce TG to prefer 
a right handed helix over the left handed helix. Then, we focused our attention on the 
hydrophilic (red) and structural (green) sectors. In order to enhance the mild 
amphipathic character of TG, we introduced the positively charged Lys or Arg in place 
of Gly. These substitutions should not preclude helical formation, but aim at 
introducing charges on the hydrophilic side of the helix. The occurrence of these two 
amino acids in natural peptides and proteins is dependent on the particular biological 
function [133] and arginine-rich peptides are known for their cell-penetrating properties 
[134]. For example, in previous works [Lys5,6] TG showed a remarkably increased 
activity against S. aureus bacterial strain [2]. Here, TG analogs containing either Lys or 
Arg have been prepared to assess whether the type of charged residue influences the 
toxicity of the peptide towards the cells. The enhancement of the overall hydrophobicity 
was achieved by Aib-to-Leu substitutions. Leu is a known helix-supporting residue; 
although it is less effective than Aib, Leu in position 4 or 8 should not heavily perturb 
 
Figure 3.1 Helical wheel representation of TG. The octanoyl tail present at the N-
terminus is shown in the bottom right part. The grey lines divide the peptide in three 
sectors. 
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the helicity and stability of the helix. Perturbation of the hydrophobic/hydrophilic 
balance in TG has been achieved by inserting an Api residue, a positively charged C-
tetrasubstituted amino acid. This substitution was chosen since it has been previously 
reported that a slight perturbation of amphipathicity, via the introduction of a charged 
residue in the hydrophobic sector, leads to an improvement in the selectivity of peptides 
[135]. It has been placed in positions naturally occupied by Aib so to guarantee the 
maintenance of helicity in TG analogs. Several analogues carry the paramagnetic amino-
acid TOAC in position 1 were synthesized. Additionally, few analogs carrying TOAC in 
positions 4 or 8 have been synthesized to carry out the immersion depth measurements 
(see paragraph 3.5.2.4). With this modification we do not significantly impact the helical 
formation, although TOAC is quite big and sterically hindered. Indeed, it has already 
been published that TOAC is able to reinforce helical conformation and impart good 
 
Figure 3.2 The three non-standard residues used in the syntheses. From left, Aib, Api, 
TOAC. 
NH3
O
O
H3C CH3
NH3
O
O
N
H2
NH3
O
O
N
H3C
H3C
CH3
CH3
O
Table 3.1 Short name and primary sequence of the studied peptides. 
Peptide Primary sequence Peptide Primary sequence 
TG Oct-UGLUGGLUGI-Lol [Arg2] TG Oct-URLUGGLUGI-Lol 
[TOAC1] TG Oct-XGLUGGLUGI-Lol [TOAC1, Arg2] TG Oct-XRLUGGLUGI-Lol 
[TOAC4] TG Oct-UGLXGGLUGI-Lol [TOAC1, Arg9] TG Oct-XGLUGGLURI-Lol 
[TOAC8] TG Oct-UGLUGGLXGI-Lol [Api8] TG Oct-URLUGGLUGI-Lol 
[Lys6] TG Oct-UGLUGKLUGI-Lol [TOAC1, Api4] TG Oct-XGLZGGLUGI-Lol 
[TOAC1, Lys6] TG Oct-XGLUGKLUGI-Lol [Leu4] TG Oct-XRLUGGLUGI-Lol 
[TOAC4, Lys6] TG Oct-UGLXGKLUGI-Lol [TOAC1, Leu4] TG Oct-XGLUGGLURI-Lol 
[TOAC8, Lys6] TG Oct-UGLUGKLXGI-Lol [TOAC1, Leu8] TG Oct-XGLUGGLLGI-Lol 
[Lys5,6] TG Oct-UGLUKKLUGI-Lol TG-FITC 
Oct-UGLUGGLUGIL-
FITC 
[TOAC1, Lys5,6] 
TG 
Oct-UGLUKKLUGI-Lol [Lys6] TG-FITC 
Oct-UGLUGKLUGIL-
FITC 
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biological properties to peptides [88]. Moreover, two additional analogues with the C-
terminus modified with the fluorescent probe fluorescein isothiocyanate (FITC) were 
used for the fluorescence microscopy experiments. A summary of all the studied analogs 
is reported in Table 3.1. Finally, some peptides were synthesized in the first stages of 
this project, but measurements on them were subsequently discontinued: they were TG 
analogs with TOAC positions 1, 4 and 8 or Lys in position 6, all lacking the C-terminal 
amino-alcohol and carrying a methyl ester instead. The toxicity data obtained for these 
peptides were in agreement with recently published data [78] that underlined the 
importance of the terminal amino-alcohol for the bioactivity of TG analogs. Therefore, 
we decided to focus only on TG analogs that kept both the C- and N-termini intact.  
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3.2 Peptide synthesis 
All the TG analogs studied in this work were synthesized by Solid Phase Peptide 
Synthesis (SPPS). SPPS was developed in the middle 60s by Merrifield [136-139] and it 
brought a significant improvement with respect to the synthesis in solution, leading to 
the win of the Noble Prize in 1985 [140]. In the SPPS, the C-terminal amino-acid of the 
desired peptide is covalently linked to an insoluble resin, from which it is cleaved only 
when the synthesis is completed. The solid support allows to use reagents in large excess 
to drive the reactions to completion and to wash the resin effectively, obtaining the final 
peptide in a relatively pure form. The SPPS can also be conducted as an automated 
synthesis, further reducing the synthetic time and solvent consumption. The general 
process to synthesize peptides on a resin is schematized in Figure 3.3. It starts by loading 
the resin with the C-terminal amino-acid. The residue, as well as all the other residues 
that will be added in the subsequent passages, are protected at the alpha amino group 
with a protecting group, to avoid polymerization. Moreover, also the reactive side chains 
are kept protected with an orthogonal protecting group until the synthesis is complete. 
The next step is the removal of the protecting group at the N-terminal; then, the next 
amino-acid, protected at the N-alpha, is coupled to the N-terminal amino-acid on the 
resin. After the coupling, it is possible to remove the protection at the new N-terminal 
residue and repeat the deprotection-coupling cycle until the sequence is complete. All 
the protecting groups at the side chains are removed in one 
 
Figure 3.3 Schematic representation of the SPPS process. 
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Figure 3.4 2-chlorotrytil resin linked to Leucinol. 
 
Figure 3.5 Mechanism of the coupling reaction. After deprotonation by means of a base, 
the deprotonated, protected, residue is activated by reacting with HBTU that induces a 
favorable orientation of the growing peptide for the coupling with the desired residues 
thanks to a hydrogen bond with a nitrogen on the HBTU ring. The HATU ring has an 
additional nitrogen that enables one additional coupling geometry. 
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step before the peptide is cleaved from the resin. For the synthesis of the TG analogs, 
a protocol was developed and optimized [2,141] in the research group of Prof. C. 
Toniolo and Prof. F. Formaggio, University of Padova. The used resin is a styrene 
copolymer containing 1-2% of divynilbenzene, acting as a cross-linker. The C-terminal 
is separated from the resin by 2-chlorotrytil [142-144], that is optimal for the synthesis 
of TOAC-labeled peptides since it is removable in mild acidic conditions (see below). 
The Lol residue is already linked to the resin (Figure 3.4). The coupling procedure 
involves the activation of the N protected amino-acid via the uronium salt HBTU ([2- 
(1H-1,2,3-benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate]) for 
the standard residues, while for the less reactive C-tetrasubstituted residues (Aib, 
TOAC, Api) it is required a strong activant [145,146], i.e. HATU ([2-(1H-7-aza-1,2,3-
benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate]). Figure 3.5 
schematizes the reaction mechanism for both activation pathways [147-149], that 
enhance the electrophilic propensity of the carbonyl group; an activated ester is formed, 
that reacts quickly with the N-terminal of the peptide. Both HBTU and HATU lead to 
the formation of the ester that perform its catalytic effect promoting an optimal 
geometry between the peptide on the resin and the coupling amino-acid. As shown in 
the figure, HATU has a higher activating capability since it has two nitrogens that can 
form hydrogen bonds with the N-terminus of the peptide, favoring the attack of the 
new residue. After the coupling, the Fmoc (9-fluorenylmethyloxycarbonyl) group that 
protects the N-terminal part of the peptide is removed with a basic treatment with a 
secondary amine that attacks the acidic proton of the fluorenyl ring. The chosen base is 
piperidine, since it has the double purpose: it removes the Fmoc group from the peptide 
sequence via a -elimination and it scavenges the byproduct dibenzofulvene that would 
form a covalent bond with the N-terminal part of the peptide if not readily removed 
from the solution. The -elimination reaction is schematized in Figure 3.6. At the end 
of the coupling steps, the completed peptide is cleaved from the resin in mild acidic 
conditions using HFIP (1,1,1,3,3,3,-hexafluoropropan-2-ol), that are appropriate to  
preserve the radical function of the paramagnetic amino acid TOAC, present in most 
of the peptide sequences. The mechanism of reaction involved in the resin cleavage is 
shown in Figure 3.7. However, some amino-acids had reactive side-chains that were 
 
Figure 3.6 Mechanism of the elimination reaction. 
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protected during the coupling reactions. In particular, Lys and Api side-chains were 
protected with Boc (t-Butyloxycarbonyl) group and Arg was protected with Pbf 
(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulphonyl), see Figure 3.8. All these 
protecting groups are acid labile, so it was chosen to remove them as a single step with 
the cleavage of the peptide from the resin. This required stronger acidic conditions 
(TFA or HCl) that cause the partial TOAC disproportion to an oxoammonium cation 
and hydroxylamine [150] (see figure 3.9). The regeneration of the TOAC radical moiety 
was achieved with a basic treatment with ammonia and followed with reverse phase 
HPLC. All the peptides were, subsequently to the cleavage, purified by reverse phase 
liquid chromatography and characterized by ESI-MS and, for peptides without the 
TOAC residue, 1H-NMR. All the peptides were purified until a purity >98% was 
obtained. 
 
Figure 3.7 Mechanism of the reaction of cleavage of the peptide from the resin. 
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Figure 3.8 The two protecting groups Boc (left) e Pbf (right). 
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Figure 3.9 Disproportion reaction that can happen on TOAC in acidic environment.  
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3.3 Biological assays 
3.3.1 Cytotoxicity assay 
We studied the effect of TG and its analogues on normal (HDF) and transformed (T67 
and HeLa) cells. The cellular viability was assessed after 24 hours of exposure to the 
peptides by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay. The MTT assay is a standard colorimetric assay that measures the activity of the 
enzymes that transform MTT to formazan. The enzymes, that are only active in viable 
cells, exert their activity cleaving the tetrazolium ring of the MTT, that has a light yellow 
color, forming formazan, an insoluble salt with an intense violet color (see Figure 3.10 
and [151]). After the treatment, viable cells are quantified by measuring the absorbance 
of the formazan at =570 nm. To perform the assay, the desired cell line is cultured in 
plates or flasks with the proper culture medium in controlled atmosphere and at 
constant temperature (T=37°C, 5% CO2). The cells are seeded in a multiwell plate so 
to have ~ 30000-50000 cells per well. Then, different amounts of peptide are added to 
the different wells. A typical treatment scheme is represented in Figure 3.11.  After 24 
hours of treatment, the culture medium is removed and each well is treated with a 
solution of MTT. Only the viable cell are able to transform the MTT to formazan, 
thanks to the succinate dehydrogenase enzyme. After 1 hour of treatment, the solution 
with the unreacted MTT is removed and each well is filled with DMSO, which has the 
 
Figure 3.10 The reaction the leads to the formation of the violet formazan salt from the 
MTT molecule. 
 
Figure 3.11 An example of the usage of a multiwell plate for a MTT assay. 
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double function of solubilizing the formazan salts and killing all residual viable cells to 
avoid any further reaction. Finally, the absorbance at =570 nm is measured: it is 
directly proportional to the quantity of formazan, i.e. directly related to the viable cells 
present in the well. Then, the results are weighted to consider the absorbance of DMSO 
and normalized so the absorbance of the control wells is set to 100%. From the 
percentages of absorbance it is possible to draw toxicity curves, from which the EC 50 is 
calculated; an example of the curves is reported in Figure 3.12. The EC50 is 
representative of the toxicity of the peptide: it is the concentration at which the 
measured absorbance is 50% of the absorbance measured in the control wells. In Table 
3.2 the EC50 of all the studied TG analogs is reported.  The sequence of the main 
isoform of trichogin GA IV showed moderate toxicity with EC50 values of 2, 8 and 4 
µM for T67, HeLa and HDF cells, respectively. Surprisingly, the enhancement of the 
amphipathic character of the peptide with the introduction of charged residues in the 
hydrophilic face does not improve the toxicity significantly. The introduction of a single 
Lys at position 6 slightly improved the toxicity, while the introduction of two Lys at 
positions 5 and 6, or of a single Arg in positions 2 or 9, slightly lowered it. The 
substitutions in the structural/hydrophobic face of the peptide, introducing a Leu in 
place of an Aib in position 4 or 8, had a more dramatic effect, completely abolishing the 
cytotoxic activity of the peptides up to 20 µM. From the point of view of selectivity, the 
best results were obtained with the introduction of the charged amino acid Api at 
position 4 or 8. Api conferred to the TG sequence a selective toxicity against T67 cells, 
in fact no cytotoxic effects were observed on the other two lines.  
Concerning the influence of TOAC on TG analogs toxicity, we observe that the 
radicalic amino acid TOAC in position 1 is an optimal probe since its insertion has 
almost no influence on the toxicity of the TG analogs. TOAC in position 8 also did not 
alter the toxicity of the corresponding analog without the sin label. [TOAC4] TG 
represents the only exception since it is completely non-toxic. As can be easily observed, 
 
Figure 3.12 Two MTT toxicity curves of two peptides against three cell lines. [TOAC4, 
Lys6] TG is highly toxic against all cell lines, while [TOAC1, Leu4] TG is always non-toxic. 
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position 4 is a key position to influence the behavior of TG and its analogs; this aspect 
will be discussed more extensively later. We chose to use mainly the analogues bearing 
the TOAC residue at position 1 for both CD and EPR experiments, since the insertion 
of the spin labelled amino acid TOAC at position 1 did not significantly influence the 
cytotoxicity in any of the analogs with respect to the same analogs without the spin 
label, as previously observed for the bioactivity of other peptides [88]. In light of the 
MTT assay results, we decided to focus our attention, for the spectroscopic studies, on 
four peptides that are representative of the different behaviors displayed by the peptides 
towards the cells. [TOAC1] TG as the reference peptide. [TOAC1, Leu4] TG that shows 
no toxicity. [TOAC1, Lys6] TG that is the most toxic peptide on all the cell lines. 
[TOAC1, Api4] TG that has a selective toxicity. Finally, the analogues labelled with FITC 
could not be reliably tested on cell viability since the label interferes with the MTT assay. 
 
3.3.2 Quantification of cell membrane constituents 
As described in paragraph 1.2.1, membrane composition is an important aspect to take 
into account to understand the binding propensity and behavior of peptides. We 
focused on two components that are most extensively considered to influence peptide-
membrane relationship, phosphatidylserine (PS) and cholesterol. Indeed, the amount of 
PS and cholesterol in the plasma membrane has been suggested to partake in the 
selectivity of AMPs towards tumor cells [116]. The negative charge of PS exposed on 
the outer leaflet favors the binding of positively charged peptides to the membrane, 
Table 3.2 Toxicity of all the studied peptides, expressed as EC50 (M). Peptides that were 
non-toxic at up to 20 M are reported as n.t. (non-toxic). The EC50 values have an average 
error of about ±2 M. 
Peptide 
EC50 (M) 
Peptide 
EC50 (M) 
T67 HeLa HDF T67 HeLa HDF 
TG 2 8 4 [TOAC1, Arg9] TG 8 5 8 
[TOAC1] TG 1 3 5 [Lys5,6] TG 7 10 15 
[TOAC8] TG 4 4 7 [TOAC1, Lys5,6] TG 10 6 15 
[Lys6] TG 4 2 2 [TOAC1, Api4] TG 8 n.t. n.t. 
[TOAC1, Lys6] TG 1 3 5 [Api8] TG 13 n.t. n.t. 
[TOAC4, Lys6] TG 2 3 6 [TOAC4] TG n.t. n.t. n.t. 
[TOAC8, Lys6] TG 2 3 5 [Leu4] TG n.t. n.t. n.t. 
[Arg2] TG 8 4 8 [TOAC1, Leu4] TG n.t. n.t. n.t. 
[TOAC1, Arg2] TG 8 9 15 [TOAC1, Leu8] TG n.t. n.t. n.t. 
 
48 
 
while cholesterol, altering the membrane fluidity, can interfere with the peptide binding. 
In particular, regions rich in cholesterol, such as lipid rafts, are more rigid, with the lipids 
being in a liquid-ordered phase rather than in the liquid crystalline (fluid) phase [152-
154]. We tested the different cell lines for the exposition of phosphatidylserine (PS) on 
the membrane surface and for their total amount of cholesterol. It has to be noted that 
the ratio between intracellular and membrane cholesterol levels do not vary significantly 
between cell lines [155], therefore the total amount of cholesterol reflects directly its 
abundance on the membrane surface. The details of both assays are reported in the 
Experimental details section. 
As shown in Figure 3.13, the three cell lines are characterized by significantly different 
compositions of the outer surface of the plasma membrane. T67 cells have high negative 
surface charge (high PS expression on the outer membrane leaflet) and low cholesterol 
levels, a composition that is typical of tumor cells. HeLa, although transformed cell line, 
have high cholesterol levels and low negative charge. HDF has an in-between profile. 
A fourth cell line, 769P (a kidney tumor), was acquired and MTT assays started also on 
this cell line. It displayed in-between values for PS expression and cholesterol quantity; 
moreover, the MTT assays of some peptides on 769P showed no difference in toxicity 
with respect to the other three cell lines. Therefore, we decided to focus the 
experimental efforts only on the three cell lines that are reported in Figure 3.13.   
  
 
Figure 3.13 Left, Annexin V assay to quantify the amount of PS exposed on the outer cell 
membrane. Right, cholesterol content assay, quantifying the total cellular cholesterol. The error 
bars are relative to the standard deviation of three repeated experiments. 
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3.4 Structural characterization 
3.4.1 Circular Dichroism 
The secondary structure of all the peptides have been studied by far-UV CD in methanol 
and in SDS micellar environment. CD is based on the interaction of a chiral sample with 
a linearly polarized light. A linearly polarized light can be expressed as the vector sum 
of a right-handed and a left-handed component of a circularly polarized light; these two 
components (ER and EL) have the same amplitude and are in-phase. Being itself chiral, 
the circularly polarized light interacts with optically active chiral molecules. The two 
components ER and EL are absorbed differently, ER and EL after interacting with a chiral 
sample have different amplitudes, and the light becomes elliptically polarized. The 
measure of this difference in absorbance (A) is expressed as degree of ellipticity, that 
is related to the difference of absorbance with the relation  = 33·A.  has positive 
values if ER > EL, while it has negative values for ER < EL. The molar ellipticity [] is 
the ellipticity normalized for the sample concentration (c, in mol/L) and the cell optical 
path (l, in cm): [] = /(c·l). The variation of [] varying the incident wavelength , 
caused by the variation of A, gives the CD spectrum. CD is often used to investigate 
the secondary structure of proteins and peptides. Indeed, the far-UV spectrum of a 
polypeptide chain has a typical fingerprint lineshape that allows to distinguish helices,  
sheets and random coils [156]. The random coil conformation has a negative maximum 
at ≈ 200 nm and a weak maximum at ≈ 220 nm.  structures present an intense 
 
Table 3.3 R value of peptides in MeOH and SDS environment. The symbol – indicates 
that measurements are still in progress due to experimental issues. Peptides concentration 
10-4 M. SDS concentration 0.1 M. (a) data taken from [2]. (--) experimental data not available 
/ still in progress. 
Peptide 
R= [θ]222/[θ]208
Peptide 
R= [θ]222/[θ]208 
MeOH SDS MeOH SDS 
TG 0.2 0.5 [TOAC1, Arg9] TG 0.4 0.6 
[TOAC1] TG 0.3 0.6 [Lys5,6] TG 0.5 0.5 
[TOAC8] TG 0.5 0.7 [TOAC1, Lys5,6] TG 0.6 0.8 
[Lys6] TG 0.5a 0.5a [TOAC1, Api4] TG 0.5 0.6 
[TOAC1, Lys6] TG -- -- [Api8] TG 0.4 0.4 
[TOAC4, Lys6] TG 0.5 0.7 [TOAC4] TG -- -- 
[TOAC8, Lys6] TG -- -- [Leu4] TG 0.3 0.6 
[Arg2] TG 0.4 0.6 [TOAC1, Leu4] TG 0.4 0.7 
[TOAC1, Arg2] TG 0.3 -- [TOAC1, Leu8] TG 0.2 0.7 
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maximum at ≈ 195 nm and a negative maximum of medium intensity at ≈ 218 nm. -
helices have an extremely intense maximum at ≈ 192 nm and two negative maxima at 
≈ 208 and 222 nm of about the same intensity. For all the analogues, in the CD spectra 
we can observe two negative Cotton effects at 204-206 nm and 220-224 nm and a 
positive Cotton effect at about 195 nm, features typical of right-handed helix 
conformations. The first two negative maxima are related to the parallel component of 
the π→π* transition and to the n→π* transition of the peptide chromophore, while the 
positive maximum is related to the perpendicular component of the π→ π* transition  
[157]. An estimation of the helical type (whether 310 or α) can be achieved by the 
measurement of the ratio of the two negative maxima [157-159] of the ellipticity, R= 
[θ]222/[θ]208. In the spectra registered in methanol this parameter ranges from 0.2 to 0.6, 
indicating that the peptides adopt mostly a well-established 310-helix. In SDS solution, 
the experimental R value increases for almost all of the peptides, ranging from 0.4 to 
0.8. These values are consistent with the presence of a prevalent α-helical conformation. 
Moreover, a large change in R upon changing the solvent indicates that the structure of 
the peptide is able to flip from 310 to  helix. The values of R calculated for all peptides 
in the two environments are reported in Table 3.3. 
In addition the CD spectra of four analogs (see paragraph 3.3.1) were recorded in a 
model membrane composed by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) at a peptide/lipid ratio of 1/20 (Figure 3.14). The shape of the CD spectra are 
all consistent with the presence of a well-developed, right-handed, mixed 310/α-helical 
conformation in membrane (R≈0.6). Therefore, it can be safely concluded that the 
helical conformation is conserved in phospholipid bilayers. This result will be exploited 
to interpret some of the findings of the EPR spectroscopy (see paragraph 3.5.2) and to 
perform the calculation of the amphipathic moment of the TG analogs, as will be 
discussed in the next section.  
  
 
Figure 3.14. Far-UV CD spectra of [TOAC1] TG, [TOAC1, Api4] TG, [TOAC1, Lys6] TG 
and [TOAC1, Leu4] TG in 2∙10-4 M POPC SUV. Peptide concentration, 10-4 M. 
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3.4.2 Hydrophobicity ‹H› and hydrophobic moment  
Useful structural parameters to understand the peptide-membrane interaction are the 
mean hydrophobicity (‹H›) and hydrophobic moment (). They are widely used to 
characterize peptide sequences [1,10]. ‹H› depends only on the primary sequence and is 
higher for more hydrophobic peptides, while  depends on the peptide secondary 
structure and is directly proportional to the amphipathicity.  
From the individual H values, the mean hydrophobicity per residue is calculated as the 
mediated hydrophobicity of all the amino acids of a peptide sequence: 
⟨𝐻⟩ =  (∑𝐻𝑖
𝑁
𝑖=1
) 𝑁⁄  Equation 19 
where Hi is the hydrophobicity of the amino acid and N the number of the residues of 
the peptide. Since amphipathicity and helical secondary structure are considered of 
primary importance to predict the behavior of AMPs, the hydrophobic moment  was 
introduced to rationalize and quantify the amphipathicity of peptides. Assuming a 
helical secondary structure,  is defined by following the relationship [59]: 
𝛍 = {[∑𝐻𝑖𝑠𝑖𝑛(𝛿𝑖)
𝑁
𝑖=1
]
2
+ [∑𝐻𝑖𝑐𝑜𝑠(𝛿𝑖)
𝑁
𝑖=1
]
2
}
1/2
𝑁⁄  Equation 20 
where Hi is the hydrophobicity of the amino acid n and i is the angle at which successive 
side chains emerge from the backbone when the helix is viewed down its axis. A 
geometric representation of  is given in Figure 3.15, where each H value is represented 
as a red vector pointing in the direction of the corresponding side chain, and the vector 
sum of all H vectors, represented as a blue arrow, is the final  value.  
 
Figure 3.15 Schematic representation of the helical wheel of trichogin (A) and magainin 2 
(B). For each residue is reported the vector associated to its hydrophobicity. Their vector 
sum is the hydrophobic moment, represented as a blue arrow. 
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Hydrophobic interactions play an important role in the affinity of peptides for the 
phospholipid bilayer of biological membranes, so it is reasonable to seek correlations 
between the mean hydrophobicity of a peptide and its activity towards membranes and 
cells. However, the estimation of the propensity of peptides and protein to move to a 
hydrophobic phase is not trivial, and since the middle 1980s nearly two hundred t 
heoretical or experimental hydrophobicity scales of coded amino-acids have been 
developed, each one considering different peculiar characteristics. In 1984, D. 
Eisenberg reviewed the existing hydrophobicity scales [160], pointing out the difficulty 
to make a rational comparison between them. He then proposed a new scale, called 
Normalized Consensus Scale (NCS), that was designed to mitigate the effect of the 
outlier values of four different existing scales: (1) von Heijne scale [161], that performed 
a theoretical calculation on the octanol-water partition coefficient; (2) Janin scale [162], 
that measured the insertion depth of the residues in globular proteins; (3) Chothia scale 
[163], that, similarly to Janin scale, observed the distribution of amino-acids side chains 
between the surface and the interior of a protein; (4) Wolfenden scale [164], that is an 
experimental measure of the G of transfer of an amino-acid from water to a 
hydrophobic phase. The NCS became one of the most exploited to calculate the mean 
hydrophobicity of peptides.  Lately, an extensive work by Tossi & Sandri [10,165,166] 
developed the new Combined Consensus hydrophobicity Scale (CCS) based on a set of 
195 scales present in the literature, determined with theoretical, statistical and 
experimental methods. CCS defines the hydrophobicity of the amino acids in a scale 
from -10 (Arg, considered the most hydrophilic among standard amino-acids) to +10  
(Phe, considered the most hydrophobic amino-acid) and it has been widely used 
[167,168] to calculate the hydrophobicity of antimicrobial peptides because it firstly 
included non proteinogenic amino acids, as the frequently occurring Aib. However, the 
CCS scale does not include the amino acids Api and TOAC, present in our analogs. 
Additionally, TG and its derivatives are characterized by peculiar N- and C-terminal 
groups (1-Oct and Lol, respectively) that are fundamental for the cytotoxic effect and 
are also not included in the list. Therefore, in order to exploit this tool for the TG 
analogs synthesized during this project, it was necessary to calculate the hydrophobicity 
values for the missing residues. Exploiting the good correlation [166] of the CCS scale 
 
Figure 3.16 The hydrophobicity scale used in this work (see text). Values highlighted in 
yellow have been calculated in this work for the first time. 
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with the octanol/water partition coefficient (logP) for N-acetylated and C-amidated 
residues, we calculated logP as the average of the slightly different values obtained from 
different software (Kowwin v. 1.68 and ChemDraw v. 9.0) and extrapolated H values 
on the CCS scale (for the details, see Experimental details section). The obtained values, 
along with the H values of the residues already present in the original work, are reported 
in Figure 3.16. Given the extremely high hydrophobicity of the alkylic chains, the 
residues that include the octanoyl chain at the N-terminus have H values that widely 
exceed the value +10 of Phe. The obtained ‹H› values for the peptides are reported in 
Table 3.4 together with the values of their hydrophobic moment. The validity of the 
calculated ‹H› values has been confirmed by comparison with the retention times in 
reverse phase HPLC of a selection of peptides (see Figure 3.17). It should be stressed 
 
Figure 3.17. Calculated H of some TG analogs plotted against their retention times on 
reverse phase HPLC. Eluant system: solvent A, H2O/CH3CN 9:1 + 0.05% TFA; solvent 
B, CH3CN/H2O 9:1 + 0.05% TFA; gradient 60-100% B in 30 mins; Phenomenex C18  
Jupiter 300A column. 
 
Table 3.4 H and  values for all the studied TG analogs. 
Peptide ‹H›  Peptide ‹H›  
TG 5.23 3.09 [TOAC1, Arg9] TG 4.49 3.75 
[TOAC1] TG 5.18 3.08 [Lys5,6] TG 3.87 3.96 
[TOAC8] TG 5.21 3.08 [TOAC1, Lys5,6] TG 3.81 3.95 
[Lys6] TG 4.55 3.63 [TOAC1, Api4] TG 4.45 2.43 
[TOAC1, Lys6] TG 4.49 3.61 [Api8] TG 4.50 2.82 
[TOAC4, Lys6] TG 4.53 3.60 [TOAC4] TG 5.21 3.07 
[TOAC8, Lys6] TG 4.53 3.61 [Leu4] TG 6.01 3.83 
[Arg2] TG 4.54 3.78 [TOAC1, Leu4] TG 5.96 3.82 
[TOAC1, Arg2] TG 4.49 3.77 [TOAC1, Leu8] TG 5.96 3.51 
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that the retention times of the peptides in closely linked to the elution conditions that 
have been properly chosen in order to elute peptides with very different hydrophobicity 
with the same column in the same conditions. Therefore, a linear correlation between 
‹H› and retention times should not be expected: it is sufficient that peptides with 
increasing hydrophobicity display higher retention times. In the calculation of , given 
the results of CD spectra in SUV (Figure 3.14), we used an angle of 100°, typical of an 
-helical structure, for all the peptides. Indeed, it was previously reported [16] that the 
310 portion of the TG helix is confined to the 1-3 resides at the N terminus. Using an 
angle n of 120° (typical of the 310 helix) for those amino acids leads to no significant 
difference in the final value of . The values of  are reported in Table 3.4. TG analogs 
with hydrophobic substituents (Leu in position 4 or 8) are more hydrophobic than TG, 
while all the other analogs, carrying one or two positive charges, have a minor H value. 
All the analogs with an enhanced amphipathicity have a higher  value than TG. The 
only analogs with a minor hydrophobic moment are Api-bearing analogs, since they 
have a charged residue in the hydrophobic face.  
 
3.4.3 Structure-activity relationship 
The overall results of the MTT assay (Table 3.2) made clear that a subtle equilibrium 
exists between the physico-chemical and structural parameters of the analogues and 
their cytotoxicity. To investigate and rationalize, we plotted ‹H› against  in the so-
called Eisenberg plot (Figure 3.18) for all the analogues. This plot has been created  in 
the middle 1980s to categorize proteins depending on their surface-seeking propensity 
[160]: indeed, it was observed that proteins or peptides from fragments of proteins have 
different combinations of ‹H› and  values depending on their propensity to seek the 
aqueous phase, to assume a globular structure, or to locate transmembrane. Since then, 
parameters as ‹H›, , amphipathic angle, net charge, secondary conformation have been 
studied in detail in search of a correlation between at least some of them and peptide 
activity [1]. One graphical tool that was often employed to seek these correlations is the 
Eisenberg plot. Unfortunately, cytotoxic peptides can be hardly distinguished from 
inactive ones only on the basis of their plot localization [1,169] due to the complex 
interplay between the many structural and chemical parameters that govern their 
behavior. This may be due to the fact that the Eisenberg plot has been generally used 
to seek correlations between a large variety of peptides with very different structures, 
lengths etc.; therefore, small, but significant, variations may be hard to detect. On the 
contrary, our TG analogs are similar to each other, and the small variations in ‹H› and 
 become readily visible. Indeed, for our TG analogues, the plot clearly shows that there 
is a good linear correlation (R=0.94) between ‹H› and  for all the cytotoxic peptides, 
while the other peptides fall in other regions of the plot. An exception is represented by 
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[TOAC4] TG, since it is non-toxic but has the same ‹H› and  values as [TOAC1] TG 
and [TOAC8] TG. It is interesting to note that the peptides carrying the Aib-to-Api 
substitutions (the selective peptides) are out from the linear correlation of the plot and 
fall in a region that is diametrically opposed to that occupied by the inactive Aib-to-Leu 
substituted analogues. This observation suggests that only particular pairs of ‹H› and  
values result in fully active peptides. In particular, the substitutions that overly enhance 
the total hydrophobicity result in activity loss, while substitutions that only decrease the 
hydrophobic moment, perturbing the hydrophilic-hydrophobic balance, induce a 
selective toxicity towards a specific cell line. It is important to note that both selective 
peptides have positive charge in the hydrophobic side of the helix; they are only toxic 
towards T67 cancer cells, i.e. the cell line that showed the highest quantity of the 
negatively charged PS in the surface. Moreover, non-toxic peptides carry hydrophobic 
substitutions in the same positions of the sequence. Then, it may be deduced that 
charges act as leading force for the activity of these peptides; additionally, the structural 
sector appears to be remarkably important, as small variations on it result in great 
modification in peptides activity. These aspect will be studied in more details in the next 
sections.  
Thereby, we observed that modifications, especially those occurring on the structural 
sector, might have a strong impact on both toxicity and selectivity of the different 
peptides. Moreover, the Eisenberg plot revealed to be a useful tool that highlighted a 
correlation between structural parameters and TG analogs activity. Thus, even though 
it cannot provide alone a quantitative explanation for peptides cytotoxicity, it can be 
exploited for the design of the modification of new analogs.  
  
Figure 3.18. Eisenberg plot for the TG analogues studied in this work. Cytotoxic peptides 
are represented in red circles; non-toxic peptides in green diamonds and selective peptides 
in yellow triangles. The dashed line indicates the linear correlation between  and ‹H› of 
the toxic TG analogues. 
56 
 
3.5 Characterization of the peptide-membrane interaction 
3.5.1 Fluorescence microscopy 
Two TG analogs were modified at position 11 with the fluorescent probe FITC (TG-
FITC and [Lys6] TG-FITC). These peptide are used to observe the localization in HeLa 
cells. The cells were treated for 3 hours with the peptides at a final concentration of 0.5 
M; the green signal of the FITC, at = 545 nm, was observed with a fluorescence 
microscope, further details are described in the Experimental details section. The 
micrographs reported in Figure 3.19 show that the fluorescence is mainly located in the 
outer plasma membrane, accordingly to the hydrophobic nature of the TG analogs. 
Cells treated with TG-FITC appear mostly intact, as could be expected since the TG 
analog lacks of the C-terminal amino alcohol, that is required for the cytotoxicity [78]. 
On the other hand, [Lys6] TG-FITC induces a visible membrane lysis; we speculate that, 
since TG analogs with lysine in position 6 are the most toxic, this modification is able 
to counterbalance the lack of the C-terminal alcohol. Cells treated with TG-FITC and 
[Lys6] TG-FITC were also stained with rhodamine that is known to localize in 
 
Figure 3.19 Fluorescence microscopy of HeLa cells treated with 0.5 µM of TG-FITC 
conjugate analogs for 3 hours. Panels A and D refer to the bright field images in the 
presence of [FITC11] TG and [Lys6, FITC11] TG respectively. Panels B and E refer to the 
green fluorescence images in the presence of [FITC11] TG and [Lys6, FITC11] TG 
respectively. Panels C and F refer to the merging of bright and fluorescence fields. 
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mitochondria. The micrographs, shown in Figure 3.20, confirm that in the case of 
treatment with TG-FITC, that does not damage the cell membrane, there is no 
colocalization of the two fluorescent probes: FITC is located only on the outer cell 
membrane, while rhodamine in located only in mitochondria. Conversely, since HeLa 
cells membranes are severely damaged by [Lys6] TG-FITC, the intracellular material 
leaks outside the cells and the two probes are dispersed in the same areas. 
 
3.5.2 Electron Paramagnetic Resonance 
3.5.2.1 TG analogs in model membrane systems 
We recorded cw EPR spectra of all the spin labeled analogs in POPC (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine) model membranes in HEPES buffer at pH=7.0, 
at a P/L of 1/100. The SUV diameter has been checked for different samples by 
dynamic light scattering measurements and has always found to be 40-60 nm. These 
conditions were chosen to resemble the conditions used to perform the CD 
 
Figure 3.20 Fluorescence microscopy of HeLa cells treated with 0.5 µM of TG-FITC 
conjugate analogs for 3 hours and, subsequently, with rhodamine. Panels A and D refer to 
the bright field images in the presence of [FITC11] TG and [Lys6, FITC11] TG respectively. 
Panels B and E refer to the red fluorescence images in the presence of [FITC11] TG and 
[Lys6, FITC11] TG respectively. Panels C and F refer to the merging of red and green 
fluorescence fields. 
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experiments. The  EPR spectra of all the labeled peptides recorded at these conditions 
are reported in Figure 3.21. All spectra exhibit a broad lineshape, indicative of the slow 
motion (on the EPR timescale) of the nitroxide bound to a peptide that is located almost 
100% in the membrane. For comparison, the top part of Figure 3.21 reports the 
spectrum of [TOAC1] TG in buffer: it shows three sharp lines typical of a fast-moving 
peptide in aqueous solution. The EPR spectra of [TOAC1, Api4] TG and [TOAC1, Arg9] 
TG show additional contributions indicative of the presence of fast moving peptides 
(less than 1% of the total spins). It has previously been explained that the mobility of 
the nitroxide strongly influences the spectral lineshape: since all spectra have almost the 
same lineshape, there are no variation in the dynamics of the different analogs when 
bound to the membrane. Then, only the spectrum of [TOAC1] TG was simulated to 
determine the peptide dynamics that is quantitatively expressed by the isotropic 
rotational correlation time,  value of ≈ 9 ns was obtained. The details of the 
simulations are reported in the Experimental details section.  
 
Figure 3.21 EPR spectra of the TOAC-labeled TG analogs interacting with POPC SUV. 
In dashed line the simulation of the spectrum of [TOAC1] TG. P/L ratio 1/100, HEPES 
buffer pH=7.0. All spectra have been normalized to unit intensity for convenience. The 
asterisks indicate the spectral contributions of the small fraction of peptides in solution. 
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We then performed further measurements with some spin labeled TG analogs with 
significantly different activity ([TOAC1]TG is the reference peptide, [TOAC1, Leu4]TG 
is non-toxic, and [TOAC1, Api4]TG is the only labeled peptide with selective toxicity). 
Their binding and mobility were tested on model membranes of different compositions 
and in different solvent conditions to verify if these parameters can influence the 
binding propensity of different peptides. We used SUV of POPC as a model membrane 
for zwitterionic eukaryotic cells, and POPC/POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-L-serine) in 7/3 molar ratio as a model for the negatively charged bacterial 
and cancer cells such as the T67 cell line. The SUV diameter has been checked also for 
POPC/POPS vesicles and has been found equal to that of POPC vesicles. The three 
peptides were added to SUV in a peptide/lipide (P/L) ratio of 1/100 and 1/250; the 
complete set of measurements was performed in both HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffer with zero salts at pH=7.0 and in PBS (phosphate 
buffered saline) buffer at pH=7.4. The EPR spectra, recorded at a constant temperature 
of 308 K in HEPES buffer, are shown in Figure 3.22. All peptides bind with high affinity 
(>99%) to both types of membranes and in each buffer, and the slight differences 
shown by some spectra are negligible.  
 
 
Figure 3.22 EPR spectra of the three tested peptides in POPC vesicles (left) and 
POCP/POPS 7/3 vesicles (right) at two different peptide/lipid ratio (black lines, 1/250; 
grey lines, 1/100). Buffer HEPES, pH = 7.0, T = 308 K. 
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3.5.2.2 TG analogs in reconstituted cell membranes 
We performed EPR measurements in conditions similar to the physiological 
environment has been the preparation of reconstituted cell membranes. These systems 
are prepared by centrifuging the cells at proper experimental conditions to isolate a 
fraction containing mainly the plasma membrane and some intracellular material, such 
as nuclei; the fraction is mechanically stressed and resuspended in the desired buffer. 
The details of the preparation of these samples are reported in the Experimental Details 
section. The EPR experiments were performed on reconstituted membranes, the 
diameter of which was checked with dynamic light scattering, obtaining a mean diameter 
of ≈ 400 nm with a broad distribution for reconstituted membranes derived from T67 
and HeLa cell lines. Some samples were also sonicated, obtaining a smaller, more 
homogeneous diameter of ≈ 100 nm. We did not observe any difference in the EPR 
spectra depending on the diameter of the reconstituted membranes, therefore we 
focused our experiments on the samples without sonication.   
First, four peptides were chosen to observe their interaction in reconstituted T67 
membranes at the two P/L ratio that were used also in the SUV experiments. The four 
chosen peptides were [TOAC1] TG as the reference peptide, [TOAC1, Leu4] TG as a 
non-toxic peptide, [TOAC1, Api4] TG since it is the labeled peptide that displayed 
selective toxicity, and [TOAC4, Lys6] TG as a highly cytotoxic peptide. For these 
samples, the P/L ratio must be estimated from the lipid content of the reconstituted 
membranes. The lipid content is estimated from the protein count, assuming a fixed 
protein/lipid ratio for the cell lines. The spectra of all peptides interacting with the 
membranes, along with their simulations, are reported in Figure 3.23. The amounts of 
peptide in the two phases (membrane and solution) are obtained from the relative 
contribution of each spectral component to the total area of the simulated spectrum. 
All of them show two spectral components, indicating that the TOAC-labelled peptides 
are only partially bound to the cell membrane. A P/L ratio of 1/250 is generally enough 
 
Figure 3.23 Simulation (colored lines) of the EPR spectra (black lines) of TG analogs 
interacting with reconstituted cell membranes from T67 cells at a P/L of 1/250 (blue lines) 
and 1/100 (light blue lines) 
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to saturate the membrane, and the addition of more peptide to reach a P/L of 1/100 
only leads to finding more peptides in solution. It can be noted that, in this case, 
[TOAC1, Api4] TG exhibits a lower affinity than the other TG analogs. While the other 
three peptides have binding percentages higher than 94%, only 85% of [TOAC1, Api4] 
TG is bound at P/L 1/250, and the value reduces to 81% at P/L 1/100.  
We then performed the experiments on two peptides, one completely hydrophobic 
([TOAC1, Leu4] TG), and one highly toxic and positively charged ([TOAC4, Lys6] TG), 
interacting with reconstituted membranes of HeLa cells, that have a considerably lower 
amount of exposed PS (see paragraph 3.3.2). The experimental spectra, shown in Figure 
3.24, show that [TOAC4, Lys6] TG has almost the same affinity for the HeLa and T67 
cells, while [TOAC1, Leu4] TG has a considerably minor affinity for HeLa cells relative 
to T67 cells. These differences are difficult to interpret, and cannot be directly correlated 
to the different charge exposed on the membranes surfaces, because the procedures of 
isolation of the membrane material and the subsequent sonication, may have led to 
membranes with very different composition with respect to the membranes of the 
corresponding viable cells. Indeed, often membranes are asymmetric, i.e. they have 
different composition on the inner leaflet with respect to the outer leaflet; an example 
is PS content, since it is usually over expressed on the outer leaflet of many cancer cells. 
With the membrane breaking and reconstitution, this asymmetry is lost. Therefore, 
although interesting, these experiments present the main disadvantage that the sample 
preparation leads to vesicles, the composition of which is not precisely determined, and 
could be altered by the presence of intracellular material. Therefore, we did not further 
pursue the experiments on these systems and preferred to develop an experimental 
procedure that allowed us to work directly with viable cells. 
 
Figure 3.24 EPR spectra of TG analogs interacting with reconstituted cell membranes from 
T67 and HeLa cells at a P/L of 1/100. 
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3.5.2.3 TG analogs in viable cells 
We performed EPR experiments in viable cells of the three cell lines used for the MTT 
toxicity assay to assess the peptide dynamics and peptide binding to the cell membrane. 
We chose to use the four labeled TG analogs that were chosen also for CD 
measurements in model membranes: [TOAC1] TG as the reference peptide; [TOAC1, 
Leu4] TG that shows no toxicity; [TOAC1, Lys6] TG that is the most toxic peptide on 
all the cell lines; [TOAC1, Api4] TG that has a selective toxicity.  
We decided to perform EPR experiments in cells in the same experimental conditions 
of the MTT toxicity assays. The samples contain 25 nmol of peptides per million cells: 
this peptide-to-cell ratio is comparable to 2 M concentration in the MTT assay. The 
spectra were recorded after 15-20 minutes of incubation of the peptide to the cell 
suspension. For further details on the preparation of the samples, see Experimental 
Details section. As for the experiments with reconstituted cell membranes, we faced the 
issue of estimating the P/L ratio to see whether the EPR experiments in viable cells can 
be compared to those in model membranes. The estimate was made for the HeLa cell 
line for which the cell volume has been measured, V~2.4∙10-15 m3 [170]. The average 
 
Figure 3.25 EPR spectra of selected TOAC-labeled TG analogs interacting with the 
different cell lines. Experimental spectra in black, simulations in colored lines. From left to 
right the different analogs; from top to bottom the different cell lines. For each spectrum 
is reported the percentage of the membrane-bound peptide as obtained from the 
simulations. Temperature 293 K, peptide to cell ratio: 25 nmol/106 cells. All spectra have 
been normalized to unit intensity. 
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area per lipid at 30 °C for choline headgroups (PC) is ~6.5∙10-19 m2 [171]. The cell 
number in each well of the MTT assay is ~40000 cells for 500 L of buffer. Considering 
a spherical cell and a double layer of phospholipids and ignoring the protein content to 
get an upper limit of the estimate, there are ~2.7∙109 lipid molecules per each cell. Then 
the P/L ratio for the 1 M concentration in the MTT assay is 3/1. This ratio is extremely 
high, and raises doubts on the reliability of the estimate. Nevertheless, it is clear that the 
experiments in cells and in model system cannot be directly compared. The 
concentration range to prepare a sample of a peptide with viable cells is extremely 
limited due to the concentration and time limits over which cells begin to precipitate; 
thus experiments with much lower P/L ratios (such as 1/100 or 1/250) are impossible 
to perform since the signal is below the detection limit of our instrument.  
The spectra of all peptides interacting with the three cell lines, along with their 
simulations, are reported in Figure 3.25. All of them show two spectral components, 
indicating that the TOAC-labelled peptides are only partially bound to the cell 
membrane. The amounts of peptide in the two phases (membrane and solution) are 
obtained from the relative contribution of each spectral component to the total area of 
the simulated spectrum. Among the analogues, [TOAC1, Lys6] TG and [TOAC1, Leu4] 
TG show the largest percentages of bound peptide (≥90%), [TOAC1] TG is slightly less 
bound to the cells (~80%), while [TOAC1, Api4] TG is mostly free in solution (<40% 
bound). Moreover, from the simulation was also obtained the rotational correlation time 
that for all spectra has a similar value of ≈ 10 ns, suggesting that there are no 
significant differences in dynamics neither between different analogues nor between 
different cell lines. 
 
Considerations on the binding of peptides to model and cell membranes 
EPR experiments in model and cell membranes were made after verifying by 
fluorescence microscopy that peptides locate in the cell membrane, without affecting 
nuclei or mitochondria, differently from the experimental evidence found on other 
AMPs [116].  
The binding percentages of peptides towards HeLa cells are generally slightly lower than 
towards the other cell lines. This could be related to the membrane composition of 
HeLa cells, particularly rich in cholesterol, which is supposed to interfere with the 
peptide binding [153]. 
[TOAC1, Api4] TG displayed a very low level of binding for all the cell membranes, 
regardless its toxicity to them: this could be explained considering that it carries a 
positive charge in the structural region of the helix; this perturbation destabilizes the 
favorable interaction between the hydrophobic side of the peptide and the hydrocarbon 
region of the bilayer. Moreover, [TOAC1, Api4] TG is selectively toxic towards T67 cells, 
64 
 
where the binding is higher with respect to the other two cell lines. This higher binding 
can be explained by the higher negative charge on the membrane surface of T67 cells, 
that electrostatically interact with the positively charged Api. 
The dynamics of all peptides bound to the different membranes are similar, as 
confirmed by the correlation times (≈8-12 ns). The values of  are almost identical in 
cells and POPC SUV, where the lipids are in the liquid crystalline phase. These results 
suggest that all peptides bind to zones of the plasma membrane having a high fluidity, 
thereby it is highly unlikely that they are embedded in lipid rafts, regions rich in 
cholesterol that are in a liquid-ordered phase [153,172]. 
The EPR results both in model and in cell membranes show that there is no apparent 
correlation between the amount of peptide binding and cytotoxicity since three of the 
four analogs (a non-toxic and two toxic analogs) show very high binding to the three 
cell lines, the exception being [TOAC1, Api4] TG. However, the results obtained for 
[TOAC1, Api4] TG suggest that even if the cytotoxicity cannot be directly related to the 
affinity of the peptide for the membrane surface, that regulates the level of binding, 
nevertheless a critical peptide concentration in the membrane must be reached to trigger 
toxicity and membrane lysis. Therefore, it can be deduced that a certain level of binding 
is required for peptides to exert their toxicity, but is not sufficient. Other factor must 
play a role, such as peptides penetration depth, that has been measured for our labeled 
TG analogs and will be discussed further below. 
 
Evolution of EPR spectra of TG analogs in viable cells over 24 hours 
The time evolution of some EPR spectra of peptides interacting with viable cells has 
been followed, to verify the lifetime of the nitroxide moiety in the cell suspension. 
Indeed, EPR experiments with cells are sometimes difficult to perform since nitroxides 
are quickly reduced to diamagnetic hydroxylamines by antioxidants present in the 
cytoplasm [173]. Then, if the nitroxides enters in contact with the cytoplasm, whether 
the peptides enter the cell or the cytoplasm leaks out, the EPR signal is expected to 
decay with time. Indeed, it has been previously reported [174] that when the TOAC 
amino acid is incubated with cell extracts under nearly “in-cell” conditions, it displays a 
half-life of only few minutes because it is quickly reduced by enzyme-mediated 
reactions. Figure 3.26 reports the evolution over time of two peptides ([TOAC1, Leu4] 
TG and [TOAC1, Lys6] TG) interacting with viable cells for over 24 hours, together with 
the total area of the spectra, expressed as a percentage of the area of the first collected 
spectrum.  
All nitroxides consumed very slowly, with more than 80% of the spins still present after 
roughly 2 hours (see the inset in Figure 3.26). This confirms that the EPR signal of 
peptides in cells (as those reported in Figure 3.25) can be accumulated for several 
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minutes after the addition to peptide into the cell suspension to improve S/N ratio 
without causing distortions due to nitroxide consumption. 
After 24 hours, when the cells are certainly dead, the nitroxide is almost completely 
consumed (10-15%) for both peptides: this suggests that both toxic and non-toxic 
peptides are exposed to the cell antioxidants. The amount of residual signal after 24 
hours is probably tied to the overall amount of antioxidants in the samples. 
The rate of consumption is comparable for both peptides, a result that is puzzling 
considering that 1) [TOAC1, Leu4] TG is non-toxic while [TOAC1, Lys6] TG is above 
its EC50 value in the conditions of this experiment; 2) toxic peptides disgregate the cell 
membrane (see paragraph 3.5.1) releasing the antioxidant in solutions. We suggest that 
in both cases the TOAC labels in the peptides are protected from the action of the 
cytosolic antioxidants by being buried in the membrane (see the next paragraph). 
Nevertheless, further experiments need to be devised to further explore this aspect. 
 
Figure 3.26 EPR spectra over time of three peptides interacting with T67 cells. On the top 
part, the spectra with the time, in minutes, at which the signals are collected after the 
addition of the peptide to the cell suspension. On the bottom part, the area of the spectra, 
expressed as the percentage with respect to the first collected spectrum; for each graph, it 
is also reported a zoom of the areas of the spectra collected in the first 160 minutes. 
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3.5.2.4 Immersion depth of TG analogs in model and cell membranes 
The insertion depth of spin labeled TG analogs was measured to understand their exact 
location in model membrane of POPC SUV. We followed two approaches: 1) we 
measured all analogs labeled at position 1 to evaluate whether there are differences in 
insertion depth between them; 2) we chose two analogs and labeled all TOAC positions 
to determine the orientation of the helix in the membrane. We also started to perform 
the penetration depth experiments in viable cells. 
 The method for the measurement of the insertion depths, described in paragraph 1.3.5, 
is based on the dipolar interaction of a nitroxide with paramagnetic reagents that are 
differently soluble in aqueous and in lipid phase [17]. The measurements were 
conducted loading the sample in a gas-permeable TPX capillary first under oxygen flow, 
then under nitrogen flow, and finally adding a Ni(EDDA) solution to the sample under 
nitrogen flow. The samples are composed of TG analogs in POPC vesicles at a P/L 
ratio of 1/100, in consistency with the CD and the CW EPR experiments. The obtained 
depth parameters are reported in Table 3.5, along with those of the molecular ruler, for 
comparison.  
Table 3.5 Depth parameters of the spin labelled TG analogs interacting with POPC SUV 
and, for comparison, of the spin labelled phospholipids used as reference. POPC vesicles 
concentration, 10 mM, P/L ratio 1/100. (a) Repeated measurements of TempoPC showed 
a large variability in , but always lower than 0.3. (b) The apparent inversion of is present 
also in the original paper [17]. 
Labelled peptides 
Depth 
parameter  
 
Labelled 
phospholipids 
Depth 
parameter  
[TOAC
1
] TG 0.9  TEMPO PC -0.1a 
[TOAC
4
] TG 2.9  5DPC 1.4 
[TOAC
8
] TG 1.4  7DPC 1.2b 
[TOAC
1
, Lys
6
] TG 1.0  10DPC 2.1 
[TOAC
4
, Lys
6
] TG 2.7  12DPC 2.4 
[TOAC
8
, Lys
6
] TG 1.8  14DPC 3.0 
[TOAC
1
, Lys
5,6
] TG 0.9    
[TOAC
1
, Arg
2
] TG 0.4    
[TOAC
1
, Arg
9
] TG 0.6    
[TOAC
1
, Api
4
] TG 1.3    
[TOAC
1
, Leu
4
] TG 1.3    
[TOAC
1
, Leu
8
] TG 0.9    
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A first observation of the depth parameters  allows to note that for almost all the TG 
analogs, the TOAC in position 1 locates at the same depth. The only exception is 
represented by analogs with an Arg residue, whose nitroxide is closer to the aqueous 
phase with respect to the other analogs. This is probably due to the combined effect of 
the positive charge and the position of the Arg residues, that are able to strongly interact 
with the hydrophilic phase. This experimental values alone already give a hint on the 
most probable orientation of the peptide: indeed, the TG analogs must lie parallel to 
the  membrane surface in order to expose both residues 2 and 9 to the aqueous phase. 
Two series of TG analogs with the TOAC in the three positions originally occupied by 
the Aib ([TOAC1/4/8] TG and [TOAC1/4/8, Lys6] TG) were measured to obtain the 
orientation of the peptide in the bilayer. For both analogs, the depth parameters increase 
in the order TOAC1<TOAC8<TOAC4. In general, helical AMPs adopt two main 
orientations: they lie parallel to the membrane surface or adopt a largely transmembrane 
orientation. We modeled the TOAC labels into the crystal structure of the TG helix and 
built an in-scale cartoon to distinguish, on the basis of the depth parameters, the most 
probable orientation of TG: the results are shown in Figure 3.27. The transmembrane 
orientation (Figure 3.27A) can be promoted by the octanoyl chain that anchors the 
peptide to the lipid tails, if the N-terminus is inserted first. This orientation implies that 
the TOAC moiety in position 1 is the most buried, the one in position 8 is the closest 
 
Figure 3.27 In-scale cartoon of two possible orientations of TG in a POPC bilayer at P/L 
ratio of 1/100: (A) TG inserted into the membrane; (B) TG parallel to the membrane. The 
peptide secondary structure is in agreement with crystallographic data [16], with the three 
TOAC labels added in positions 1 (green), 4 (purple) and 8 (orange). The other side chains 
are represented as thin sticks for clarity. 
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to the aqueous phase, and the TOAC in position 4 lies in the middle. Comparing the 
depth parameters  of [TOAC1/4/8] TG and their analogs with Lys in position 6, it is 
clear that this orientation is not supported by the data collected in our experimental 
conditions. The other possible orientation is represented by TG that lies parallel to the 
membrane surface (Figure 3.27B). In this case, the hydrophobic side chains and the 
octanoyl moiety are in contact with the hydrophobic bilayer, while the Gly residues (that 
are eventually substituted by hydrophilic amino acids like Lys or Arg) are facing the 
polar headgroups. This orientation is optimal to match the calculated depth parameters: 
TOAC in position 4 is located between carbon 12 and carbon 14 of the lipid chain, 
TOAC in position 8 is located between carbon 5 and carbon 7, and, finally, TOAC in 
position 1 is next to the polar headgroups. 
We started to perform the insertion depth measurements in viable cells, but the work 
has encountered several difficulties that are still being solved at the time of this writing, 
among which the peptide-cells system stability over time and the lower sensitivity limit 
of the instrument, that is critical for these samples.  
As yet, three peptides have been tested with T67 or HeLa cells and the depth parameters 
are reported in Table 3.6. The samples contain 125 nmol of peptides per million cells: 
this peptide-to- cell ratio is comparable to a 10M concentration in the MTT assay. It 
can be observed that the toxic peptide, [TOAC1, Lys6] TG, has the TOAC spin label 
positioned deeper than the other two non-toxic peptides. This difference could be 
significant, however further experiments in all cell lines need to be performed. 
Moreover, it should be kept in mind that the molecular ruler was built for a POPC SUV 
system; therefore it cannot be considered valid for the cells a priori. A new molecular 
ruler should be created doping the cells with a small amount of phospholipids labeled 
in different positions before deducing the actual depth of the labeled peptides in the 
cell membranes. 
  
Table 3.6 Depth parameters of spin labelled TG interacting with whole cells. Cells 
concentration, 5∙106 cells/mL; peptide/cell ratio, 125 nmol/106 cells. 
Labelled peptides Depth parameter  Cell line 
[TOAC1] TG 1.4 HeLa 
[TOAC1, Leu4] TG 0.9 T67 
[TOAC1, Lys6] TG 1.8 HeLa 
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4. Conclusions 
In this Ph.D. thesis, a rational search for TG analogs with different substitution has 
been performed. The goal was to synthesize and characterize different analogs to 
understand the key features that regulate the behavior of this family of lipopeptaibols 
towards the cell membranes.  
The cell lines were chosen to have different level of exposed phosphatidilserine (PS, 
that negatively charges the outer leaflet of the membranes) and cholesterol (that reduces 
the membranes fluidity), two components that proved to influence the selectivity of 
cationic -helical peptides towards membranes of bacteria and cancer cells. 
We synthesized, via solid phase peptide synthesis, a wide number of helical peptides 
that had different charge, hydrophobicity and hydrophobic moment. The Gly-to-Arg 
and Gly-to-Lys substitutions enhanced the amphipathicity of the natural sequence with 
the introduction of one or two positively charged amino-acids. All these peptides 
displayed a non-selective toxicity, tested with the MTT assay, comparable to that of the 
native TG. The perturbation of the hydrophobic/structural sector caused significant 
modification to the analogs behavior. Aib-to-Leu substitutions completely abolished 
toxicity, while, interestingly, Aib-to-Api substitution conferred selectivity towards the 
T67 cell line to the peptides. Many analogs carried the spin labeled TOAC amino acid, 
that was inserted to perform EPR experiments and that, in the majority of the cases, 
did not alter the peptides toxicity; only one exception has been found, [TOAC4] TG 
that lost its toxicity. 
The interpretation of the Eisenberg plot (that relates the mean hydrophobicity per 
residue, ‹H›, with hydrophobic moment, ) in light of the toxicity results, highlights 
that a defined ratio between ‹H› and  is required to retain toxicity. Strong deviations 
from this balance result in activity dramatic lowering or complete loss. Therefore, ‹H› 
and  appear to be key feature to predict toxicity in this family of peptides, so this 
correlation can be exploited in the design of future TG analogs. [TOAC4] TG, that was 
an exception since it is the only case where the introduction of TOAC led to toxicity 
loss, has the same ‹H› and values of [TOAC1] TG and [TOAC8] TG. These 
observations highlight the position 4 as particularly sensitive to amino acids 
substitutions. 
Further experiments were carried out to examine in depth the interaction of the peptides 
with model and cell membranes and to understand peptides localization and affinity for 
the membranes, and in particular to understand the selectivity of the Api-derivatives. 
Fluorescence microscopy and EPR spectra on model membranes of POPC confirmed 
that peptides have a strong affinity for the lipid phase and locate on the outer membrane 
leaflet. Moreover, the similarity of the correlation times calculated by simulations of the 
EPR spectra of the peptides interacting both with model and cell membranes led to the 
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conclusion that peptides likely locate in regions with the same fluidity and composition. 
From the calculated binding percentages of the peptides interacting with cells, we 
observed that a lower membrane fluidity, caused by high cholesterol content, such as 
that of HeLa cells, slightly hinders the binding of the peptides to the surface. Moreover, 
the overall high affinities displayed by both toxic and non-toxic peptides suggest that 
binding is a required stage, but not sufficient, for the peptides action. Finally, we observe 
a singular low affinity of the selective Api-bearing analog for the membranes, with an 
even lower affinity for those cells against which it is not active. The reason for this 
behavior resides in the perturbation of the hydrophobic/structural sector with a positive 
charge that lowers the affinity of the peptide helix for the lipid bilayer. At the same time, 
the electrostatic interaction between the positive charge and the highly negative surface 
of T67 cells acts as a driving force that lets the local peptide concentration reach a 
critical limit after which it becomes toxic.  
Immersion depth measurements on spin labeled TG analogs showed that, in model 
membranes TG and [Lys6] TG lie parallel to the membrane surface. The hydrophobic 
side chains and the octanoyl moiety are in contact with the hydrophobic bilayer, while 
the hydrophilic residues are facing the polar headgroups. First attempts to perform these 
experiments in viable cells were encouraging. Although they still need to be perfected, 
they showed significantly differences in the depth of toxic and non-toxic TG analogs. 
Overall, this work studied promising TG analogs, characterizing their structural features 
and their biological activity. We found that TG is very sensitive to amino acids 
substitutions, since even one single modification can significantly alter the peptide 
behavior. The EPR spectroscopy represented an unconventional tool in the study of 
peptides and gave important information on the binding of peptides to different 
membranes (model and cell membranes). It was possible to work often in physiological 
conditions, a task of primary importance for this project. The results obtained so far are 
promising and encourage further studies.  
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5. Experimental details 
Instrumentation for peptide characterization 
UV-Vis spectroscopy. UV measurements were performed by means of a Shimadzu UV-
2501PC spectrometer using quartz reduced optical path cell. 
FT-IT spectroscopy. The FT-IR absorption spectra of peptides dissolved in deuterated 
chloroform were recorded with a spectrophotometer Perkin-Elmer model 1720X 
operating in the Fourier transform, using cells with pathway length of 0.1 cm with CaF2 
windows. The room that houses the sample is maintained under constant flow of 
nitrogen in order to minimize the contributions due to water vapor. 
Mass spectroscopy. To record the mass spectra, a mass spectrometer was used, TOF 
(time Of Flight) and as ESI ionization technique was used, positive ions formed were 
accelerated to 10, 15,20 or 30 keV and analyzed linearly. The ESI generates the spray 
from an aqueous medium acidified with formic acid to improve the ionization of the 
molecules. 
HPLC analysis. The HPLC measurements were performed using an Agilent 1200 series 
apparatus, equipped with a UV detector at variable wavelengths. The used wavelength 
is 226 nm. Eluents: solvent A, H2O/CH3CN 9:1 + 0.05% TFA; solvent B, CH3CN/H2O 
9:1 + 0.05% TFA. Column: C18 Phenomenex Jupiter 300A. 
 
Peptide Synthesis 
All the peptides have been synthesized by Solid Phase Peptide Synthesis (SPPS). The 
employed resin is H-L-Leu-ol-2-chloro-trytil, which has a loading of 0.62 mmol/g (i.e., 
number of active sites per grams of resins. Amino acids are protected at the -NH with 
the Fmoc protecting group. Side chains of the amino acids Api and Lys were protected 
with Boc protecting group, while the side chain of Arg was protected with Pbf. The 
general synthesis method is as follows: 
- The desired quantity of resin in put in a plastic syringe of proper size; the resin 
is mixed for 60 minutes with dimethylformamide (DMF) to solvate it to obtain 
a “gel” in which penetration and removal of reagents is favorable. 
- The coupling reaction is carried out adding to the resin 2 equivalents of Fmoc-
AA-OH, 2 equivalents of the proper activating agent (HBTU/HOBt or HATU), 
4 equivalents of base (N,N-diisopropyltehylamine, DIPEA), using anhydrous 
DMF as solvent. The solution is mixed for 60 minutes. 
- The excess of reagents is removed by filtration and the resin is washed 5 times 
with DMF. 
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-  The Fmoc protecting group is removed with a 20% solution of piperidine 
mixed with the resin for about 10 minutes; the operation is repeated again and 
then the resin is then washed with DMF. 
- The coupling of the subsequent amino acids is carried out as described above, 
until the end of the desired sequence. 
- The N-terminus of the TG analogs is capped by reaction with the n-octanoic 
acid: 2 equivalents of n-octanoic acid and 2 equivalents of HATU are mixed 
with the resin for 60 minutes. 
- In the end, the peptide is cleaved from the resin with a solution of 30% 
hexafluoroisopropanol (HFIP) in dichloromethane. the resin is washed with this 
solution several times: first, the solutions are collected separately after 1 hour of 
mixing, then, a cleavage is conducted overnight. 
Regarding the synthesis, it has to be added that: 
- The coupling of Aib, Api, TOAC and of the amino acids that follow them in 
the sequence, is repeated twice due to the scarce reactivity of the C-
tetrasubstituted amino acid. 
- During the synthesis, it is possible to perform a “small cleavage” of a small 
portion of the resin to check, via mass spectrometry, that the coupling is 
proceeding as desired. 
After the cleavage of all the peptide from the resin, the collected fractions of peptides 
are characterized by mass spectrometry (ESI/TOF) and HPLC. Then, it is necessary to 
purify the products using reverse phase HPLC.  
Two peptides were synthesized by me during the Ph.D. project; the synthesis of 
[TOAC1, Leu4] TG ad [TOAC1, Leu8] TG is reported here. The other peptides were 
synthesized in the group of Dott. C. Peggion, University of Padova. The detailed 
synthesis of them can be found in [175,176]. 
 
[TOAC1, Leu4]TG. The peptide has been synthesized using the general method that is 
described in this paragraph, starting from 106.9 mg of resin (0.0535 mmol). For each 
step, 1 ml of DMF containing 0.107 mmol of Fmoc-AA-OH amino acid, 0.107 mmol 
of HBTU, 0.107 mmol of HOBt (or 0.107 mmol of HATU for C-tetrasubstituted 
amino acids) and 0.214 mmol of DIPEA is added to the resin and mixed for 60 minutes. 
Then the resin is washed 5 times with 1 ml of DMF. 1 ml of solution of DMF containing 
20% of piperidine is mixed for 5 minutes with the resin, then another ml of the same 
solution is mixed for 10 minutes. Finally, the resin is washed 8 times with 1 ml of DMF. 
The coupling proceeded with the same steps for all the amino acids and the n-octanoic 
acid. The cleavage is performed in multiple steps, each one of them carried out mixing 
3 ml of DCM containing 30% of HFIP for 1 hour. 27.4 mg of crude peptide are isolated. 
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They are then purified with a column Sep-Pak C18 35cc Vac Cartridge, 10 g, 55-105 µm 
Particle Size, using the following elution method: 100 ml H20 100%; 100 ml H20 90% 
and MeCN 10%; 100 ml H20 70% and MeCN 30%; 200 ml H20 50% and MeCN 50%; 
200 ml H20 30% and MeCN 70%; 200 ml H20 10% and MeCN 90%; 100 ml MeCN 
100%; 100 ml MeOH 100%. The fractions are checked by HPLC using a C18 
Phenomenex Jupiter 300A reverse phase column with the following eluant system: 
solvent A, H2O/CH3CN 9:1 + 0.05% TFA; solvent B, CH3CN/H2O 9:1 + 0.05% TFA; 
gradient 70-90% B in 20 mins. The fractions containing the pure product were 
concentrated in vacuum, freeze-dried and characterized. 
Yield: 27%. 
Purity: 98.8%. 
IR: 3314 cm-1 (Amide A: stretching of the N-H bonds of peptides in helical 
conformation); 1656 cm-1 (Amide I: stretching of the C=O group, bending of the N-H 
and stretching of the C-N typical of peptides in helical conformation); 1538 cm-1 (Amide 
II: stretching of the C-N and bending of the N-H). [177-179] 
MS (ESI-TOF): [M+H]+calc = 1206.80; [M+H]
+
sper = 1206.79; [M+H]
++
sper = 603.91. 
HPLC gradient 70-90% B in 20 mins, flux 1 mL/min; reverse phase column C18 
Phenomenex Jupiter 300A: retention time = 17.77 min. 
 
[TOAC1, Leu8]TG. The peptide has been synthesized using the general method that is 
described in this paragraph, starting from 108.7 mg of resin (0.0544 mmol). For each 
step, 1 ml of DMF containing 0.109 mmol of Fmoc-AA-OH amino acid, 0.109 mmol 
of HBTU, 0.109 mmol of HOBt (or 0.109 mmol of HATU for C-tetrasubstituted 
amino acids) and 0.218 mmol of DIPEA is added to the resin and mixed for 60 minutes. 
Then the resin is washed 5 times with 1 ml of DMF. 1 ml of solution of DMF containing 
20% of piperidine is mixed for 5 minutes with the resin, then another ml of the same 
solution is mixed for 10 minutes. Finally, the resin is washed 8 times with 1 ml of DMF. 
The coupling proceeded with the same steps for all the amino acids and the n-octanoic 
acid. The cleavage is performed in multiple steps, each one of them carried out mixing 
3 ml of DCM containing 30% of HFIP for 1 hour. 27.0 mg of crude peptide are isolated. 
They are then purified with a column Sep-Pak C18 35cc Vac Cartridge, 10 g, 55-105 µm 
Particle Size, using the following elution method: 100 ml H20 100%; 100 ml H20 90% 
and MeCN 10%; 100 ml H20 70% and MeCN 30%; 200 ml H20 50% and MeCN 50%; 
200 ml H20 30% and MeCN 70%; 200 ml H20 10% and MeCN 90%; 100 ml MeCN 
100%; 100 ml MeOH 100%. The fractions are checked by HPLC using a C18 
Phenomenex Jupiter 300A reverse phase column with the following  (eluant system: 
solvent A, H2O/CH3CN 9:1 + 0.05% TFA; solvent B, CH3CN/H2O 9:1 + 0.05% TFA; 
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gradient 70-90% B in 20 mins. The fractions containing the pure product were 
concentrated in vacuum, freeze-dried and characterized. 
Yield: 43%. 
Purity: 95.5%. 
IR: 3307 cm-1 (Amide A: stretching of the N-H bonds of peptides in helical 
conformation); 1656 cm-1 (Amide I: stretching of the C=O group, bending of the N-H 
and stretching of the C-N typical of peptides in helical conformation); 1540 cm-1 (Amide 
II: stretching of the C-N and bending of the N-H). 
MS (ESI-TOF): [M+H]+calc = 1206.80; [M+H]
+
sper = 1206.75; [M+H]
++
sper = 603.41. 
HPLC gradient 70-90% B in 20 mins, flux 1 mL/min; reverse phase column C18 
Phenomenex Jupiter 300A: retention time = 14.02 min. 
 
Cell culture 
Culture media, fetal bovine serum (FBS) and antibiotics were purchased from Carlo 
Erba Dasit Group. The T67 human glioma cell line was derived by Lauro et al. [180] 
from a World Health Organization (WHO) Grade III gemistocytic astrocytoma. Human 
dermal fibroblasts (HDF) were obtained by ATCC. HDF were cultured in Fibroblast 
Basal Medium (ATCC) supplemented with 10% FBS. T67 and HeLa cells were cultured 
in Dulbecco's modified Eagle's medium (MMedical) supplemented with 10% FBS, 100 
UI/ml penicillin, 100 μg/ml streptomycin, and 40 μg/ml gentamycin, and kept in a 5% 
CO2 atmosphere at 37 °C, with saturating humidity. Cell viability and number were 
measured by trypan blue exclusion method [181]. 
 
Cytotoxicity assay 
Cytotoxicity of peptides was estimated using a MTT assay. All the chemicals used for 
this assay have been purchased by sigma Aldrich and used without further purification. 
T67, HeLa and HDF cells were seeded in 24-well plates at 1 × 105 cells/well. 
Experiments were performed after 24 h of incubation at 37 °C in 5% CO2. After this 
time cells were washed and treated for 24 h with different concentrations of peptides; 
the cells are then incubated for 60 mins with 300 μM of MTT in culture medium. The 
absorbance of each well was measured at 450 nm with a spectrofluorometer (Wallac 
Victor multilabel counter; Perkin-Elmer Inc., Boston, MA, USA). Data are reported as 
the mean ± standard deviation of at least three independent experiments. 
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Cholesterol quantification 
The cholesterol content of cultured cells was determined using the cholesterol oxidase 
method with minor modifications [182]. Pelleted cells were treated with lysis buffer 
(0.1% Triton X-100 v/v) to a final protein concentration of 0.5 mg/ml. Then, 10 
microliters of reaction mix (500 mM MgCl2, 500 mM Tris buffer (pH 7.4), 10 mM 
ditiotreitol, 5% sodium cholate (w/v), 0.1% Triton X-100 (w/v), 0.8 U/ml cholesterol 
oxidase and 0.8U/ml cholesterol esterase) were added to 100μL of cell suspension. The 
solution was incubated at 37°C for 30 minutes and was stopped by adding 100μl of a 
1:1 methanol/ethanol (v/v) solution and incubated at 0°C for 30 min. After 10 min of 
centrifugation at 10000 x g, 10μL of the supernatant was analyzed by HPLC. The 
oxidized cholesterol was separated on a Kinetex C18 column (100 x 4.6 mm, 2.6 μm; 
Phenomenex, CA, USA) using a mobile phase consisting in 1:99 acetic acid/methanol 
(v/v) at a flow rate of 0.4 ml/min with a Agilent 1100 HPLC system. Absorbance at λ 
240 nm was monitored by a photodiode array detector. To quantitate the amount of 
cholesterol, external cholesterol calibration standards were used. 
 
Annexin V assay 
The phosphatidylserine (PS)  located on the outer leaflet of the plasma membrane was 
measured using Alexa Fluor® 488 Annexin V Kit (Molecular Probes, Invitrogen) 
following manufacturer instruction. The fluorescent signal was detected by flow 
cytometry using a Beckman-Coulter Epics XL-MCL cytofluorimeter at λexc 488 nm, λem 
525 nm. 
 
Circular Dichroism 
Spectrograde MeOH (Acros) and 100 mM SDS were used as solvents. The small 
unilamellar vesicles (SUV) used in this study were prepared from POPC. The lipids were 
dissolved in chloroform and a homogeneous lipid film was obtained by drying the 
solution under a gentle dry nitrogen stream; the film was left overnight under vacuum 
in a desiccator to remove any trace of solvent. The following day the film was 
resuspended in HEPES buffer (5mM, pH 7.4) to obtain a lipid concentration of 2 mM. 
SUV in the 30-50 nm diameter range were prepared by sonication: the lipid suspension 
was immersed in a water bath and sonicated until the solution started to clear. Vesicle 
dimensions were checked during preparation by dynamic light scattering using a 
NICOMP Model 370 Submicron Particle Sizer by Pacific Scientific. The peptides were 
incorporated in the liposomes as follows: a methanol solution of the peptide was 
evaporated in an Eppendorf tube. The pre-formed liposomes were added and the 
solution was then sonicated for 3 min.  Vesicles were used fresh after preparation. CD 
recordings were carried out on a JASCO J-715 (Tokyo, Japan) spectropolarimeter. The 
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CD spectra were acquired and processed using the J-700 program for Windows. All 
spectra were recorded at r.t., using Hellma (Müllheim, Germany) cylindrical quartz cells 
with Suprasil windows, optical path-lengths of 0.01 cm, a bandwidth of 2 nm, and a 
time constant of 2 s at a scan speed of 20 nm/min. The signal-to-noise ratio was 
improved by accumulating 36 scans. The values are expressed in terms of []R, the total 
molar ellipticity [deg∙cm2∙dmol-1]. 
 
Determination of the hydrophobicity values for new residues 
The CCS scale (see paragraph 3.4.2) has been correlated with literature experimental 
LogP values, finding an excellent correlation (Figure 5.1A). Then, the H values on the 
CCS scale for many N-acetylated and C-amidated residues has been related to the 
estimated value obtained for those residues from two different software (Figure 5.1B 
and 5.1C). The linear fit of these data showed a good correlation and led to the 
equations: 𝑦 = 0.13𝑥 − 1.34 (5.1B) and 𝑦 = 0.12𝑥 − 1.43 (5.1C), where y is the 
estimated H value on each scale and x is the H value on the CCS scale. From these 
equation, the estimated values of Api (and Api linked to the octanoyl chain), TOAC 
(and TOAC linked to the octanoyl chain) and Lol have been reported on the CCS scale. 
All the values are reported in Table 5.1 and Table 5.2. 
 
 
Figure 5.1 Correlation between the CCS scale with the experimental LogP (A), the estimated 
LogP from Kowwin (B) and the estimated LogP from ChemDraw (C). 
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Table 5.1 H values of different residues on the CCS scale relate to the experimental values, and 
the estimated LogP with the two used software. 
Residue 
H (CCS 
scale) 
Experimental 
LogP 
Estimated LogP 
from Kowwin 
Estimated LogP  
from ChemDraw 
Phe 10.0 -0.04 +0.13 -0.02 
Trp 9.7 +0.42 +0.20 -0.55 
Leu 9.7 -0.13 -0.17 -0.45 
Ile 8.7 -0.03 -0.17 -0.4 
Met 4.6 -0.60 -1.49 -1.43 
Val 4.1 -0.61 -0.66 -0.78 
Tyr 2.5 -0.87 -0.35 -0.38 
Pro -0.2 -1.34 -1.68 -1.39 
Ala -1.1 -1.52 -1.57 -1.6 
Cys -2.3 -0.29 -1.63 -1.33 
Gly -2.4 -1.83 -1.99 -2.02 
Thr -3.8 -1.57 -1.62 -2.07 
His -3.8 -1.70 -1.80 -2.64 
Ser -4.3 -1.87 -2.04 -2.40 
Gln -6.0 -2.05 -3.08 -2.60 
Asn -7.1 -2.41 -3.57 -2.94 
Asp -8.3 -2.60 -2.32 -2.44 
Glu -8.3 -2.47 -1.83 -2.16 
Lys -9.9 -2.82 -1.57 -1.76 
Arg -10.0 -2.84 -2.59 -2.38 
Nle 9.1 -- -0.10 -0.32 
Deg 6.0 -- -0.14 -0.06 
Nva 5.3 -0.45 -0.59 -0.74 
Abu 1.7 -- -1.08 -1.16 
Aib 1.1 -0.87 -1.12 -1.00 
Orn -9.0 -- -2.06 -2.19 
Dab -9.3 -- -2.55 -2.64 
Dap -9.5  -3.04 -2.84 
 
Table 5.2 H values estimated with the two software and reported on the CCS scale. 
Residue 
Est LogP 
(Kowwin) 
H value on 
CCS scale 
Est LogP 
(ChemDraw) 
H value on 
CCS scale 
Mean of the 
two H values 
on the CCS 
Api -2.45 -8.54 -2.06 -5.25 -6.9 
TOAC -1.53 -1.46 -1.06 3.08 0.81 
Lol 0.15 11.46 0.30 14.42 12.94 
Oct-Aib 1.83 24.38 1.38 23.42 23.90 
Oct-TOAC 1.41 21.15 1.62 25.42 23.29 
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Fluorescence Microscopy 
HeLa cells were washed with PBS (NaCl 137 mM, KCl 2.7 mM, Na2HPO4 10 mM, 
KH2PO4 1.8 mM, pH 7.4), detached with 0.05% trypsin–EDTA solution and 
centrifuged for 3 min at 300×g. The pellet was resuspended in DMEM medium and 
cells were counted by using trypan blue exclusion method. Then, 5 × 103 cells were 
seeded on custom chambers [183] with glass bottom, in 100 μL of complete DMEM 
medium and incubated at 37 °C in a humidified atmosphere with 5% CO2. After 24 h, 
cells were washed with PBS and incubated for 3 hours with 10µM of  [FITC11] TG and 
[Lys6, FITC11] TG dissolved in DMEM.  After this time, cells were carefully washed 
with PBS, then 50 μL of PBS supplemented with calcium and magnesium (NaCl 
137 mM, KCl 2.7 mM, Na2HPO4 10 mM, KH2PO4 1.8 mM, CaCl2 1 mM, MgCl2 0.5 mM, 
pH 7.4) was added to each chamber. Finally, chambers were mounted on the 
microscope stage for analysis. Micrographs were acquired on a Zeiss Axiovert 200 
inverted microscope equipped with XBO xenon 75W short arc lamp and a Photometrics 
Coolsnap FX CCD camera (Roper Scientific) with Metafluor Imaging Software version 
6.1r6 (Universal Imaging Inc.) at λexc 500 nm, λem 545 nm. 
 
EPR in membranes: model membranes, reconstituted cell membranes and 
viable cells 
Methanol, 99.9%, spectrophotometric grade, [4-(2-hydroxyethyl)-1-piperazinyl] 
ethanesulfonic acid (HEPES), and PBS buffer (NaCl 137 mM, KCl 2.7 mM, 
Na2HPO4 10 mM, KH2PO4 1.8 mM, pH 7.4) were purchased from Sigma-Aldrich. A 50 
mM, pH 7.0, HEPES buffer solution was prepared to be used for liposomes. 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was purchased from Avanti 
Polar Lipids, Alabaster (AL) as chloroform solution. For the EPR experiments in 
liposomes, POPC liposomes preparation and peptide incorporation were carried out in 
the same way as for CD experiments. Reconstituted cell membranes are prepared by 
culturing the cells as already described. Cells are centrifuged for 5 minutes at 800 g with 
a Eppendorf Centrifuge 5810; the supernatant is removed and the pellet is resuspended 
in the desired buffer. The pellet is kept at 0°C and homogenized by mechanical friction; 
after this operation the pellet is ready to be stored until use. For the EPR experiments 
in cells, T67, HeLa and HDF cells were cultured as described above and then stored in 
liquid nitrogen as a 5∙106 cells/mL suspension in PBS buffer until use. The frozen 
suspension was quickly warmed in a 37°C water bath and washed twice with PBS. The 
peptides were incorporated in the cells as described in the CD section; the 3 min 
sonication was avoided to prevent damages to the cells. CW-EPR spectra were 
performed using a Bruker ER200D spectrometer operating at X-band (~9.5 GHz), 
equipped with a rectangular cavity, ER4102ST, fitted with a cryostat, and a variable-
temperature controller, Bruker ER4111VT. The microwave frequency was measured by 
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a frequency counter, HP5342A. All spectra were obtained using the following 
parameters: microwave power 2.1 mW; modulation amplitude 0.10 mT; modulation 
frequency 100 kHz; time constant 41 ms; conversion time 82 ms; scan width 12 mT; 
1024 points; temperature 293 K. The spectra were obtained as the average of 16 or 25 
scans. The spectra of the TOAC-labeled peptides were simulated with a program based 
on the stochastic Liouville equation [184], that is extensively used to simulate the EPR 
spectra of spin-labeled peptides, proteins and lipids [185-189]. The simulation method 
relies on several reference systems: the g and 14N hyperfine (A) tensors of the TOAC 
label are considered collinear and their orientation relative to the rotational diffusion 
reference frame is determined by a set of Euler angles. The simulation approach was 
simplified, using a single isotropic value (D iso) for the diffusion tensor, and the rotational 
correlation times  are related to Diso via the classic equation =1/ 6Diso. The principal 
values of the g (gxx=2.0096, gyy=2.0064, gzz=2.0027) and A tensors were obtained from 
the literature [190], except for the value of the Azz component. Since the values of the 
Azz hyperfine component depend strongly on the polarity of the environment, its value 
has been optimized: Axx = Ayy = 0.56 mT in all environments, while Azz = 3.27 mT for 
peptides bound to SUV, Azz = 3.35 mT for peptides bound to cells, Azz = 3.47 mT for 
peptides bound to reconstituted cell membranes and Azz = 3.75 mT for peptides in 
solution. 
 
Immersion depth measurements 
Power saturation experiments were performed in POPC liposomes prepared in the same 
way as those used for CD experiments. The peptides were incorporated into liposomes 
as follows: a methanol solution of the peptide was evaporated in an Eppendorf tube. 
The pre-formed liposomes were added and the tube was repeatedly vortexed. The 
solution was then sonicated for 3 min. The EPR experiments were performed using a 
Bruker ESP380 spectrometer operating at the X-band (B9.5 GHz), equipped with a 
room temperature dielectric resonator, ER4123D. The microwave frequency was 
measured using a frequency counter, HP5342A. All spectra were obtained using the 
following parameters: a modulation amplitude of 0.16 mT; a modulation frequency of 
100 kHz; a time constant of 41 ms; a conversion time of 82 ms; a scan width of 1.25 
mT; 512 points; a temperature of 298 K. The microwave power was ramped down 
automatically from 95 mW to 0.05 mW (the attenuation ramp in dB units was 2.0, 4.0, 
6.0, 8.0, 10.0, 12.0, 14.0, 16.0, 18.0, 20.0, 25.0, 30.0, 35.0). The spectra at each power 
were averaged 3 times. The experimental protocol for the insertion depth measurements 
is as follows: approximately 5 mL of the sample were loaded into a gas-permeable TPX 
capillary (L&M EPR Supplies, Inc., Milwaukee, WI, USA) and 3 saturation experiments 
were performed. The first experiment was done on the sample in equilibrium with air 
to saturate the membrane with oxygen. The second experiment was performed on the 
same sample after de-oxygenation under a dry nitrogen flow for 20 min. The third 
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experiment was carried out on a new sample to which NiEDDA was added to a final 
concentration of 50 mM; the sample was then de-oxygenated as above. All experiments 
were performed at least in duplicate. The power saturation data were obtained using a 
home-written program in Matlab that measures the peak-to-peak amplitudes of the 
central line of the spectra. The saturation curves were obtained by plotting the amplitude 
data vs. the microwave power, and fitted using equation 14. The dimensionless 
immersion depth parameter  is calculated from the ratio of the P1/2 parameters 
obtained from the fitting of the three experiments described above, using equation 18. 
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7.  Appendices 
7.1  Appendix A 
As observed in the EPR spectra reported in paragraph 3.5.2, the signal of a nitroxide depends 
on its dynamics, and therefore it closely reflect the dynamic of the molecule at which the 
nitroxide is bound. A fast moving spectrum is determined by the mean values of the isotropic 
magnetic tensors. A slow moving spectrum is observed when the motion rate equals the rate 
of the magnetic interactions of the studied system. The interpretation of the experimental 
spectra requires complex models. A general model has been developed by J. Freed in 
collaboration with the Theoretical Chemistry group of the University of Padova, which allows 
to calculate the EPR spectrum for any motion regimen of the nitroxide and, moreover, it 
allows to consider the effect of anisotropic motions and orienting phases. The method is 
based on the Stochastic Liouville Equation (SLE), which combines the quantomechanic 
description of the energy of the system with the stochastic approach for the description of 
the microscopic dynamics. The program used for the EPR spectra simulation is based on this 
model. It requires a limited number of parameters and a deep knowledge of the theory is not 
necessary. The main parameters required for the simulation of an EPR spectrum in a slow 
motion regimen are: 
- The principal values of the tensors g (gxx, gyy, gzz) and A (Axx, Ayy, Azz). 
- The reciprocal orientation of the two principal tensors and their orientation with 
respect to the molecule, for a case in which the motion is not considered isotropic. 
- The linewidths. 
- In the case of anisotropic motion, the principal values of the tensor R, which 
represents the motion frequency along the principal axes of the molecule (Rxx, Ryy, 
Rzz). 
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7.2  Appendix B 
In Appendix B are reported the three papers that have been published during my Ph.D. 
period. They concern side projects that are at some extent correlated with the main topic of 
the thesis and with work that was useful to learn and develop experimental procedures that 
have been exploited also in the study of TG analogs. 
- Bortolus Marco, Dalzini Annalisa, Toniolo Claudio, Hahm Kyung-Soo, Maniero 
Anna Lisa. Interaction of hydrophobic and amphipathic antimicrobial peptides with 
lipid bicelles, Journal of Peptide Science, 2014, 20, 7, 517-525. In this paper, EPR 
spectroscopy is exploited to study how AMPs with different composition and 
amphipathicity perturb spin labeled bicelles, a model membrane system that can be 
macroscopically oriented in a magnetic field at physiological temperature. We observe 
that peptides that are known to disrupt the membrane by different mechanisms show 
very distinct trends of the order parameter (the parameter that describes the degree 
of perturbation of the bicelles) as a function of the peptide concentration. So, it was 
possible to exploit these differences to evaluate the mechanism of membrane 
disruption of new peptides. 
- Mobbili Giovanna, Crucianelli Emanuela, Barbon Antonio, Marcaccio Massimo, 
Pisani Michela, Dalzini Annalisa, Ussano Eleonora, Bortolus Marco, Stipa Pierluigi, 
Astolfi Paola. Liponitroxides: EPR study and their efficacy as antioxidants in lipid 
membranes, RSC Advances, 2015, 5, 98955-98966. In this paper the inclusion of a 
series of lipid-functionalized nitroxides in phospholipids bilayer has been studied by 
EPR spectroscopy. The molecular ruler, i.e. the immersion depth of nitroxides bound 
at different positions of the lipid tail of a doxyl-PC, has been developed and then 
exploited to determine the immersion depth of the studied compounds. Thanks to 
these measurements, it was possible to correlate the antioxidant activity and the mode 
of action of the liponitroxides with their penetration into the phospholipid bilayer. 
- Bortolus Marco, Dalzini Annalisa, Formaggio Fermando, Toniolo Claudio, Gobbo 
Marina, Maniero Anna Lisa. An EPR study of ampullosporin A, a medium-length 
peptaibiotic, in bicelles and vesicles, PCCP, 2016, 18, 749-760. In this paper, EPR 
spectroscopy has been exploited for various experiments. From immersion depth 
measurements of peptides labeled in different positions and at different 
concentration, we observed that the peptide orientation in the bilayer is dependent 
on its concentration. We also obtained information of the secondary conformation, 
orientation and aggregation of ampullosporin in different model membrane systems. 
 
Special Issue Article
Received: 28 February 2014 Accepted: 10 April 2014 Published online in Wiley Online Library
(wileyonlinelibrary.com) DOI 10.1002/psc.2645Interaction of hydrophobic and amphipathic
antimicrobial peptides with lipid bicelles‡
Marco Bortolus,a Annalisa Dalzini,a Claudio Toniolo,a Kyung-Soo Hahmb
and Anna Lisa Manieroa*Bicelles are model membrane systems that can be macroscopically oriented in a magnetic ﬁeld at physiological temperature.
The macroscopic orientation of bicelles allows to detect, by means of magnetic resonance spectroscopies, small changes in the
order of the bilayer caused by solutes interacting with the membrane. These changes would be hardly detectable in isotropic
systems such as vesicles or micelles. The aim of this work is to show that bicelles represent a convenient tool to investigate the
behavior of antimicrobial peptides (AMPs) interacting with membranes, using electron paramagnetic resonance (EPR)
spectroscopy. We performed the EPR experiments on spin-labeled bicelles using various AMPs of different length, charge,
and amphipathicity: alamethicin, trichogin GA IV, magainin 2, HP(2–20), and HPA3. We evaluated the changes in the order
parameter of the spin-labeled lipids as a function of the peptide-to-lipid ratio. We show that bicelles labeled at position 5
of the lipid chains are very sensitive to the perturbation induced by the AMPs even at low peptide concentrations. Our study
indicates that peptides that are known to disrupt the membrane by different mechanisms (i.e., alamethicin vs magainin 2)
show very distinct trends of the order parameter as a function of peptide concentration. Therefore, spin-labeled bicelles
proved to be a good system to evaluate the membrane disruption mechanism of new AMPs. Copyright © 2014 European
Peptide Society and John Wiley & Sons, Ltd.
Keywords: antimicrobial peptides; bicelles; EPR; order parameter; membrane interaction; peptaibiotics* Correspondence to: Anna Lisa Maniero, Department of Chemistry, University of
Padova, via Marzolo 1, Padova, 35131, Italy. E-mail: annalisa.maniero@unipd.it
‡ This article is published in Journal of Peptide Science as part of the Special Issue
devoted to contributions presented at the 1st International Conference on Pep-
tide Materials for Biomedicine and Nanotechnology, Sorrento, October 28-31,
2013, edited by Professor Mariano Venanzi, Professor Claudio Toniolo and
Professor Giancarlo Morelli.
a Department of Chemistry, University of Padova, via Marzolo 1, Padova, 35131, Italy
b BioLeaders Corp., 559 Yongsan-Dong, Yuseong-Ku, Daejeon, 305-500, KoreaIntroduction
Antimicrobial peptides (AMPs) play an important role in the host
defense mechanism of most living organisms and they are
known to possess antibiotic activity against bacteria and fungi
[1–3]. These peptides usually interact with the lipid bilayer of
microbial cell membranes, causing an increase in permeability
and cell disruption. As a consequence, they possess a great
potential as therapeutic agents that can overcome the increasing
resistance of bacteria to common antibiotics [4]. The large amount
of data collected so far indicate that the strength and mechanisms
of interaction of AMPs with membranes strongly depend on the
combination of several features including main-chain length,
secondary structure, charge, hydrophobicity, and amphipathic
character [2,5,6]. Understanding the structure–activity relation-
ships of AMPs appears essential for the development of antimicro-
bial agents with improved properties [1].
Several mechanisms of membrane disruption have been
hypothesized, but all of them can be reconducted to two main
categories: the barrel-stave model [7], characterized by AMPs
self-assembly governed by the peptide–peptide hydrophobic
interactions and the Shai–Matsuzaki–Huang model [8], domi-
nated by the peptide–lipid interaction. In the barrel–stave model,
AMPs generate a pore structure where the peptides form the
walls and expose their hydrophilic face toward the inner part
[9]. The barrel–stave model has been closely associated with
the peptaibiotic alamethicin that forms voltage-dependent pores
[7,9,10] and has been also invoked for other hydrophobic pep-
tides [11,12]. The Shai–Matsuzaki–Huang mechanism involves
several levels of membrane disruption that can be caused by
AMPs depending on their strength and effective concentrationJ. Pept. Sci. 2014as follows: (i) AMPs can be absorbed parallel to the membrane
surface, causingmembrane thinning, (ii) AMPs can form disordered
pores where peptides and lipids are mixed (called toroidal pores),
(iii) AMPs can act as detergents micellizing the membrane [1,13].
The Shai–Matsuzaki–Huang mechanism is usually invoked for
cationic amphipathic AMPs, the hydrophilic or positively charged
side of which promotes the binding to the surface of negatively
charged bacterial membranes, whereas the hydrophobic side is
responsible for the interaction with the lipid components.
Model membrane systems play a key role to dissect the different
aspects of the peptide–membrane interaction. Among model
membranes, bicelles have one unique advantage over micelles
or vesicles that makes them an ideal system for magnetic spectros-
copies [14]: they can be macroscopically oriented in solution (no
solid support is needed) at physiological temperature under a
magnetic ﬁeld. Additionally, bicelles are in the ﬂuid phase at
physiological temperature, the curvature stress of the bilayer is
negligible, and the membrane is fully hydrated. A schematic
representation of a bicelle is shown in Figure 1. The system isCopyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.
Figure 1. Schematic representation of a bicelle. The cartoon shows the
long-chain phospholipids (DMPC), the short-chain phospholipids (DHPC),
the spin-labeled phospholipids (5DPC), and the lanthanide ions (Tm3+)
used to align the membrane normal parallel to an external magnetic ﬁeld.
For the abbreviations see Materials and Methods.
BORTOLUS ET AL.composed of planar regions, made primarily of long-chain
phospholipids, and curved edge regions, composed essentially of
short-chain phospholipids. Normally, bicelles align in a strong
magnetic ﬁeld with the membrane normal n perpendicular to
the ﬁeld, but, in the presence of paramagnetic lanthanide ions,
bicelles can be aligned, even at low magnetic ﬁelds (less than
1 T), with the membrane normal parallel or perpendicular to the
external ﬁeld, depending on the chosen lanthanide [14].
Magnetic spectroscopies, such as NMR and electron paramag-
netic resonance (EPR) can take advantage of the high spectral
resolution afforded by the macroscopic orientation of bicelles
to characterize the interaction of solutes with the bilayers.
Spin-labeling EPR spectroscopy is a well-proven technique for
studying the interactions of peptides and other solutes with
lipid membranes: the spin label, usually a nitroxide, can be placed
either on the lipids or on the solute [15–18]. EPR experiments
performed using bicelles can provide a wealth of information
both on the effects of solutes on the lipid packing and on solute
characteristics, as orientation, dynamics, and aggregation [17–19].
In this work, using bicelles and EPR spectroscopy, we investi-
gated the membrane disruption mechanisms of several AMPs
having different length, hydrophobicity, hydrophobic moment,
and charge. These parameters have been shown to inﬂuence
the activity of AMPs in different ways [6]. The peptides studied
are listed in Table 1: despite the different lengths, all these AMPs
adopt a mostly helical conformation in membrane or membrane-
like environments. For this reason, they are shown in Figure 2
in the helical wheel representation. We studied two peptidesTable 1. The peptides studied in this work. The common name, sequence,
organism that produces them are reported
Peptide Sequencea Hydrophobicity Hyd
m
Alamethicin
(main isomorph)
Ac–UPUAUAQ
UVUGLUPVUUEQ–Phol
0.57
Trichogin GA IV 1-Oct-UGLUGGLUGI-Lol 2.86b
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS 0.58
HP(2–20) AKKVFKRLEKLFSKIQNDK 2.75
HPA3 AKKVFKRLEKLFSKIWNWK 0.98
aAc, acetyl; Phol, phenylalaninol; U, α-aminoisobutyric acid (Aib); 1-Oct, 1-o
bHydrophobicity and hydrophobic moment for trichogin GA IV are not eas
and the 1-Oct group cannot be taken into account in the calculations.
wileyonlinelibrary.com/journal/jpepsci Copyright © 2014 Europthat are archetypical of the two principal mechanisms of pore
formation, namely, alamethicin (barrel–stave) [9,20–22] and
magainin 2 (Shai–Matsuzaki–Huang) [22–26] and three
peptides the mechanism of action of which is currently under
debate, trichogin GA IV, HP(2–20), and HPA3. Alamethicin and
trichogin GA IV are peptaibiotics, a family of AMPs rich in
hydrophobic residues and characterized by the presence of an
alcoholic function at the C-terminus and an acyl group at the
N-terminus [27]. The formation of a helical secondary structure
in both peptides is promoted by the presence of several
Cα-tetrasubstituted Aib residues. Alamethicin, the most studied
peptaibiotic, is composed of 19 amino acids [28]. Trichogin GA IV
is a shorter peptaibiotic formed by ten residues, none of which
is charged. Moreover, it carries 1-octanoyl fatty acyl chain at the
N-terminus [29,30], which likely plays a role in the anti-
microbial activity of this peptide [31]. Magainin 2, the ﬁrst
AMP that has been discovered, is a positively charged peptide
composed of 23 residues that shows strong bactericidal, fun-
gicidal, and virucidal activities [32,33]. HP(2–20), derived from
the N-terminal region of the Helicobacter pylori ribosomal protein
L1, is a positively charged peptide composed of 19 amino acids. Its
central portion (residues 4–16) is arranged in an amphipathic
helical structure [34,35]. Several analogs of HP(2–20) have been
synthesized, the most promising of which is HPA3 [34]. It is
characterized by an increase of amphipathicity combined with a
limited extension of the helical region (residues 4–18).
Materials and Methods
Materials
Alamethicin from T. viride (mixture of the natural isomorphs) was
purchased from Sigma-Aldrich, Saint Louis, MO, USA. Magainin 2
was purchased from Bachem AG, Bubendorf, Switzerland. The
synthesis of HP(2–20) [34], HPA3 [34], and trichogin GA IV [37]
has all been previously reported. 1,2-Dihexanoyl-sn-glycero-3-
phosphocholine (DHPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), and 1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phos
phocholine (5DPC) were purchased as chloroform solutions from
Avanti Polar Lipids, Alabaster, AL, USA. 2-[4-(2-Hydroxyethyl)-1-
piperazinyl]ethanesulfonic acid (HEPES) and the lanthanide salt
TmCl3 6H2O were purchased from Sigma-Aldrich. A 50mM,
pH 7.0, HEPES buffer solution was used for bicelle preparation
and for the stock solutions of Tm3+.hydrophobicity, hydrophobic moment, overall and net charges, and the
rophobic
oment
Overall
charges
Net
charge
Origin
1.70 0/1 1 Fungus (Trichoderma viride)
3.30b 0/0 0 Fungus (Trichoderma longibrachiatum)
3.28 +5/1 +4 Frog (Xenopus laevis)
3.98 +7/2 +5 Bacterium (Helicobacter pylori)
4.07 +7/1 +6 Synthetic analog of HP(2–20)
ctanoyl; Lol, leucinol.
ily comparable with those of other peptides because it is much shorter
ean Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014
Figure 2. Helical wheel representations of the peptides studied in this work. The colors follow the convention given in Ref. [36]. U is α-aminoisobutyric
acid (Aib).
ANTIMICROBIAL PEPTIDES INTERACTING WITH BICELLESHelical Wheels and Hydrophobic Moment Calculation
The helical wheels in Figure 2 were drawn using the program
Pepwheel of the EMBOSS suite [38] that can be found at http://
emboss.bioinformatics.nl. The hydrophobic moments given in Ta-
ble 1 were calculated with the formula reported by Eisenberg
[39], using the new consensus hydrophobicity scale reported by
Tossi [40].J. Pept. Sci. 2014 Copyright © 2014 European Peptide Society and JohBicelle Stock Preparation
The chloroform solutions of the phospholipids and a methanol
solution of the peptides were mixed in a glass test tube. Samples
at different peptide concentrations were prepared keeping
the lipid content constant and varying the amount of peptide
to obtain the desired peptide-to-lipid (P/L) ratio. The P/L
ratios reported in this work refer to DMPC only. The ﬁnal lipidn Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
BORTOLUS ET AL.composition of each solution was 11.2μmol of DMPC, 3.1μmol
of DHPC, and, where present, 25 nmol of 5DPC spin label
(~0.2% of the total lipids). The q= (DMPC)/(DHPC) ratio was
therefore ~3.5. A thick ﬁlm, containing the lipids and the pep-
tide, was produced by evaporation of the solvent under a
stream of dry nitrogen gas. The ﬁlm was dried under vacuum
overnight and then scratched off the glass tube and placed
into an Eppendorf tube. Then 33μL of buffer was added,
obtaining a solution of 25% (w/w) lipid concentration. The
resulting suspension was vortexed until it appeared homoge-
neous. The sample was then placed in a bath sonicator ﬁlled
with an ice/water mixture and sonicated for 30min. Finally,
the solution was subjected to four freeze/thaw cycles: 30min
in a 328 K water bath was followed by a quick freeze in liquid
nitrogen (vortexing of the sample at each step was performed
to insure perfect homogeneity). This procedure yielded a clear,
viscous, stock of bicelles with the peptide incorporated in
the bilayers.EPR Sample Preparation
The samples for EPR experiments were prepared as follows: 15μL
of bicelles was added to 10μL of a buffered lanthanide solution
of Tm3+ [corresponding to a ﬁnal (Tm3+)/(DHPC) ratio of 0.1].
The ﬁnal concentration of the phospholipids was 17% (w/w).
The resulting solution (25μL) was transferred to a 1-mm inner
diameter EPR quartz tube. Given the experimental conditions
(lipid concentration, q ratio, temperature), the bicelles used in
this work are not ideal disks but rather stacks of almost planar
phospholipid bilayers dotted with DHPC pores and separated
by buffer regions ~15-nm wide [41].
A literature procedure [14] was used to obtain aligned samples:
the sample tube was placed at room temperature (~298 K) in the
EPR cavity, and the magnetic ﬁeld was set to 800mT. Then, the
temperature was slowly raised to 318 K and subsequently
lowered to the selected temperature of 308 K (35 °C). The
magnetic ﬁeld was set to ~350mT, and the spectrum was
recorded immediately. Loss of order in the sample during themea-
surement time (~40 s) is negligible as a result of the high viscosity
of the bicelle solution, which prevents membrane reorientation.Table 2. Parameters used for ﬁtting the spectra of 5DPC at all P/L ratios:
g and A tensors, diffusion tensor (D), angles between the magnetic and
the diffusion frame (ΩD), angle between the diffusion frame and the
membrane normal (Ψ )
g A/mT D/106 s1
ΩD
a
Ψα β γEPR Experiments
Electron paramagnetic resonance spectra were performed using
a ER200D spectrometer operating at X-band (~9.5 GHz),
equipped with a rectangular cavity, ER4102ST, ﬁtted with a
cryostat, and a variable-temperature controller, ER4111VT, all from
Bruker BioSpin GmbH, Rheinstetten, Germany. The microwave
frequency was measured by a frequency counter, HP5342A. All
spectra were obtained using the following parameters: microwave
power, 2.1mW; modulation amplitude, 0.16mT; modulation
frequency, 100 kHz; time constant, 20ms; conversion time,
41ms; scan width, 15mT; 1024 points; and temperature, 308 K.
All spectra were obtained in a single scan.5DPCb x 2.0088 0.65 8 0° 33° 0° 0°
y 2.0061 0.58 8
z 2.0027 3.35 500
aFor an axial diffusion tensor, the angle α is irrelevant [42].
bg and A tensors were taken from Ref. [48].EPR Spectral Simulations
We performed simulations of 5DPC spectra with a program based
on the stochastic Liouville equation [42] that is extensively used
to simulate EPR spectra of spin-labeled systems [19,43–47]. The
simulation method relies on several reference systems, thewileyonlinelibrary.com/journal/jpepsci Copyright © 2014 Europrelative orientation of which is deﬁned by different sets of Euler
angles [42]. The simulation strategy has been previously given
in detail [18]: the experimental spectra could be precisely
simulated by keeping all the magnetic and motional parameters
of the nitroxide constant, while changing the order parameter S.
The principal values of g and 14N hyperﬁne (A) tensors, the
principal values of the diffusion tensor (D), and the relative
orientation of its principal axes relative to the g tensor reference
frame (ΩD), reported in Table 2, were taken from the literature
[18,48]. The β = 33° value has been attributed to the presence of
a lipid mismatch between the DMPC chains (14 carbons) and
those of 5DPC (18 carbons) [18].Results
Hydrophobic Peptides: Alamethicin, Trichogin GA IV
In a previous report [18], we have shown that alamethicin
progressively perturbed the bilayer upon increasing its concen-
tration. The order parameter of 5DPC decreases exponentially
with the P/L ratio, but the membrane is not completely destroyed
even at a P/L ratio of 1 : 20.
The experimental spectra of 5DPC in bicelles in the absence
and in the presence of trichogin GA IV and the corresponding
simulations are illustrated in Figure 3. The spectrum in the
absence of peptide [Figure 3(A)] shows a simple three-line
structure typical of a partially oriented nitroxide. Macroscopically,
the membrane normal n (Figure 1) lies parallel to the magnetic
ﬁeld of the spectrometer; from a microscopic point of view, the
plane of the 5DPC nitroxide ring is roughly perpendicular to
the membrane normal. Therefore, the average direction of the
nitrogen pz orbital (corresponding to the Azz and gzz tensor
components) is parallel to the external magnetic ﬁeld. Then, the
spectral width of 5DPC in the partially oriented bicelles is
dominated by the largest hyperﬁne tensor component (Azz),
partially averaged because of the complex motions of the lipid
side chains [49].
The lineshape does not change in the presence of trichogin
GA IV up to a P/L ratio of 1 : 300 [Figure 3(B–D)]. Trichogin GA
IV is a hydrophobic peptaibiotic as alamethicin and it is fully
bound to the membrane at these P/L ratios [50]. Thus, our
results suggest that at low P/L ratio, where the peptide is likely
to be monomeric, trichogin GA IV does not perturb the bilayer
structure [50]. At higher P/L ratios [Figure 3(E–H)], the spectra
change in a remarkable way as evident from the ‘kinks’ (see
the arrows in Figure 3) and the general broadening observed.ean Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014
Figure 3. Simulated (colored lines) and experimental (black lines) EPR
spectra of DMPC/DHPC bicelles labeled with 5DPC and oriented with
the magnetic ﬁeld parallel to the bilayer normal, T=308 K. The bicelles
incorporate trichogin GA IV at increasing P/L ratios: (A) no peptide; (B) 1 :
1000; (C) 1 : 500; (D) 1 : 300; (E) 1 : 200; (F) 1 : 100; (G) 1 : 50; and (H) 1 :
25. The arrows indicate the most signiﬁcant changes in the lineshape
induced by the peptide.
Figure 4. Simulated (colored lines) and experimental (black lines) EPR
spectra of DMPC/DHPC bicelles labeled with 5DPC and oriented with
the magnetic ﬁeld parallel to the bilayer normal, T=308 K. The bicelles
incorporate magainin 2 at increasing P/L ratios: (A) no peptide; (B) 1 :
500; (C) 1 : 400; (D) 1 : 300; and (E) 1 : 100.
ANTIMICROBIAL PEPTIDES INTERACTING WITH BICELLESThe changes in lineshape induced by increasing amounts of
peptide have been rationalized using the easily interpretable
order parameter of the spin label, S [18]. S decreases upon
increasing the peptide concentration as the spin labels, and
therefore the phospholipid chains, experience a progressive loss
of order. The graph of the order parameters as a function of the
P/L ratio, which collects the data for all peptides, is shown in the
Discussion section. Overall, the changes in lineshape for
trichogin GA IV as a function of the P/L ratio are very similar to
those of alamethicin [18]. Trichogin GA IV shows an exponential
decrease of the order parameter and a non-vanishing order
parameter even at a P/L ratio of 1 : 25 [Figure 3(H)].Amphipathic Peptides: Magainin 2, HP(2–20), and HPA3
The experimental spectra of 5DPC in bicelles in the presence of
magainin 2 and the corresponding simulations are reported in
Figure 4. The spectra exhibit a dramatic alteration of the
lineshape when magainin 2 is present, relative to the one
observed in the absence of peptide [reported for convenience
in Figure 4(A)]. This alteration is evident at a P/L ratio of 1 : 500.
Moreover, the overall spectral lineshape indicates that magainin
2 induces a much more severe disordering effect on the
membrane than alamethicin and trichogin GA IV. Indeed, the
lineshape observed for magainin 2 at a P/L ratio of 1 : 500 isJ. Pept. Sci. 2014 Copyright © 2014 European Peptide Society and Johvery similar to that observed for trichogin GA IV only at a P/L ratio
of 1 : 50.
The experimental spectra and the corresponding simulations
for the two peptides derived from Helicobacter pylori, HP(2–20)
and HPA3, are illustrated in Figure 5. The two peptides, with the
same length but different net charge and amphipathicity, show
remarkably different effects on the lineshape of the 5DPC spectra
as a function of the P/L ratio. HP(2–20) has no effect on the
bilayer up to a P/L ratio of 1 : 75 [Figure 5(A–C)]. Changes in
lineshape begin at P/L ratios of 1 : 70 and continue up to the
maximum concentration explored in this study at a P/L ratio of
1 : 25 [Figure 5(D–F)]. On the other hand, HPA3 shows strong
alterations of the lineshape at P/L ratios as low as 1 : 375. At P/L
ratios of 1 : 190 and lower, the spectra exhibit an almost
isotropic lineshape.Discussion
The lipid order alterations caused by AMPs can be studied by
different techniques, among others NMR [51–54] and EPR
spectroscopies [18,55], or X-ray diffraction [22]. The experimental
data are typically analyzed in terms of order parameters that
provide information on the average orientation of chemical
bonds, molecular segments, molecules, or assembly of molecules
[56]. In this work, we quantitatively express the bilayern Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
Figure 5. Simulated (colored lines) and experimental (black lines) EPR spectra of DMPC/DHPC bicelles labeled with 5DPC and oriented with the
magnetic ﬁeld parallel to the bilayer normal, T=308 K. The bicelles incorporate HP(2–20), left, or HPA3, right, at increasing P/L ratios: HP(2–20), (A) 1 :
255; (B) 1 : 100; (C) 1 : 75; (D) 1 : 70; (E) 1 : 50; (F) 1 : 25. HPA3, (G) 1 : 375; (H) 1 : 310; (I) 1 : 190; (J) 1 : 100; (K) 1 : 70; and (L) 1 : 50.
BORTOLUS ET AL.perturbation caused by AMPs through S, the order parameter of
the nitroxide moiety in 5DPC, determined from the simulation
of the EPR spectra. In Figure 6, we summarize the results
obtained for all of the peptides at increasing P/L ratios at near
physiological temperature (308 K). As evident from Figure 6, S is
very sensitive to the perturbation induced by AMPs even at low
P/L ratios. Instead, 2H-NMR spectroscopic studies reveal a chain
order proﬁle in which bonds close to the head group region are
almost unaffected [57,58]. The order parameters obtained by EPR
and NMR are not directly comparable because they refer to
different molecular segments and are calculated from different
magnetic interactions. The order parameters obtained by 2H-Figure 6. Plot of the 5DPC order parameter S as a function of the P/L ratio.
The order parameter has been obtained from the simulations of the EPR
spectra of DMPC/DHPC bicelles at 308 K. The horizontal black line at S=0.44
represents the order parameter observed in the absence of peptides.
wileyonlinelibrary.com/journal/jpepsci Copyright © 2014 EuropNMR experiments are determined from the quadrupolar splittings
for the different C–D bonds of the lipid chains (and extended to
the different C–C segments) [54,59], whereas the order parameters
obtained by EPR are calculated from the hyperﬁne interaction of
the nitroxide moiety.
In Figure 6, the ﬁrst point at S=0.44 corresponds to the order
parameter observed in the absence of peptides [Figure 3(A)]. This
value is the upper limit observed in the spectra of oriented
bicelles. When the peptides bind to the bicelles, the order
parameter decreases with the P/L ratio. This trend, however, is
not identical for all peptides, and some important differences
can be observed. Two main groups can be identiﬁed: alamethicin
and trichogin GA IV, hydrophobic peptaibiotics, show an expo-
nential decrease of the order parameter that never approaches
the isotropic limit. Magainin 2 and HPA3, amphipathic cationic
peptides, exhibit a very steep decrease of S at very low P/L ratios;
then, S quickly reaches a plateau at values close to the isotropic
limit (S= 0). The behavior of HP(2–20) is different from those of
both hydrophobic and amphipathic peptides; an initial extended
plateau, where S is at its maximum value, is followed by a sudden
drop to an almost constant value of S (≈0.25).
The AMPs under study are characterized by different length,
hydrophobicity, hydrophobic moment, and charge (Table 1).
These parameters are known to inﬂuence binding and activity
of AMPs toward membranes [6]. For zwitterionic membranes,
such as the DMPC/DHPC bicelles, hydrophobic rather than
electrostatic interactions were shown to affect the AMPs behavior
[6,57]. Thereby, the effects on the order parameter shown in
Figure 6 are not expected to be critically dependent on the net
charge. Our results can be rationalized starting from the observa-
tion that the loss of order in the lipid chains induced by helical
AMPs depends on their insertion depth and on their orientationean Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014
ANTIMICROBIAL PEPTIDES INTERACTING WITH BICELLESrelative to the membrane normal n [57], which in turn are tied to
the mechanism of membrane disruption. Peptides that absorb
parallel to the membrane surface can have very different effects
on the lipid packing (and consequently on the order parameter)
depending on their insertion depth. Peptides that intercalate in
the polar headgroup region cause a large alteration of the lipid
packing, resulting in a strong decrease of the order parameter
[57]. Peptides that penetrate deeper into the membrane should
minimally perturb the bilayer because the mass density and
lateral pressure proﬁle of the bilayer have a local minimum below
the headgroup region [60]. On the other hand, a transmembrane
orientation always leads to a modest decrease of the order
parameter, because the perturbation of the membrane packing
is minimal [57].
We will ﬁrst discuss alamethicin and magainin 2, the mecha-
nism of action of which is well-known. Alamethicin interacts with
the membrane through formation of concentration-dependent
and voltage-dependent barrel–stave pores that do not involve a
strong deformation of the bilayer. Additionally, we have shown
that alamethicin adopts a transmembrane orientation in bicelles
at all P/L ratios [18]. Overall, the gradual and modest decrease
of the order parameter shown in Figure 6 is in excellent
agreement with the behavior of alamethicin. Magainin 2, a
cationic and amphipathic AMP, is the ﬁrst AMP that has been
shown to form the so-called toroidal pores. These are disordered
pores where the peptides and the polar lipid headgroups are
mixed [23–26]. Toroidal pores are now recognized as one aspect
of the more general Shai–Matsuzaki–Huang mechanism that is
usually invoked for cationic amphipathic AMPs. In this model,
the peptides bind parallel to the headgroup region close to the
membrane-water interface. At higher concentrations, they bend
the lipids, forming toroidal pores, and eventually they could
micellize the membrane. Thus, magainin 2 is expected to
strongly disrupt the lipid packing even at low P/L ratio, leading
to the steep and marked decrease of the order parameter
shown in Figure 6.
In this framework, we discuss the effect of the other AMPs on
the bilayer order. Trichogin GA IV is another hydrophobic
peptaibiotic, like alamethicin. Its location in the bilayer and its
mechanism of action have been studied by EPR and several other
spectroscopic and theoretical methods [50,61–68]. Although the
detailed mechanism is still under debate, there is a general
consensus that at low P/L ratios, the peptide is monomeric and
absorbed parallel to the membrane surface below the polar
headgroups. It becomes oligomeric and adopts a transmembrane
orientation at high P/L ratios [66–68]. The insertion depth of
trichogin GA IV at low P/L ratios explains the plateau of the
order parameter that we observe for P/L ratio up to 1 : 300. At
higher P/L ratios, the trend of the order parameter is very similar
to that of alamethicin, indicating a transmembrane insertion.
The curve of trichogin GA IV is shifted to lower values of S than
that of alamethicin, indicating a slightly greater disrupting
effect on the membrane. Alamethicin is long enough to span
the whole bicelle, and tilts its helical axis to minimize the lipid
mismatch, allowing a stable insertion [18]. On the contrary,
trichogin GA IV is too short to span the membrane. We can
speculate that the orientation of its helical axis would be
subjected to large ﬂuctuations because the peptide cannot be
anchored to the membrane surfaces. Moreover, the peptide
has a very ﬂexible linear octanoyl chain at the N-terminus. Both
factors can explain the greater decrease of the order parameter
with respect to alamethicin.J. Pept. Sci. 2014 Copyright © 2014 European Peptide Society and JohBoth HP(2–20) and its synthetic analog HPA3 are amphipathic
and cationic: HPA3 is characterized by two pinpoint substitutions
at the hydrophobic/hydrophilic interface of the helix i.e. two Trp
residues substituted for Gln and Asp (Figure 2). HPA3 was
designed to have higher hydrophobicity and amphipathicity than
HP(2–20), because it was suggested that for good activity AMPs
should possess a high hydrophobic moment coupled to a
moderate hydrophobicity [6]. In agreement with the predictions,
HPA3 has improved activity against bacteria and fungi relative to
HP(2–20) [34]. Its mechanism of action has been studied using a
combination of ﬂuorescence, electron microscopy, and cross-
linking experiments [35]. The experimental data suggest that
HPA3 acts as oligomeric species with formation of discrete
toroidal pores (≈4 nm in diameter) [35]. Our data fully support
the formation of toroidal pores for HPA3, because the curve
of the order parameter shows the same trend as that of
magainin 2, characterized by a steep decrease of the order
parameter at very low P/L ratios and a ﬁnal value of S close to
the isotropic limit.
For HP(2–20), no conclusive evidence for a speciﬁc mechanism
can be found in the literature [35,69–71]. The peptide was shown
to bind as a monomer causing membrane thinning and to create
small pores (2 nm in diameter) in the oligomeric form. In
agreement with the complex picture described in the literature,
the trend of S for HP(2–20) is different from that of the other
peptides. There is an initial plateau where no membrane
perturbation takes place, which extends to a P/L ratio of 1 : 75.
Then, S rapidly drops and stabilizes at intermediate values, in
between those shown by alamethicin and trichogin GA IV. These
results can be discussed in light of the much lower hydrophobic-
ity of HP(2–20) relative to that of HPA3. We calculated that
although the difference in the hydrophobic moment is modest,
3.98 for HP(2–20) versus 4.07 for HPA3, there is a great variation
in the hydrophobicity, 2.75 for HP(2–20) versus 0.98 for
HPA3 (Table 1). The very low hydrophobicity, compared with
those of the other peptides, implies that the afﬁnity of HP(2–20)
for the zwitterionic lipid bilayer is limited, and the binding
constant is probably low. The initial plateau of the order parame-
ter is the result of extremely low concentrations of membrane-
bound peptide. Once a critical concentration is reached, the
peptide binds to the membrane and causes the observed
decrease of the order parameter. Given its high hydrophobic
moment, it is reasonable to hypothesize that the peptide is
bound parallel to the surface. However, because the angle
formed by the hydrophilic sector of HP(2–20) is very high
(~220°), much higher than those of HPA3 (~180°) or magainin 2
(~120°), HP(2–20) probably resides closer to the surface as compared
with the other two peptides. The limited decrease of the order
parameter seems to indicate that HP(2–20) saturates the membrane
at low concentrations of bound peptide. Overall, our data suggest
that the behavior of HP(2–20) cannot be simply reconducted to
either of the two mechanisms of membrane disruption discussed
earlier. More probably, this peptide induces the formation of
transient openings in the membrane when the regions of irregular
lipid packing surrounding each monomer overlap.Conclusions
In this work, we studied the interaction of macroscopically
oriented DMPC/DHPC bicelles, doped with the spin-labeled
phospholipid 5DPC, with several AMPs at physiological temperaturen Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
BORTOLUS ET AL.and at different P/L ratios using EPR spectroscopy. The lineshape of
5DPC proved to be very sensitive to the presence of the peptides,
even at very low P/L ratios. The simulation of the EPR spectra
allowed us to determine the variation of S, the order parameter of
5DPC, as a function of the P/L ratio.
We compared the EPR spectra obtained for three peptides for
which the mechanism of action is not well-deﬁned, HP2-20,
HPA3, trichogin GA IV, with the results on two peptides that are
prototypes of the principal mechanisms of pore formation,
magainin 2 (toroidal pores) and alamethicin (barrel-stave pores).
In our experiments, magainin 2 shows a strong perturbation of
the order parameter at very low P/L ratios and leads to a steep
decrease of the lipid order parameter that almost reaches the
isotropic limit as the peptide concentration is increased. On the
contrary, alamethicin displays a gradual lowering of the order
parameter, moderate even at high P/L ratios. On the basis of
the results for the two archetypical peptides, we conclude that
trichogin GA IV, a hydrophobic lipopeptide, inserts deeply below
the lipid head groups and acts in a similar way as alamethicin. HPA3,
a cationic, amphipathic peptide, shows the same behavior of
magainin 2 and thus likely forms toroidal pores. Finally, HP(2–20),
also a cationic, amphipathic peptide, but much more hydrophilic
than HPA3, does not follow simply one of the two classic
mechanisms of membrane disruption.
In conclusion, we have shown that AMPs with different mech-
anisms of action show very different trends of the order parame-
ter as a function of peptide concentration. Therefore, we suggest
that bicelles, in combination with EPR spectroscopy, represent a
valuable tool to evaluate how the membranes are disrupted by
new AMPs.
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A series of lipid-functionalized nitroxides having a pyrroline nitroxide moiety linked either to a glycerol or to
a steroid unit has been synthesized, and their inclusion inside phospholipid bilayers has been investigated by
Electron Paramagnetic Resonance (EPR) spectroscopy. The antioxidant behavior of these nitroxides has
been studied in azo-initiator induced lipid peroxidation by means of the Thiobarbituric Acid Reactive
Species (TBARS) assay; a correlation with their penetration depth within the bilayer has been found. The
possible mechanisms involved in the antioxidant action have been considered, discussed and alternative
pathways have been suggested for the synthesized liponitroxides due to their diﬀerent localization. The
steroid derivative is limited to scavenging radicals that are generated in the aqueous phase, while the
glycerolipids can also act as chain breaking antioxidants.Introduction
Lipid peroxidation (LP) is a critical and common damaging
process in biological membranes and liposomial dispersion
containing polyunsaturated fatty acids (PUFAs). The associated
damage is highly detrimental to the functioning of the cell and
its survival, since membranes form the basis of many cellular
organelles like mitochondria, plasma membranes, lysosomes,
peroxisomes, etc. Thus, prevention of LP represents an inter-
esting therapy in many diseases and pathologies involving free
radicals1 and is also an important aspect in the preparation and
preservation of liposomes to be used as carriers for several
agents in medicinal, pharmaceutical, cosmetic and food
industry applications.
In this context cyclic nitroxides (aminoxyls), stable
compounds with an unpaired electron on the N–O functionnces, Universita` Politecnica delle Marche,
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hemistry 2015included in an aliphatic or aromatic ring system, have gained
popularity as a distinct class of antioxidants thanks to their
protective eﬀects against oxidative stress in a multiplicity of
biological systems.2 It has been shown that nitroxides eﬀectively
protect cells, tissues, organs, and animals from radical-induced
damage and that these antioxidant activities derive from their
abilities to scavenge radicals,3 catalyze superoxide dis-
mutation,4 facilitate catalase-like activity of heme-proteins,5
detoxify hypervalent metals, and oxidize reduced transition
metals ions.6 The antioxidant activity of both aliphatic7 and
aromatic8 nitroxides against radical-induced LP has been
extensively studied due to the importance and seriousness of
this phenomenon. In fact, their reactivity toward lipid derived
radicals (Lc) via radical–radical coupling is well known and
documented, whereas more controversial is that toward oxygen-
centred radicals (ROS, reactive oxygen species)9 which is still
debated.10 However, it has been shown that nitroxides are able
to reduce alkylperoxyl radicals forming the corresponding
oxoammonium cations (pN+]O) and that a relationship
between the oxidation potentials of nitroxides and their peroxyl
radicals scavenging abilities exists.10a Since peroxyl radicals are
important intermediates in LP, it follows that the antioxidant
power of a nitroxide against lipid peroxidation should be
determined by its radical scavenging ability as well as its redox
potential. However, these are not the only aspects that demand
consideration, given the complexity of biological lipid
membranes and of LP, a process in which the formation of the
damaging species is not uniform across the membrane. Since
the peroxidation normally takes places at the fatty acids double
bonds, which are located at specic positions in the bilayers,
the structure of the nitroxide, its penetration as well as itsRSC Adv., 2015, 5, 98955–98966 | 98955
Chart 1 Lipid-functionalized nitroxides NOXs synthesized and tested
for their antioxidant activity.
Table 1 Half-wave (E1/2) redox potentials (vs. NHE) of studied species
at 298 K
Speciesa (Red) – E1/2/V (Ox) – E1/2/V
DOG-NOa 1.58b,c 1.33
OG(L)-NOa 1.57b,c 1.31
OG(L)-NO(ads) — 1.12
Chol-NOa 1.59b,c 1.32
Chol-NO(ads)d 1.07c 1.16
a In a 0.08 M TBAPF6/THF solution.
b Sluggish electrochemical process.
c Irreversible process, peak potential. d Drop casted species on GC
electrode in a 0.08 M NaBF4 aqueous solution buﬀered (pH ¼ 7.4)
with phosphate buﬀer.
RSC Advances Papermobility in the membrane interior have also to be taken into
account. For these reasons, lipid-functionalized nitroxides that
have a good aﬃnity for lipid bilayer are attractive molecules to
be used as antioxidants, but so far, they have been synthesized
mainly as potential spin probes for Electron Paramagnetic
Resonance (EPR) spectroscopy11 in the context of membrane
structure studies.12 Only in one case the antioxidant activity of
two steroidic nitroxyl radicals has been also studied.7a
In this work, a series of lipid-functionalized nitroxides
(NOXs) has been synthesized (Chart 1) with the double aim of
locating the nitroxide at diﬀerent depths inside the lipid
membrane, and to look for relationships between their location
and antioxidant activity. These compounds have a pyrroline
nitroxide linked to a cholesterol unit or to glycerol esteried
with one or two oleoyl moieties. In particular, the glycerol-
functionalized nitroxides contain one (OG-NO/OG(L)-NO) or
two (DOG-NO/DOG(L)-NO) oleic acid chains, which may diﬀer-
ently anchor the molecule into the lipid bilayer. Moreover, two
of the NOXs have a polar spacer group in the headgroup region
(OG(L)-NO and DOG(L)-NO), which is expected to push the
pyrroline nitroxide toward the lipid–water interface. The elec-
trochemical behaviour of the synthesized compounds has been
studied both in THF solution and in an aqueous environment to
evaluate their oxidation potential. The position, orientation and
dynamics of the NOXs inside the bilayer have been determined
using diﬀerent EPR techniques both in liposomes (small uni-
lamellar vesicles, SUV) and in bicelles.13 Finally, the antioxidant
activity of the synthesized NOXs has been studied during
radical-induced peroxidation of egg-yolk L-a-phosphatidylcho-
line (Egg-PC) liposomes, chosen as model membranes, and
discussed on the basis of their position inside the lipid.
Results
Redox properties
The electrochemical investigation of the nitroxide species was
carried out by cyclic voltammetry (CV) in tetrahydrofuran (THF)
and in solid state as lm in aqueous electrolyte solution (drop-
casting the nitroxide lipid onto glassy carbon (GC) disk elec-
trode surface) in aqueous electrolyte solution, at room
temperature, using platinum and GC disk as working electrode.
THF was chosen as it has a relatively low dielectric constant and98956 | RSC Adv., 2015, 5, 98955–98966so the species are in an environment more similar to that inside
a bilayer. The redox potentials of three among the synthesized
compounds are collected in Table 1 which are representative for
all the others. In fact, it is reasonable to admit that the structure
of the lipid portion of the molecule does not substantially aﬀect
the redox activity centred on the nitroxide unit.
The cyclic voltammetric curves of Chol-NO, in THF and in
buﬀered aqueous solution (drop casted lm onto a CG disk
electrode) are reported in Fig. 1 (see also Fig. S1† for the elec-
trochemical behaviour at 213 K and Fig. S2† for the background
curves in aqueous electrolyte, in the ESI†). In both cases, it is
possible to observe a reversible one-electron oxidation process
with a half-wave potential of 1.32 V (THF) and 1.16 V (PBS) vs.
NHE. This can be safely attributed14 to the oxidation of the
nitroxide moiety to form the oxoammonium cation pN]O+. On
the negative potential side, a one-electron chemically irrevers-
ible reduction process can be observed with a cathodic peak
potential of 1.59 V (THF) and 1.06 V (PB) vs. NHE.
As expected, no substantial diﬀerences were found between
the redox potentials of the variousNOXs since the portion of the
molecule involved in the redox processes (the pyrroline moiety)
is the same in all cases.Penetration depth
The dimensionless immersion depth parameter F was ob-
tained by measuring the enhancement of the relaxation
properties (which are related to the saturation of the EPR
transitions) for the diﬀerent NOXs generated by the collision
of the radicals with paramagnetic relaxing agents having
a diﬀerent distribution inside and outside the membrane. By
using either a lipophilic or a hydrophilic agent, respectively
oxygen or the complex nickel-ethylenediamine-N,N0-diacetic
acid (NiEDDA),15 the relaxation properties of NOXs will be
aﬀected diﬀerently, depending on the localization of the
nitroxide with respect to the plane of the phosphate groups
of the bilayer. The position of the nitroxide relative to
such a plane was obtained by comparing the results on the
NOXs with those of nitroxide-labeled phospholipids (SLs)15
used as standards: 1-palmitoyl-2-stearoyl-(n-doxyl)-sn-glycero-
3-phosphocholine (nDPC) and 1-palmitoyl-2-oleoyl-sn-glycero-
3-phospho(tempo)choline (TempoPC).This journal is © The Royal Society of Chemistry 2015
Fig. 1 Cyclic voltammetric curves of species Chol-NO. (a) 1 mM in
0.08 M TBAH/THF solution. Sweep rate 1 V s1, working electrode: Pt
(125 mm, diameter), T ¼ 298 K; (b) COL-NO drop-casted onto a GC
disk electrode (3 mm, diameter), 0.08 M NaBF4 aqueous solution with
PB buﬀer at pH ¼ 7.4, sweep rate 0.2 V s1, T ¼ 298 K.
Table 2 Penetration depth parameter (F) of the diﬀerent reference
spin labels (SL) and of the NOXs in POPC small unilamellar vesicles
obtained at room temperature. The reported uncertainty is a rough
estimate based on repeated experiments
SL F (0.1) NOX F (0.1)
TempoPC <0.3a Chol-NO 0.7
5DPC 1.4b DOG(L)-NO 1.4
7DPC 1.2b DOG-NO 1.8
10DPC 2.1 OG(L)-NO 1.9
12DPC 2.4 OG-NO 2.1
14DPC 3.0
a Repeated measurements of TempoPC showed a large variability in F,
but always lower than 0.3. b The apparent inversion of F is present also
in the original paper.15
Paper RSC AdvancesEPR spectra of NOXs in 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) small unilamellar vesicles (SUV) at
room temperature (298 K) at low microwave power (2 mW) are
reported in Fig. 2, panel (f). These spectra have a lineshape
much broader than that of NOXs in buﬀer solution (the spec-
trum of OG in buﬀer is reported for comparison). The broad
lines are indicative of the damping of the nitroxide motion
caused by its incorporation in the liposomes. NOXs spectra in
membranes are discussed in detail in the next section.
In Fig. 2, panels (a)–(e), the saturation curves (and the cor-
responding tting) for each sample in the presence of either
oxygen or NiEDDA are also shown.
All the experimental details, the tting procedure, and the
used formulas are described in the Experimental section. From
the tting, the saturation parameters, pi1/2 were obtained
allowing the determination of immersion depth parameters F
(the accessibility parametersPi, to oxygen and to NiEDDA, were
determined and reported in ESI, Table S1†). The results of theFig. 2 Power saturation curves (dots), their ﬁtting (lines) and EPR
spectra of the NOXs in POPC small unilamellar vesicles acquired at
roomtemperature (298K) indiﬀerent conditions: black squares, purged
with nitrogen; red dots, in equilibrium with air (oxygen); blue triangles,
50 mMNiEDDA and purged with nitrogen. The EPR spectra are relative
to the nitrogen purged samples and are taken at lowmicrowave power.
For comparison we report the spectrum of OG in buﬀer.
This journal is © The Royal Society of Chemistry 2015analysis are summarized in Table 2, where the reported data are
the average of experiments performed at least in duplicate. The
table reports the adimensional parameters F for standard
nitroxide-labeled lipids (SL) and for our NOXs ordered by the
increasing penetration depth. Overall, the data show that the
water accessibility of NOXs decreases in the order: Chol-NO[
DOG(L)-NO > DOG-NO z OG(L)-NO z OG-NO.Liponitroxides in bicelles
To fully understand, at a molecular level, the motion and
orientation of NOXs in the bilayer, we recorded and simulated
their EPR spectra in oriented lipid bicelles at near physiological
temperature (308 K), Fig. 3. Bicelles have the peculiarity, with
respect to micelles or vesicles, to be macroscopically oriented in
solution at physiological temperature under a magnetic eld,
a property that makes them invaluable for the determination ofFig. 3 Top, schematic representation of a bicelle. Panel (a), EPR
spectra of NOX in DMPC/DHPC bicelles at 308 K. In black the spectra
recorded with B0kn, in red the spectra recorded with B0tn. Panel (b),
spectral simulations (black B0kn; red B0tn).
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RSC Advances Paperthe order and dynamics of solutes and biological molecules in
bilayers.13,16
These systems are composed of planar regions, made
primarily by long chain phospholipids 1,2-dimyristoyl-sn-glyc-
ero-3-phosphocholine (DMPC), and of curved edge regions,
composed by short-chain phospholipids, 1,2-dihexanoyl-sn-
glycero-3-phosphocholine (DHPC). EPR spectra of NOXs in
bicelles, oriented with the magnetic eld (B0) parallel (black
line) and perpendicular (red line) to the membrane normal (n),
are reported in Fig. 3, panel (a). The spectral simulations, shown
in dotted lines in panel (b), are in a rather good agreement with
experimental data and oﬀer some insight on the motional
parameters of NOXs as well as on the orientation of the nitro-
xide moiety relative to the membrane normal; the simulation
parameters are reported in Table 3. The orientation procedure
and the simulation details are described in detail in the
Experimental section.
The spectra show a single species in slow-motion re´gime,
characteristic of the inclusion of the pyrroline group inside the
high-viscosity membrane region. The principal values of the
axial rotational diﬀusion tensor D (Dkz Dt)
18 are in the order
of 108 s1, typically 1–2 order of magnitudes lower than in water
and this is a clear indication that NOXs are fully incorporated in
the bicelles. The motion of the nitroxide unit in the glycer-
olipids is strongly aﬀected by the presence of the additional
ethylene glycol unit. The lipids with the ethylene glycol linker
(OG(L)-NO, DOG(L)-NO) have an almost isotropic motion (Dkz
Dt), indicating that the rotational motion of the nitroxide is
almost independent from the motion of the lipid tail. On the
contrary, when the nitroxide is directly attached to the glycerol
unit (OG-NO, DOG-NO) the diﬀusion tensor is axial and typical
of a molecule with a prolate shape (Dk > Dt). The cholesterol
derivative Chol-NO undergoes a slower and more axial motion
than the glycerolipids, as expected from its bulky anisotropic
shape.
A further conrmation of the inclusion of the pyrroline
group inside the membrane is given by the gxx and Azz values
obtained from the simulations. These values are sensitive to the
polarity of the environment and, as found by M. Plato et al,17
they range from ca. gxx ¼ 2.0090 and Azz ¼ 3.35 mT in an apolar
environment to ca. gxx ¼ 2.0083 and Azz ¼ 3.65 mT in a highlyTable 3 Parameters used for the ﬁtting of the spectra ofNOXs in bicelles
the diﬀusion frame (UD), order parameter (S). The g tensor for all NOXs is
0.60 mT; Ayy ¼ 0.5 mT; Azz ¼ 3.35 mT for all glycerolipids Axx ¼ 0.60 m
OG-NO DOG-NO
D/s1 Dk 3.16  108 3.16  108
Dt 0.79  108 0.79  108
UD
a b 42 40
g 90 90
S Sxx 0.08 0.10
Syy 0.08 0.10
Szz +0.16 +0.20
a For an axial diﬀusion tensor the angle a is irrelevant.18
98958 | RSC Adv., 2015, 5, 98955–98966polar environment. As shown in Table 3, the obtained values
clearly indicate that all NOXs are in an apolar environment; the
Azz value for Chol-NO is larger than the others (3.45 mT vs. 3.35
mT, respectively), suggesting that the pyrroline moiety of this
nitroxide is located in a slightly more polar environment.
The linewidths (Gaussian linewidths#0.1 mT for all spectra)
are such to exclude NOXs clusterization that would have
generated signicant Lorentzian line broadening by spin–spin
interaction.
As shown in Fig. 3, diﬀerent spectra were recorded when
bicelle planes were parallel or perpendicular to the magnetic
eld. This means that NOXs are oriented with respect to the
membrane surface; with the exception of DOG(L)-NO which has
almost completely overlapping spectra. The diﬀerences in the
spectra between the two orientations depend on the degree of
order experienced by the nitroxide in the bilayer: this is quan-
titatively expressed in Table 3 by the principal values of the
adimensional, traceless, order parameter matrix S, in particular
by the Szz componenent. OG(L)-NO and DOG(L)-NO have
a smaller degree of order than OG-NO and DOG-NO. These
results, together with the observed values for the rotational
diﬀusion tensors, further conrm that the ethylene glycol unit
decouples the motion of the pyrroline unit from that of the lipid
chains. In particular, DOG(L)-NO has almost a negligible degree
of order. On the other hand, the cholesterol derivative Chol-NO
has a much larger degree of order than the glycerolipids and,
interestingly, it displays a biaxial orientation (Sxx s Syy s Szz),
which is typical for molecules having a strongly anisotropic
shape.
EPR spectra simulations also give information about the
orientation (given by the Euler angles UD) of the nitroxide ring
relative to the principal diﬀusion axis (UD) and hence of the
chain bearing the pyrroline group relative to the membrane
normal. For all glycerolipids, the plane of the nitroxide ring is
tilted relative to the membrane normal (bD s 0, Table 3),
suggesting that the headgroup is not in a fully extended
conformation. OG(L)-NO shows a signicantly larger tilt (bD ¼
65) than the other glycerolipids (bD 40) and this is evident in
the spectra with a narrower width for the B0kn orientation than
for the B0tn one. The larger tilt for OG(L)-NO suggests that the
low water accessibility of this NOXs (if compared with that of. Rotational diﬀusion tensor (D), Euler angles between themagnetic and
gxx¼ 2.0088; gyyx¼ 2.0061; gzz¼ 2.0027. The hyperﬁne tensor is Axx¼
T; Ayy ¼ 0.5 mT; Azz ¼ 3.45 mT for Chol-NO
OG(L)-NO DOG(L)-NO Chol-NO
1.94  108 1.94  108 4.20  108
1.54  108 1.54  108 0.08  108
65 40 90
90 90 48
0.05 0.015 0.19
0.05 0.015 0.22
+0.10 +0.03 +0.41
This journal is © The Royal Society of Chemistry 2015
Paper RSC AdvancesDOG(L)-NO which has the same ethylene glycol unit) is the
result of the nitroxide ring folding back on the lipid chain
towards the bilayer interior. For Chol-NO, the plane of the
nitroxide ring lies perpendicular to themembrane normal (bD¼
90) and, by considering the shape of the molecule, this
suggests that the nitroxide ring is coplanar with the cholesterol
rings.Fig. 5 Relative EPR signal intensities (h/h0) versus time in Egg-PC
liposomes loaded with nitroxides upon incubation with AAPH at 310 K.
The nitroxide radical EPR signal intensity was measured as the total
peak to peak intensity of the lower ﬁeld peak.Antioxidant activity
The antioxidant activity of the synthesized NOXs against
radical-induced lipid peroxidation was evaluated in SUV of Egg-
PC containing poly-unsaturated chains susceptible of oxidation.
The water-soluble azo-initiator 2,20-azobis(2-amidinopropane)
dihydrochloride (AAPH) was used as the radical generating
system since it thermally decomposes at a constant rate
producing a continuous ux of radicals.19
The water soluble nitroxide, 3-carboxy-2,2,5,5-tetramethyl-
pyrroline-1-oxyl (Pyrr-NO) was included in the study for
comparison.
The antioxidant activity of the synthesized lipo-nitroxides
NOXs, and of Pyrr-NO, was evaluated by measuring the
percentage inhibition of aldehydic breakdown products (Thio-
barbituric Reactive Species, TBARS) formed during the perox-
idation process and shown in Fig. 4. Even if TBARS assay is not
so specic and may give overestimated results, it remains
however the simplest, cheapest and widely used method for
identifying the presence of lipid peroxide products (malon-
dialdehyde and other aldehydes).
All synthesized compounds are able to inhibit lipid perox-
idation in a percentage range 40–70%, with glycerolipid deriv-
atives being more active than the cholesterol-functionalized
analogue. A good antioxidant activity was observed also for Pyrr-
NO.EPR signal decay
The EPR signal decay of the functionalized nitroxides incorpo-
rated in liposomes, or added to liposome suspensions as for theFig. 4 % Inhibition of TBARS formation in PC (3 mM) liposomes per-
oxidation by NOXs or Pyrr-NO (0.06 mM) induced by thermal
decomposition (310 K, 2 h) of AAPH (5 mM).
This journal is © The Royal Society of Chemistry 2015pyrroline nitroxide, was followed by EPR spectroscopy during
incubation with AAPH at 310 K. The results are given as h/h0,
where h is the total peak to peak intensity of the lowest line of
the EPR signal at time t and h0 is the total peak to peak intensity
of the same line at the initial time. The signal intensity
decreased during incubation time as shown in Fig. 5, where
typical decays are shown for OG(L)-NO, Chol-NO and Pyrr-NO
nitroxides. All the glycerolipid-derivatives have a gradual
decay similar to OG(L)-NO with the almost complete disap-
pearance of the signal aer ca. 1 hour without a clear delay (data
not shown). The same trend was observed for the decay of Chol-
NO EPR signal, but in this case the decay was slower and the
signal disappeared in almost 2 hours.
On the other hand, Pyrr-NO behaved in a diﬀerent way,
showing a delay in the EPR signal decay. The same experiment
was carried out in the absence of oxygen by degassing with
argon the sample before incubation at 310 K and a gradual and
more rapid decay without any delay (data not shown) was
observed. For comparison, also lipid-functionalized nitroxides
were incubated with AAPH in the absence of oxygen, but no
diﬀerences in their EPR behaviour were observed.Discussion
OG-NO, DOG-NO, and OG(L)-NO have a similar penetration
depth (F z 2.0) and, by comparing this value with those ob-
tained for the SLs, it can be deduced that the nitroxide function
in these derivatives is located between the seventh and tenth
carbon of the lipid tails, well inside the bilayer. DOG-(L) has
instead a F comparable to that of 5DPC, suggesting that the
combination of two lipid tails with the exible ethylene glycol
unit allows it to point towards the aqueous phase. The nitroxide
group of Chol-NO is located in the headgroup region: it has
a lowF and has a Azz value of 3.45 mT (Table 3), close to a typical
value for a polar environment.
The diﬀerent position/penetration of nitroxides can be
correlated with their antioxidant activity: in Fig. 6, the %RSC Adv., 2015, 5, 98955–98966 | 98959
Fig. 6 Linear correlation between the % inhibition of theNOXs and the
penetration depth. The red bar indicates the F value of the region
C10–C12 that includes the bis-allylic carbon (C11) of PUFAs.
Scheme 1 Initiating steps of Egg-PC lipid peroxidation.
Scheme 2 Possible mechanisms of action of NOXs towards radical
species involved in the process (initiation in the aqueous phase and
propagation in the lipid bilayer).
RSC Advances Paperinhibition of lipid peroxidation obtained in the TBARS assay is
plotted as a function of the penetration depth parameter F.
The gure shows that the antioxidant activity increases
linearly with the penetration depth. The maximal activity is
reached when NOXs are close to the most common position of
the double bonds in PUFAs (red rectangle in the gure). In fact,
the most active NOXs are located in the proximity of the bis-
allylic hydrogen atoms of the linoleic chain (15% of the fatty
acid residues of PC are represented by polyunsaturated linoleic
acid), which are preferentially abstracted by radical initiators
(peroxyls, alkoxyls, etc.) in the rst step of LP (Scheme 1). This is
in agreement with data reported in the literature according to
which nitroxides work as better inhibitors in the peroxidation of
rat liver microsomes7c if they are at the same depth of the
generated radicals in the bilayer.
Peroxyl radicals are usually considered as initiators of LP. In
the present work, they are initially formed in the aqueous phase
by the rapid reaction between AAPH-derived C-centred radicals
and oxygen (the coupling is nearly diﬀusion controlled, kx 109
M1 s1). They are able to cross the lipid membrane and to
abstract a labile hydrogen atom from a lipid chain giving the
corresponding C-centred radical Lc in the propagation step (k ¼
16 M1 s1).20 Alternatively, alkylperoxyl radicals may also
dimerize to give the corresponding unstable tetraoxide which,
in turn, decomposes with formation of molecular oxygen and of
the corresponding alkoxyls (k x 105 M1 s1 in water), as evi-
denced by spin trapping experiments,21 (reactions 3 and 4 in98960 | RSC Adv., 2015, 5, 98955–98966Scheme 2), able to initiate lipid peroxidation and to generate Lc
radicals, as well. LP process has thus been triggered and NOXs,
being incorporated in the membrane interior, might act as
chain-breaking antioxidants by reacting with the lipid-derived
C-radicals (Lc) through a fast radical coupling22 or with the
corresponding O-centred radicals (peroxyls LOOc and alkoxyls
LOc formed in the bilayer from the reaction of Lc with oxygen)
though an electron transfer process.10a At physiological
temperature and pO2, the concentration of Lc should be lower
than that of LOOc, hence the reaction between NOXs and alkyl
radicals should be disfavoured with respect to that with oxygen-
centred ones. However, a competition between nitroxides and
oxygen towards Lc radicals cannot be ruled out, although oxygen
is about four times more concentrated in membranes than in
aqueous phases.23 In fact, the reaction rate between Lc and O2 to
yield LOOc does not depend only on oxygen partition but also on
its diﬀusion, which is ca. 10 times slower in lipid bilayer than in
water.
Lipid-functionalized nitroxides could in principle react both
with C-centred radicals (Lc) and O-centred radicals derived from
AAPH, or generated from the lipid chains (LOc and LOOc), but
all these reactions have to be considered on the basis of the
redox potentials of the NOXs.
Focusing on the oxidation potentials listed in Table 1 for
NOXs and the redox potentials reported for peroxyl radicals,24
an electron transfer process25 (reaction 6, Scheme 2) is rather
unlikely to occur in a lipidic environment especially if an “outer
sphere” single electron transfer mechanism is considered. More
favorable is the reaction when the oxidizing species are alkoxyl
radicals (reaction 5, Scheme 2) instead of peroxyls due to their
higher reduction potentials.24 However, it cannot be excluded
that the reaction between NOXs and O-centred radicals (per-
oxyls and alkoxyls) proceeds according to an inner-sphere
electron transfer mechanism.10a
On the other hand, if the reactions reported in Scheme 2 are
considered from a kinetic point of view, we can observe that
once the initiating C-centred radicals are formed (Rc could
derive from AAPH in the aqueous phase or from the lipid chains
inside the membrane), they may react either with molecular
oxygen or with NOXs (reactions 1 and 2, respectively). A
competition between the two reactions is possible, both
processes being characterized by very high rate constants nearThis journal is © The Royal Society of Chemistry 2015
Paper RSC Advancesto the diﬀusion control limit in liquid solutions. However, it has
been reported that in the system under investigation, water-
soluble peroxyl radicals are generated from AAPH decomposi-
tion approximately at a rate of 108–109 M s1,26 thus repre-
senting the rate determining step for the whole process. In fact,
all the rate constants for the reactions reported in the scheme
should be 3–4 order of magnitude higher and very close to each
other,27 and could occur with the same probability. The formed
peroxyls may thus undergo self-decomposition (reactions 3 and
4) to give the corresponding alkoxyls, able to propagate
the oxidative process by a H-abstraction from lipid chains
(kabsz 10
5 M1 s1), or to be reduced by nitroxides (reaction 5).
In this latter reaction, as well in reaction 6, oxoammonium
cations are formed which are known to be strong oxidants, able
to react with alkyl radicals as indicated in reaction 9.28
The minor protection eﬀect against lipid peroxidation
observed for the cholesterol-derivative may be likely explained
considering its location close to the membrane surface, far away
from the site of generation of Lc radicals. Chol-NO could thus
react with the initiators radicals (O-centred ones) formed by
AAPH, before they reach the oxidable lipid chain. Moreover,
Chol-NO has a reduced mobility inside the membrane due to its
rigid structure and liposomes viscosity as well. As a conse-
quence, the initiating radicals generated in the aqueous phase
are only partially intercepted by the antioxidant and can thus
propagate the peroxidation of the lipid bilayers. In fact, only
a small fraction of attacking radicals is suﬃcient to induce
chain oxidation of many lipid molecules.
The good antioxidant activity of Pyrr-NO, comparable with
those of the glycerolipid functionalized nitroxides and better
than that of Chol-NO, may be explained considering its location
in the water phase, where the initiating radicals are generated
and where the reaction (electron transfer) is expected to occur.
In fact, as shown in Table 1 or reported in the literature,14 the
pyrroline moiety is more easily oxidized in an aqueous envi-
ronment even by peroxyl radicals: a rate constant of 8.1  105
M1 s1 has been reported10a for the reaction between 3-car-
bamoylproxyl nitroxide and t-butylperoxyl radicals in aqueous
solution. Similar or even higher rate constants (according to
their reduction potentials24) are expected for the reduction of an
alkoxy radical by a nitroxide.
EPR measurements of NOXs signal decay indicate that the
disappearance of the signal is gradual, with no delay, and rather
slow likely because of the occurrence of reactions 7, 8 and 9
(Scheme 2).9,29 The even slower decay observed with Chol-NO
compared to that of the other glycerolipid nitroxides can be
justied by its localization and lower mobility within the
bilayer30 and is in agreement with its lower antioxidant activity.
The presence of a delay in the Pyrr-NO signal decay indicates
that during this time interval it reacts very slowly with O-centred
radicals7e,31 generated from AAPH and, once the oxygen dis-
solved in solution has been consumed, Pyrr-NO reacts with
AAPH derived C-centred radicals (reaction 1, Scheme 2). This
latter reaction accounts also for the fact that the signal decay
was faster in the absence of oxygen and with no delay. On the
other hand, since no diﬀerences were observed with NOXs, in
the presence or in the absence of oxygen, it could beThis journal is © The Royal Society of Chemistry 2015hypothesized that with these derivatives the coupling of the
nitroxide with C-centred radicals formed from AAPH and from
the lipid chains represents the main reaction.
According to the TBARS assay, glycerolipid nitroxides and
Pyrr-NO seem to have the same antioxidant activity, whereas
EPR signal decays are rather diﬀerent. This could be explained
by considering the diﬀerences between the two kinds of exper-
iments. As already said, TBARS assays allow the determination
of the nal aldehydic products of LP without considering the
fate of the antioxidant, i.e. the nitroxide in the present work. On
the other hand, when EPR measurements are performed, the
disappearance of the nitroxide is monitored and hence we have
direct information on the nitroxide, on its reactivity and on its
fate. NOXs in liposomes are consumed faster than Pyrr-NO in
the water phase and this may likely be due to the fact that Pyrr-
NO may react only with O-centred radicals, whereas NOXs react
both with C- and O-centred radicals. Moreover, the radicals
present in the aqueous phase are those deriving from the slow
decomposition of the azo-initiator, while in the lipid environ-
ment where peroxidation, a radical chain process, is occurring
we can expect that the number of radical species should be
higher.
Conclusions
The antioxidant activity of nitroxides functionalized with
cholesterol or glycerol units NOXs has been studied and corre-
lated with their penetration into POPC liposomes chosen as
model membranes. NOXs are selectively incorporated at
diﬀerent depths in the bilayer in close proximity to the site of
damage during lipid peroxidation. Those derivatives which are
closer to the oxidable carbon atoms of the lipid chains are better
inhibitors of lipid peroxidation.
Moreover, the obtained results indicate that nitroxides may
behave diﬀerently according to their localization. In particular,
they can be seen as preventive or chain-breaking antioxidants
according to their environment and to their penetration atti-
tude within the bilayer. Chol-NO, which is inserted in the
membrane but close to the surface, can scavenge initiating
radicals but not the lipophilic radicals formed during the
propagation steps and hence is not able to break the chain
propagation. On the other hand, the glycerol nitroxides residing
deeper in the membrane interior may not only block the initi-
ating radicals but may also be regarded as chain-breaking
antioxidants, being able to intercept the radicals responsible
for the propagation of the lipid peroxidation. This is of partic-
ular interest since the antioxidant activity oen depends more
on the localization than on the chemical reactivity.
As a concluding remark, we point out that our approach is
based on the combination of advanced experimental tech-
niques that allowed us to probe the properties of these system
in-depth. Nevertheless, in modern EPR spectroscopy, there is
not only a trend towards to the use of DFT methods for the
evaluation of the EPR parameters,32 but also to the integration
of spectroscopic data, DFT and molecular dynamics to better
characterize the eﬀects of the molecular motions in diﬀerent
environments.33 Despite the availability of these methods, theyRSC Adv., 2015, 5, 98955–98966 | 98961
Scheme 3 Reagents and conditions: (A) (i) DCC, DMAP, dry DCM, rt,
on, 63%. (B) (ii) DCC, DMAP, DCM, rt, on, 51%. (iii) p-TsOH, CH3OH, rt,
on, 72%. (iv) Oleic acid (1 or 2 eq.), DCC, DMAP, DCM, rt, on, 50% (OG-
NO), 88% (DOG-NO). (C) (v) NaH (60%), dry THF, 0 C then rt, on, 40%.
(vi) LiAlH4, dry THF, 0 C, 83%. (vii) DCC, DMAP, DCM, rt, on, 62%. (viii)
p-TsOH, CH3OH, rt, on, 72%, 98%. (ix) Oleic acid (1 or 2 eq.), DCC,
DMAP, DCM, rt, on, 40% (OG-(L)-NO), 67% (DOG(L)-NO).
RSC Advances Paperhave not been applied yet to rene the interpretation of EPR
data in complex environments such as biological membranes,
and we think that this approach could represent an interesting
development in this eld.
Experimental section
All materials and reagents used in the synthesis of NOXs were
purchased from Sigma-Aldrich and used without purication.
2,2,5,5-Tetramethyl-3-pyrrolin-1-oxyl-3-carboxilic acid (Pyrr-NO)
was prepared according to the method of Rozanstev.34
1H NMR spectra and 13C NMR spectra were recorded on
a VarianMercury 400 (400MHz and 100MHz, respectively) at 25
C aer in situ reduction with hydrazobenzene. Chemical shis
(d) are given in ppm and residual solvent signals for CHCl3 (dH
7.26 ppm and dC 77.0 ppm) were used as internal references.
Coupling constants (J) are given in Hertz. Electron spray ioni-
zation mass spectrometry (ESI-MS) was performed on an Agilent
Series 1100 MSD Mass Spectrometer. High resolution mass
spectrometry was performed on a Xeno G2-S QTof Waters
spectrometer. Elemental analysis was performed on a Thermo
Fischer Scientic FLASH 2000 Organic Elemental Analyzer.
FTIR spectra were acquired using DRIFT technique on a Perkin
Elmer Spectrum GX1 and are expressed in wave number (cm1).
Tetrabutylammonium hexauorophosphate (TBAH), sodium
tetrauoborate (NaBF4) and phosphate buﬀer solution (PB)
were used as received as supporting electrolyte, and all were
electrochemical or analytical grade from Sigma-Aldrich. Water
was milliQ grade. Dry tetrahydrofuran (THF) was puried and
dried as previously reported,35 stored in a specially designed
Schlenk ask and protected from light.
Shortly before performing the electrochemical measure-
ments, the solvent was distilled via a closed system into an
electrochemical cell containing the supporting electrolyte and
the species under examination.
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and all
nitroxide-labeled phospholipids (SLs): 1-palmitoyl-2-stearoyl-(n-
doxyl)-sn-glycero-3-phosphocholines (5DPC, 7DPC, 10DPC,
12DPC and 14DPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
pho(tempo)-choline (TempoPC) were purchased from Avanti
Polar Lipids (Alabaster, AL, USA) as chloroform solutions.
Nickel(II)-ethylene-N,N0 diaminediacetic acid (NiEDDA) was
prepared from ethylenediamine-N,N0-diacetic acid (EDDA) and
nickel(II) hydroxide [Ni(OH)2] according to published proce-
dures.15 These reagents, 2-[4-(2-hydroxyethyl)-1-piperazinyl]
ethanesulfonic acid (HEPES), and the lanthanide salts TmCl3-
$6H2O and DyCl3$6H2O were purchased from Sigma-Aldrich. A
50 mM, pH 7.0, HEPES buﬀer solution was prepared to be used
for the preparation of POPC small unilamellar vesicles (SUV)
and bicelles, and for the stock solutions of Tm3+ and Dy3+.
Egg-yolk L-a-phosphatidylcholine (Egg-PC) as chloroform
solution for liposomes preparation was purchased from Sigma-
Aldrich and used without purication. A 5 mM phosphate
buﬀer (PB) solution was prepared to be used for PC liposomes,
for Pyrr-NO and AAPH solutions.98962 | RSC Adv., 2015, 5, 98955–98966Synthesis
Chol-NO was synthesized by N,N-dicyclohexylcarbodiimide
(DCC) coupling of a cholesterol molecule with
2,2,5,5-tetramethyl-3-pyrrolin-1-oxyl-3-carboxylic acid Pyrr-NO
(Scheme 3A). Glycerolipid nitroxides were synthesized
following a synthetic procedure already reported in the litera-
ture.36 (Scheme 3B and C), starting from 1,2-isopropyliden-3-O-
sn-glycerol.
For OG-NO and DOG-NO, it was condensed with Pyrr-NO
and, aer removal of the isopropylidene protecting, was ester-
ied with one (OG-NO) or two equivalents of oleic acid (DOG-
NO). OG(L)-NO and DOG(L)-NO were prepared with the same
reactions, but in these cases 1,2-isopropyliden-3-O-sn-glycerol
was rst reacted with ethyl bromoacetate in order to introduce
the oxyethylene linker.
Spectroscopic characterization of the synthesized NOXs can
be found in the ESI.†
Electrochemical measurements
Electrochemical experiments were carried out in an airtight
single-compartment cell described elsewhere37 by using plat-
inum and glassy carbon (GC) as working electrode, a platinum
spiral as counter electrode and a silver spiral as a quasi-
reference electrode. For the measurements in aprotic solvent,
the cell containing the supporting electrolyte and the electro-
active compound was dried under vacuum at about 110 C for at
least 48 h before each experiment. All the E1/2 potentials have
been directly obtained from CV curves as averages of the
cathodic and anodic peak potentials for one-electron peaks and
by digital simulation for those processes closely spaced inThis journal is © The Royal Society of Chemistry 2015
Paper RSC Advancesmultielectron voltammetric peaks. The E1/2 values are referred
to a normal hydrogen electrode (NHE) and have been deter-
mined by adding, at the end of each experiment, ferrocene as an
internal standard and measuring them with respect to the
ferrocenium/ferrocene couple standard potential. The poten-
tials thus obtained were not corrected for the two unknown
contribution of the liquid junction potential between the
organic phase and the aqueous NHE solution. Experiments in
aqueous solution of the species immobilized as lm, onto the
electrode surface, have been carried out in the same cell
described above. The species were immobilized on the GC
working electrode (3 mm diameter disk) as thin lm by drop-
casting 100 mL of a 0.1 mM chloroform solution of the
compounds investigated.
Voltammograms were recorded with an AMEL Mod. 552
potentiostat or a custom made fast potentiostat38 controlled by
an AMEL Mod. 568 programmable function generator. The
potentiostat was interfaced to a Nicolet Mod. 3091 digital
oscilloscope and the data transferred to a personal computer by
the program Antigona.39 Minimization of the uncompensated
resistance eﬀect in the voltammetric measurements was ach-
ieved by the positive-feedback circuit of the potentiostat. Digital
simulations of the cyclic voltammetric curves were carried out
either by Antigona or DigiSim 3.0.Penetration depth measurements
Penetration depth experiments were performed in POPC SUV
prepared by mixing the chloroform stock solutions of POPC and
NOXs or SLs in a 100 : 1 ratio. The mixed solutions were evap-
orated in a glass test tube under a stream of dry nitrogen gas
and the resulting lm was dried overnight under vacuum. The
lipid lm was hydrated for 30 minutes with HEPES buﬀer to
a nal concentration of 10 mM for the lipid and 100 mM for NOX
or SL. Lipid suspensions were sonicated in a water bath until
they started to clear. SUV in the 30–50 nm diameter range were
obtained and their dimensions were checked during prepara-
tion by Dynamic Light Scattering (DLS) using a NICOMP Model
370 Submicron Particle Sizer by Pacic Scientic. Vesicles were
used fresh aer preparation.
The EPR experiments were performed using a Bruker ESP380
spectrometer operating at X-band (9.5 GHz), equipped with
a room-temperature dielectric resonator, ER4123D. The micro-
wave frequency was measured by a frequency counter,
HP5342A. All spectra were obtained using the following
parameters: modulation amplitude 0.16 mT; modulation
frequency 100 kHz; time constant 41 ms; conversion time 82
ms; scan width 1.25 mT; 512 points; temperature 298 K. The
microwave power was ramped down automatically from 95 mW
to 0.05 mW (the attenuation ramp in dB units was 2.0, 4.0, 6.0,
8.0, 10.0, 12.0, 14.0, 16.0, 18.0, 20.0, 25.0, 30.0, 35.0). The
spectra were acquired in a single scan. The experimental
protocol for the insertion depth measurements is as follows.
Approximately 5 mL of sample were loaded into a gas-permeable
TPX capillary (L&M EPR Supplies, Inc., Milwaukee, WI, USA)
and three saturation experiments were performed. The rst
experiment was done on the sample in equilibrium with air toThis journal is © The Royal Society of Chemistry 2015saturate the membrane with oxygen. The second experiment
was performed on the same sample aer de-oxygenation under
a dry nitrogen ow for twenty minutes. The third experiment
was performed on a new sample to which NiEDDA was added to
a nal concentration of 50 mM; the sample was then de-
oxygenated as above. All experiments were performed at least
in duplicate. The power saturation data were obtained using
a home-written program in Matlab that calculates the peak-to-
peak amplitudes of the central line of the spectra. The satura-
tion curves were obtained plotting the amplitude data vs. the
microwave power, and tted using the standard equation:15
y ¼ Ap1/2[1 + (21/h  1)x/p1/2]h
p1/2 is the saturation parameter, namely the power where the
rst derivative amplitude is reduced to half of its unsaturated
value, h is the homogeneity parameter, indicating the homo-
geneity of saturation of the resonance line, (ranging between h
¼ 1.5 for a fully homogeneously-broaden line and h ¼ 0.5 for
a fully inhomogeneously-broaden line), and A is a scaling factor
that accounts for the absolute signal intensity. The saturation
prole and the saturation parameter were obtained also for
DPPH (2,2-diphenyl-1-picrylhydrazyl).40 The best-t p1/2 param-
eters of the three experiments described above were used to
calculate the dimensionless immersion depth parameter (F) as
F ¼ ln p
oxygen
1=2  pnitrogen1=2
pNiEDDA1=2  pnitrogen1=2
Bicelle stock preparation and EPR experiments
Chloroform solutions of the phospholipids (DMPC and DHPC)
and a methanol solution of the NOX were mixed in a glass test
tube in a 1 : 100 NOX to DMPC ratio. The obtained solutions
contained 11.2 mmol of DMPC, 3.1 mmol of DHPC, and, where
present, 25 nmol of NOX (0.2% of the total lipids); the q ¼
[DMPC]/[DHPC] ratio was therefore q  3.5. A thick lipid lm
was produced by evaporation of the solvent under a stream of
dry nitrogen gas which was then dried under vacuum overnight.
The following day the lipids were scratched oﬀ the glass tube
and placed into an Eppendorf tube, to which 33 mL of buﬀer
were added, obtaining a 25% (w/w) lipid concentration. The
resulting suspension was vortexed until it appeared homoge-
neous. The sample was then placed in a bath sonicator that was
lled with an ice/water mixture and sonicated for 30 minutes.
Finally, the solution was subjected to four freeze/thaw cycles:
30 minutes in a 328 K water bath followed by a quick freeze in
liquid nitrogen; vortexing of the sample at each step was per-
formed to insure perfect homogeneity. The procedure yielded
a clear, viscous, stock of bicelles with the NOX incorporated in
the bilayers. Starting from the stock solution, 25 mL were
prepared as follows: 15 mL of bicelles were added to 10 mL of
buﬀer (for isotropic samples), or, for oriented samples, to 10 mL
of buﬀered lanthanide solution of Tm3+ or Dy3+ (corresponding
to a nal [Ln3+]/[DHPC] ratio of 0.1). The resulting solution was
transferred to a 1 mm inner diameter EPR quartz tube. The nal
concentration of the phospholipids was 17% (w/w). Given theRSC Adv., 2015, 5, 98955–98966 | 98963
RSC Advances Paperexperimental conditions (lipid concentration, q ratio, temper-
ature), the bicelles used in this work are not ideal disks, but
rather stacks of almost planar phospholipid bilayers dotted
with DHPC pores and separated by buﬀer regions 15 nm
wide.41
Samples with n oriented along and perpendicular to the
magnetic eld can be obtained in two ways: (a) by preparing two
samples doped with lanthanide salts that yield bicelles with
diﬀerent orientation in a strong magnetic eld (B0), Tm
3+ for
nkB0 or Dy3+ for ntB0; (b) by preparing a single sample doped
with Tm3+ and taking the spectra before and aer a rotation of
the sample tube by 90 inside the cavity of the spectrometer.
This latter method exploits the extremely high viscosity of the
bicelle solution at 308 K and the slow relaxation of the oriented
phase at the magnetic eld of the experiment (350 mT) which
prevents the lipid reorientation within the timeframe of the EPR
experiments (3 minutes). Aer having veried the equivalence
of the procedures, the second method was adopted in this work
since it requires a single sample.
A literature procedure13 was used to obtain aligned samples:
the sample tube was placed at room temperature (298 K) in
the EPR cavity and the magnetic eld was set to 800 mT; then
the temperature was slowly raised to 318 K and subsequently
lowered to the temperature of choice, 308 K (35 C). The
magnetic eld was set to 350 mT and the spectrum was
recorded immediately: loss of order in the sample during the
measurement time (40 s) is negligible as a result of the high
viscosity of the bicelle solution and slow relaxation of the
oriented phase at the magnetic eld of the experiment (350 mT)
which prevents the lipid reorientation.
EPR spectra were performed using a Bruker ER200D spec-
trometer operating at X-band (9.5 GHz), equipped with
a rectangular cavity, ER4102ST, tted with a cryostat, and
a variable-temperature controller, Bruker ER4111VT; the
microwave frequency was measured by a frequency counter,
HP5342A. All spectra were obtained using the following
parameters: microwave power 2.1 mW; modulation amplitude
0.16 mT; modulation frequency 100 kHz; time constant 20 ms;
conversion time 41 ms; scan width 15 mT; 1024 points;
temperature 308 K; all spectra were obtained in a single scan.EPR spectral simulations
We performed simulations of the NOX spectra with a program
based on the stochastic Liouville equation,18 that is extensively
used to simulate EPR spectra of spin-labeled systems.16d,42 The
simulation method relies on several reference systems whose
relative orientation is dened by diﬀerent sets of Euler angles.18
The simulation parameters are listed in Table 3. The principal
values of the g and 14N hyperne (A) tensors were obtained from
the literature;16d,43 the principal values of the rotational diﬀu-
sion tensor (D), the relative orientation of its principal axes
relative to the g tensor reference frame (UD), the adimensional
and traceless order parameter matrix (S, expressing the degree
of order), and the angle (J) dening the orientation of the
magnetic eld relative to the average long diﬀusion axis were
obtained from the simulation.98964 | RSC Adv., 2015, 5, 98955–98966Peroxidation of Egg-PC liposomes and assessment of
nitroxides % inhibition (TBARS assay): oxidation induced by
2,20-azobis(2-amidinopropane) dihydrochloride (AAPH)
Liposomes were prepared by the “thin lm hydration”method.
Chloroform stock solutions (2 mM) were prepared for each
tested compound except for 2,2,5,5-tetramethyl-3-pyrrolin-1-
oxyl-3-carboxilic acid (Pyrr-NO), whose 2 mM solution was
prepared in phosphate buﬀer PB. Appropriate amounts of
chloroform solutions of PC (100 mg mL1) and tested
compound (2 mM in CHCl3) were mixed in a 50 : 1 molar ratio.
The solvent was slowly evaporated with a stream of nitrogen and
the thin lm obtained was dried for at least 2 h under reduced
pressure. This dried lm was then resuspended by vortex
agitation in the required amount of 5 mM PB (pH 7.4) to a 3 mM
Egg-PC and 0.06 mM antioxidant nal concentration and
incubated overnight to swell and stabilize. The same procedure
was used to prepare a suspension of Egg-PC liposomes (3 mM
nal concentration) without tested nitroxides to be used as the
control in the evaluation of the percentage of inhibition of
nitroxides on the basis of the equation below. Samples con-
taining Pyrr-NO were obtained by hydrating the Egg-PC lm
with a PB- solution containing the proper volume of the 2 mM
stock solution in PB in order to have 0.06 mM nal concentra-
tion of nitroxide. The resulting MLV (Multi Lamellar Vesicles)
were sonicated for 12 min with a Sonic Vibracell sonicator to
obtain SUV (Small Unilamellar Vesicles) and the size distribu-
tion (mean diameter) was veried by Dynamic Light Scattering
(DLS) using a Nanosizer (Nano-ZS, Nanoseries, Malvern) and
found to be in the range 89–105 nm. Oxidized samples were
obtained by taking up 300 mL portions of each dispersion,
adding 25 mL AAPH 65 mM (5 mM nal concentration) and
incubating for 2 h at 310 K. Addition of 10 mL of 20 mM
methanolic BHT to the oxidized liposomes stopped the reaction
and prevented further Egg-PC peroxidation during the TBARS
assay. Other 300 mL of the liposome dispersions were added
with 25 mL of PBS (instead of AAPH) and 10 mL of 20 mM
methanolic BHT to make sure that during incubation, also in
the absence of radical initiator, no oxidation occurs and incu-
bated at 310 K for the same time. 0.9 mL of TBA–TCA–HCl
reagent (0.375% w/v TBA, 15% w/v TCA, 0.2 M HCl) were added
to all samples, oxidized and non-oxidized, which were then
heated for 15 min at 368 K, cooled and centrifugated at 5000
rpm for 10 min. A pink chromophore developed aer the
reaction between the thiobarbituric acid and malondialdehyde
and other aldehydes formed from the degradation of lipid
peroxides. Its absorbance was measured at 532 nm on a micro-
plate reader (Biotek, Synergy HT) for the determination of the
aldehydic breakdown products of lipid peroxidation (TBARS).44
The antioxidant activity of the studied compounds was
expressed as % inhibition according to the following equation:
% Inhibition ¼ (1  DAsample/DAPC)  100
where DAsample is the diﬀerence of the absorbance between the
oxidized and non-oxidized sample containing nitroxide and
DAPC is the diﬀerence of the absorbance between the oxidizedThis journal is © The Royal Society of Chemistry 2015
Paper RSC Advancesand non-oxidized Egg-PC. All experiments were run in triplicate
and repeated at least four times.EPR signal decay
SUV were prepared from PC and NOX (2 mM in CHCl3) or Pyrr-
NO (2 mM in PB) following the same procedure described for
AAPH experiments. 25 mL of AAPH (nal concentration 5 mM)
were added to 300 mL of each suspension in an Eppendorf tube,
mixed and transferred into a glass capillary tube which was then
put inside the EPR cavity. Each sample was incubated for 2 h at
310 K following the decay of the nitroxide three lines signal
upon heating. EPR spectra were recorded using a Bruker EMX
spectrometer operating at X-band (9.5 GHz), equipped with
a rectangular cavity, ER4102ST, tted with a variable-
temperature controller, a microwave frequency counter and
an NMR gaussmeter for eld calibration. Spectra were recorded
using the following parameters: microwave power 20 mW;
modulation amplitude 0.2 mT; modulation frequency 100 kHz;
time constant 0.32 ms; conversion time 41 ms; scan width 10
mT; number of scans 50; delay aer each measurement 120 s.Acknowledgements
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An EPR study of ampullosporin A, a medium-length
peptaibiotic, in bicelles and vesicles†
Marco Bortolus,ab Annalisa Dalzini,a Fernando Formaggio,a Claudio Toniolo,a
Marina Gobbo*a and Anna Lisa Maniero*a
Ampullosporin A is a medium-length (14-amino acid long) hydrophobic peptide of the peptaibol family.
In this work, electron paramagnetic resonance and circular dichroism spectroscopies were applied to
study the interaction of synthetic ampullosporin A and three spin-labeled analogs with small unilamellar
vesicles and bicelles. Zwitterionic vesicles were used to investigate the conformation and the
penetration depth of the peptide at room temperature. Bicelles were employed in combination with EPR
spectroscopy to study the order, dynamics, orientation, aggregation and the 3D-structure of the peptide
at near physiological temperature. In the membrane, the peptide adopts a helical structure that changes
in nature depending on the thickness of the membrane-mimetic system, from mostly a-helical in
vesicles to a more elongated helix in bicelles, suggesting an increase in the 310-helical content. The
orientation assumed by the peptide also shows a dependence on the membrane-mimetic system: in
bicelles, ampullosporin A has a transmembrane orientation at a peptide-to-lipid (P : L) ratio of 1 : 100 and
higher, while in vesicles it undergoes a transition from a parallel to a transmembrane orientation as a
function of the P : L ratio. In bicelles, the peptide was found to be monomeric at a P : L ratio of 1 : 25 and
lower. Overall, the comparison of the results obtained in the two membrane-mimetic systems showed
that ampullosporin A has a rather flexible structure that readily adapts to the bilayer thickness.
1. Introduction
Peptaibiotics are members of a family of non-ribosomally synthe-
sized hydrophobic peptides. Their primary structures are charac-
terized by a high content of the nonproteinogenic a-amino acid
a-aminoisobutyric acid (Aib), an acylated N-terminus and a
C-terminal 1,2-amino alcohol.1 According to the number of
residues in the sequence they are classified into three groups:
(i) short (from 4- to 10-mers), among which trichogin represents
the prototype; (ii) medium-length (from 14- to 16-mers), a less
investigated subgroup; and (iii) long (from 17- to 21-mers), with
alamethicins as the most extensively studied family. It is
generally accepted that they are membranolytic antibiotics but,
while alamethicins have been shown to form voltage-dependent
pores,2 the detailed mechanism of action of short- and medium-
length peptaibiotics is largely unknown.
Ampullosporin A, a medium-length peptaibol, was isolated
from the mycelium of Sepedonium ampullosporum together
with a mixture of less populated congeners, all bearing an
N-terminal acetyl(Ac)-aromatic amino acid and a C-terminal
leucinol (Lol) 1,2-amino alcohol.3 Although ampullosporins
display moderate antibacterial and antifungal activities,3 other
interesting biochemical and biophysical properties have been
documented.3–10 The sequence of ampullosporin A, the most
abundant isoform (Table 1), is characterized by a triplet of
consecutive Ca-tetrasubstituted Aib residues at positions 8–10
and a very high percentage (close to 50%) of Aib residues that
are responsible for its remarkable resistance to proteolysis.11
The peptide can cause leakage in liposomes12 and an increase
of conductance in planar membranes,4,13 which have been
associated with the pore-forming activity. The crystal structure
of ampullosporin A shows a right-handed helix, with a pre-
dominant a-helical content at the N-terminus and a more
disordered C-terminus.14 The helix is bent near the Gln11 residue,
even though the structure lacks prolines: the distance between the
first a-carbon and the last one is 2.2 nm. As can be appreciated
in the a-helical wheel representation shown below, (Fig. 1), the
peptide has a large hydrophobic sector (B2801) and a small
hydrophilic face characterized by three Gln residues that are
polar, but uncharged, at physiological pH.
Despite this peptaibiotic being formed by about 50% achiral
(Aib) residues, the shape and intensity of the circular dichroism
(CD) curves in several organic solvents and detergent micelles
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point to a significant right-handed helicity and, in particular, to
a high population of a-helical conformers.12,15 The high helical
content found in the crystal structure was recently observed in
frozen methanol solution using electron paramagnetic resonance
(EPR) spectroscopy.12 The ability of the peptide to adopt an
amphipathic helical structure in amembrane-mimicking environ-
ment can be related to its membrane-modifying properties.
More detailed information about the mechanism of membrane
permeabilization of ampullosporin A was undertaken by
fluorescence quenching and solid-state NMR spectroscopies.
These studies showed that the peptide adopts a parallel or trans-
membrane orientation depending on the bilayer thickness.16,17
Spin-labeling EPR spectroscopy is a well-proven technique
for studying the interactions of peptides, proteins and other
molecules with various kinds of lipid membranes, from lipo-
somes to extracted cell membranes, providing a great amount of
information on the solute and on its molecular environment.18 In
particular, EPR can precisely determine the insertion depth of a
solute relative to the plane of the phosphate groups of the bilayer,
comparing the data for the solute to those for a ‘‘molecular ruler’’
(i.e. a series of phospholipids spin-labeled at diﬀerent positions
of their lipid tails).19 EPR can also provide information on the
orientation of the solutes in themembrane when the membranes
can be macroscopically oriented:20–22 among these systems,
bicelles (Fig. 2) are the best for magnetic spectroscopies since
they form oriented phases in the magnetic field of the spectro-
meter at physiological temperature and without the need of a
solid support.23,24 Additionally, since bicelles form extremely
viscous solutions, they can be used for the determination of
distances between two paramagnetic probes in the range
0.4–2.5 nm from continuous-wave EPR (CW-EPR) spectra at
physiological temperature.22 Since peptides are diamagnetic, a
paramagnetic label must be introduced in the molecule to use
EPR spectroscopy. For peptaibiotics, one obvious choice is the
nitroxide-containing a-amino acid 4-amino-1-oxyl-2,2,6,6-tetra-
methylpiperidine-4-carboxylic acid (TOAC, Scheme 1), which
belongs to the family of conformationally constrained, helico-
genic, Ca-tetrasubstituted a-amino-acids, with 3D-structural
propensities strictly comparable to those of Aib.25,26 Thus,
TOAC exhibits a quite restricted mobility and its dynamics
reflects directly that of the peptide backbone, a great advantage
over other spin-labels such as the very flexible MTSSL, (1-oxyl-
2,2,5,5-tetramethylpyrroline-3-methyl) methanethiosulfonate
covalently linked to Cys (Scheme 1), commonly used for proteins.
For all these reasons, TOAC has been largely exploited to study
the biological properties of peptides.27
In this work, we studied the interaction of ampullosporin
A and three spin-labeled analogs (Table 1) with zwitterionic
membranes. Besides the bis-labeled AmpT3,13 analog,12 two new
Table 1 Sequences of ampullosporin A (Amp) and the spin-labeled
analogs employed in this study. The Aib-to-TOAC substitutions are shown
in bold
Peptide Sequence
Amp Ac-Trp-Ala-Aib-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Gln-
Leu-Aib-Gln-Lol
AmpT3 Ac-Trp-Ala-TOAC-Aib-Leu-Aib-Gln-Aib-Aib-Aib-
Gln-Leu-Aib-Gln-Lol
AmpT13 Ac-Trp-Ala-Aib-Aib-Leu-Aib-Gln-Aib-Aib-Aib-Gln-
Leu-TOAC-Gln-Lol
AmpT3,13 Ac-Trp-Ala-TOAC-Aib-Leu-Aib-Gln-Aib-Aib-Aib-
Gln-Leu-TOAC-Gln-Lol
Fig. 1 a-Helical wheel representation of ampullosporin A. In gray the
hydrophilic sector of the peptide (B801) made of three Gln residues.
Underlined are Aib3 and Aib13, the two positions that were chosen to insert
the TOAC spin label.
Fig. 2 Schematic representation of a bicelle. The cartoon shows the long
chain phospholipids (DMPC), the short-chain phospholipids (DHPC), and
the lanthanide ions (Tm3+) used to align the membrane normal (n) parallel
to an external magnetic field. For the abbreviations, see Experimental
section.
Scheme 1 Chemical structures of the TOAC and MTSSL spin labels.
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analogs were prepared in which the TOAC label replaces the Aib
residue at position 3 or 13 (AmpT3 and AmpT13). EPR spectro-
scopy was used to determine, at two peptide to lipid ratios (P : L),
the insertion depth of the spin-labeled analogs in liposomes,
while peptide conformation, orientation, dynamics, and aggrega-
tion properties were investigated in bicelles. For comparison, the
conformational preferences of the peptides in organic solvents
and in liposomes were examined by CD spectroscopy.
2. Experimental
2.1 Materials
Fmoc-TOAC-OH (Fmoc, fluorenyl-9-methyloxycarbonyl) and Fmoc-
Aib-F were synthesized as reported previously.25 H-L-Lol-2-
chlorotrityl resin (200–400 mesh, loading 0.43 mmol g1 resin)
was purchased from Iris Biotech (Marktredwitz, Germany).
Fmoc-amino acids were supplied by Novabiochem (Merck Bio-
sciences, La Jolla, CA), and all other amino acid derivatives and
reagents for peptide synthesis by Sigma-Aldrich (St. Louis, MO).
2-(1H-7-Aza-1,2,3-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate (HATU) was purchased from PE Biosystems
(Warrington, UK). 1-Hydroxy-1,2,3-benzotriazole (HOBt) and
2-(1H-1,2,3-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexa-
fluorophosphate (HBTU) were Acros-Janssen (Geel, Belgium)
products. 1,2-Dihexanoyl-sn-glycero-3-phosphocholine (DHPC),
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1-palmitoyl-
2-oleoyl-sn-glycero-3-phospho(tempo)choline (TempoPC), 1-palmitoyl-
2-stearoyl-(n-doxyl)-sn-glycero-3-phosphocholine (nDPC, with n
equal to 5, 7, 10, 12, or 14) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) were purchased from Avanti Polar
Lipids (Alabaster, AL, USA) as chloroform solutions. Methanol,
99.9%, spectrophotometric grade, [4-(2-hydroxyethyl)-1-piperazinyl]-
ethanesulfonic acid (HEPES) and the lanthanide salts TmCl36H2O
and DyCl36H2O were purchased from Sigma-Aldrich. A 50 mM,
pH 7.0, HEPES buffer solution was prepared to be used for
liposomes and bicelle preparations, and for the stock solutions
of Tm3+ and Dy3+.
2.2 HPLC and MS analyses
Analytical HPLC separations were carried out on a Dionex
(Sunnyvale, CA) Summit dual-gradient HPLC apparatus, equipped
with a four-channel UV-Vis detector, using a Vydac C18 (250 
4.6 mm, 5 mm, flow rate at 1.5 mL min1) from W. R. Grace
(Columbia, MD). To prepare the mobile phase, deionized water
was further purified using a MilliQ reagent grade water system
from Millipore (Bedford, MA). The eluants A (aqueous 0.1%
trifluoroacetic acid, TFA) and B (90% aqueous CH3CN containing
0.1% TFA) were employed for the preparation of binary gradients.
Analyses were carried out using a linear gradient from 35 to 90%
B in 30min. Semi-preparative HPLCwas carried out on a Shimadzu
(Kyoto, Japan) series LC-6A chromatographic apparatus, equipped
with two independent pump units, an UV-Vis detector, and a Vydac
C18 column (250  22 mm, 10 mm, flow rate at 15 mL min1).
Elutions were performed with the same mobile phases described
above, without TFA as a modifier, using a linear gradient from
65 to 95% B in 20 min. Mass spectrometry (MS) analyses
were carried out on a Mariner API-ToF workstation (PerSeptive
Biosystems, Framingham, MA), operating in the positive mode.
2.3 Peptide synthesis
The synthesis of the two new labeled ampullosporin A analogs,
AmpT3 and AmpT13, was performed by the solid-phase peptide
synthesis methodology as previously described.12 The crude
peptides (55–58% yield) were purified by semi-preparative
HPLC and characterized by analytical HPLC and ESI-MS.
[TOAC3]Ampullosporin A (AmpT3): yield 3.5 mg (17%);
analytical HPLC: tR 25.1 min; ESI-MS (m/z): calcd for
C83H138N20O20 [M + H]
+ 1735.04, found 1735.12.
[TOAC13]Ampullosporin A (AmpT13): yield 0.7 mg (2%);
analytical HPLC: tR 23.6 min; ESI-MS (m/z): calcd for
C83H138N20O20 [M + H]
+ 1735.04, found 1735.04.
2.4 CD spectroscopy in liposomes
The small unilamellar vesicles (SUV) used in this study were
prepared from POPC. The lipids were dissolved in chloroform
and a homogeneous lipid film was obtained by drying the
solution under a gentle dry nitrogen stream. The film was left
overnight under vacuum in a desiccator to remove any trace
of the solvent. The following day the film was resuspended in
buﬀer (see above) to obtain a lipid concentration of about
15 mM. SUV in the 30–50 nm diameter range were prepared
by sonication: the lipid suspension was immersed in a water
bath and sonicated until the solution started to clear. Vesicle
dimensions were checked during preparation by dynamic light
scattering using a NICOMP Model 370 Submicron Particle
Sizer. Vesicles were used immediately after preparation.
The peptide was incorporated into the liposomes by adding
the proper amount of methanol stock solution into an empty
Eppendorf tube. Methanol was then evaporated under a gentle
stream of nitrogen. The peptide was resuspended in a small
amount of buﬀer and sonicated for 3 minutes. Lastly, a proper
amount of POPC SUV solution was added in order to obtain
a final POPC concentration of 10 mM. The concentration of
the peptide stock solutions was about 1 mM, as determined by
quantitative UV absorption measurements (eTrp = 6170 M
1 cm1
at 282 nm). CD spectra were recorded at 293 K using a Jasco
(Tokyo, Japan) model J-715 spectropolarimeter, equipped with a
Haake thermostat (Thermo Fisher Scientific, Waltham, MA),
averaging 8 scans. Baselines were corrected by subtracting the
liposome contribution. Cylindrical, fused quartz cells of 0.2
or 0.1 mm path length (Hellma, Mu¨llheim, Germany) were
employed. The data are expressed in terms of [y]R, the mean
residue ellipticity (deg cm2 dmol1).
2.5 EPR power saturation experiments in liposomes
Power saturation experiments were performed in POPC liposomes
prepared in the same way as those used for CD experiments. The
peptides were incorporated into liposomes as follows: a methanol
solution of the peptide was evaporated in an Eppendorf tube. The
pre-formed liposomes were added and the tube was repeatedly
vortexed. The solution was then sonicated for 3 min. The EPR
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experiments were performed using a Bruker ESP380 spectrometer
operating at the X-band (B9.5 GHz), equipped with a room-
temperature dielectric resonator, ER4123D. The microwave
frequency was measured using a frequency counter, HP5342A.
All spectra were obtained using the following parameters: a
modulation amplitude of 0.16 mT; a modulation frequency of
100 kHz; a time constant of 41 ms; a conversion time of 82 ms;
a scan width of 1.25 mT; 512 points; a temperature of 298 K.
The microwave power was ramped down automatically from
95 mW to 0.05 mW (the attenuation ramp in dB units was 2.0,
4.0, 6.0, 8.0, 10.0, 12.0, 14.0, 16.0, 18.0, 20.0, 25.0, 30.0, 35.0).
The spectra at each power were averaged 3 times. The experi-
mental protocol for the insertion depth measurements is as
follows: approximately 5 mL of the sample were loaded into a
gas-permeable TPX capillary (L&M EPR Supplies, Inc., Milwaukee,
WI, USA) and 3 saturation experiments were performed. The first
experiment was done on the sample in equilibrium with air to
saturate the membrane with oxygen. The second experiment was
performed on the same sample after de-oxygenation under a dry
nitrogen flow for 20 min. The third experiment was carried out on
a new sample to which NiEDDA was added to a final concen-
tration of 50 mM; the sample was then de-oxygenated as above.
All experiments were performed at least in duplicate. The power
saturation data were obtained using a home-written program in
Matlab that calculates the peak-to-peak amplitudes of the central
line of the spectra. The saturation curves were obtained by
plotting the amplitude data vs. the microwave power, and fitted
using the standard equation:19 y = Ap1/2[1 + (21/h  1)x/p1/2]h,
where p1/2 is the saturation parameter, namely the power where
the first derivative amplitude is reduced to half of its unsaturated
value, h is the homogeneity parameter, indicating the homoge-
neity of saturation of the resonance line (ranging between h = 1.5
for a fully homogeneous line and h = 0.5 for a fully inhomoge-
neous line), and A is a scaling factor that accounts for the absolute
signal intensity. The dimensionless immersion depth parameter
(F) can be directly calculated from the ratio of the p1/2 parameters
obtained from the fitting of the three experiments described
above:
F ¼ ln
p
oxygen
1=2  pnitrogen1=2
pNiEDDA
1=2  pnitrogen1=2
:
The values of F for the spin labeled lipids were recently
published.28 The F parameter can be used to assess the
distance from the membrane surface of a solute (R) provided
a calibration curve is calculated:29,30 from our data we find
R/nm = 0.358F + 0.615 (see the ESI† for details).
2.6 EPR experiments in bicelles
The chloroform solutions of the phospholipids and a methanol
solution of ampullosporin A were mixed in a glass test tube.
Except when otherwise noted, samples with AmpT3 or AmpT13
were diamagnetically diluted using Amp to a final labeling
percentage of 17%: this procedure was done to avoid any
concentration-dependent lineshape broadening. Samples at
diﬀerent peptide concentrations were prepared by keeping the
lipid content constant and varying the amount of peptide to
obtain the desired P : L ratio (the P : L ratios reported in this work
refer to DMPC only). The final lipid composition of the solution
was: 11.2 mmol DMPC, 3.1 mmol DHPC; the q = [DMPC]/[DHPC]
ratio was thereforeB3.6. A thick film, containing the lipids and
the peptide, was produced by the evaporation of the solvent
under a stream of dry nitrogen gas, then the film was dried
under vacuum overnight. The following day the film was
scratched oﬀ the glass tube and placed into an Eppendorf tube,
then 33 mL of buﬀer were added, obtaining a 25% (w/w) lipid
concentration. The resulting suspension was vortexed until it
appeared homogeneous. The sample was then placed in a bath
sonicator that was filled with an ice/water mixture and sonicated
for 30 min. Finally, the solution was subjected to 4 freeze/thaw
cycles: 30 min in a 328 K water bath were followed by a quick
freeze in liquid nitrogen; vortexing of the sample at each step
was performed to ensure perfect homogeneity. The procedure
yielded a clear, viscous, stock of bicelles with the peptide
incorporated into the bilayers. The EPR samples were prepared
as follows: 15 mL of bicelle stock were added to 10 mL of buﬀer for
isotropic samples (i.e., not macroscopically oriented), or, for
oriented samples, to 10 mL of buﬀered solution of Tm3+ or
Dy3+ (corresponding to a final [Ln3+]/[DHPC] ratio of 0.9). The
resulting solution was transferred to a 1 mm inner diameter EPR
quartz tube. The final concentration of the phospholipids was
17% (w/w). Given the experimental conditions (lipid concen-
tration, q ratio, temperature), the bicelles used in this work are
not ideal disks, but rather stacks of almost planar phospholipid
bilayers dotted with DHPC pores and separated by buﬀer regions
B15 nm wide.31 A literature procedure23 was used to obtain
aligned samples: the sample tube was placed at room temperature
(B298 K) in the EPR cavity and the magnetic field was set to
800 mT; then, the temperature was slowly raised to 318 K and
subsequently lowered to the temperature of choice, 308 K
(35 1C). The magnetic field was set to be B350 mT and the
spectrum was recorded immediately: the loss of order in the
sample during the measurement time (B40 s) is negligible as a
result of the high viscosity of the bicelle solution which
prevents lipid reorientation. For each sample, the experiments
were repeated with Tm3+ or Dy3+ as dopants, to align the
membrane normal parallel or perpendicular to the external
magnetic field. EPR spectra of the peptide in bicelles were
recorded using a Bruker ER200D spectrometer operating at
the X-band (B9.5 GHz), equipped with a rectangular cavity,
ER4102ST, fitted with a cryostat, and a variable-temperature
controller, Bruker ER4111VT; the microwave frequency was
measured by a frequency counter, HP5342A. All spectra were
obtained using the following parameters: a microwave power of
2.1 mW; a modulation amplitude of 0.16 mT; a modulation
frequency of 100 kHz; a time constant of 20 ms; a conversion
time of 41 ms; a scan width of 15 mT; 1024 points; a temperature
of 308 K; all spectra were obtained in a single scan.
The spectra of the singly labeled peptides AmpT3 and AmpT13
were simulated with a program based on the stochastic Liouville
equation,32 that is extensively used to simulate EPR spectra of
nitroxides.33–40 The simulationmethod relies on several reference
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systems, the relative orientation of which is defined by different
sets of Euler angles.32 The principal values of the g and 14N
hyperfine (A) tensors of the TOAC label were obtained from the
literature.35,41 The orientations of the principal diffusion axes
relative to the g tensor reference frame (OD) were estimated from
the crystal structure. The principal values of the diffusion tensor
(D), the order parameter of the peptide (S), and the orientation of
the magnetic field relative to the average long diffusion axis (C)
were extracted from the simulation.
The interspin distances, intramolecular for the doubly labeled
peptide AmpT3,13, and intermolecular for the singly labeled
peptide AmpT3, were obtained from the CW-EPR spectra in
isotropic bicelles. The spectra were analyzed for dipolar broad-
ening, obtaining the interspin distance distributions through
the convolution methodology,42 using a program previously
described43 that was kindly provided by prof. H. S. Mchaourab,
Vanderbilt University, Nashville (TN). AmpT3,13 was diamag-
netically diluted with Amp (17% of labeled peptides) at a 1 : 100
P : L ratio. The experiments on AmpT3 were performed at
diﬀerent P : L ratios and diﬀerent labeling percentages (17%,
33%, 66%). The spectra of AmpT3 and AmpT13 with 17% of
labeled peptides were used in the convolution analysis as
reference spectra because they are not aﬀected by dipolar broad-
ening. In this work, we performed the convolution analysis of the
spectra obtained at near-physiological temperature (308 K). While
in fluid solutions the dipolar interaction is in principle partially
averaged, it is still possible to analyze the dipolar broadening
with reasonable precision, even at physiological temperature, in
highly viscous media.44,45 The interspin distance for the doubly
labeled peptide AmpT3,13 (and those for AmpT3 and AmpT13 as
references) was obtained also in POPC SUV: the SUV were the
same used for CD spectroscopy and the conditions of the EPR
experiments were identical to those in bicelles except for tem-
perature (150 K) and the addition of glycerol as a cryoprotectant
(37% v/v).
3. Results
3.1 CD spectroscopy
We initially investigated the preferred conformations of ampul-
losporin A and its [TOAC] analogs in methanol solution. As
illustrated in Fig. 3A, all CD spectra show two pronounced
negative maxima near 225 and 208 nm (associated with the n
- p* transition and the parallel component of the split p- p*
transition of the peptide chromophore, respectively) followed
by a positive maximum at approximately 195 nm (p - p*
perpendicular component). This pattern can be attributed to
mostly right-handed helical peptides46,47 with a largely prevail-
ing a-helix population, as can be estimated from the ellipticity
ratio R = [Y]222/[Y]208. This ratio has been reported
48–50 to be
o0.35 for a prevailing 310-helix population51–53 and40.70 for a
prevailing a-helix population. Under our experimental condi-
tions, we found R = 0.82 for Amp, R = 0.91 for AmpT3, and
R = 0.85 for AmpT13. These values are comparable to R = 0.8212,15
published for ampullosporin A and unambiguously indicate a
predominant a-helix 3D-structural type. The CD spectra of ampul-
losporin A in POPC SUV at two P : L ratios (Fig. 3B) show that in a
phospholipid membrane both the a-helical population (R4 1 for
both P : L ratios) and the overall helical content of the peptide
(considering the ellipticity at 222 nm)10 increase.
3.2 EPR spectroscopy
3.2.1 Insertion depth in liposomes. The insertion depth of
ampullosporin A in POPC liposomes at diﬀerent P : L ratios at
room temperature was determined by power saturation experi-
ments.19 In Fig. 4 we report the power saturation curves of the
two diamagnetically diluted, singly-labeled peptides (AmpT3,
top and AmpT13, bottom) at P : L 1 : 100 and 1 : 25. The fitting
curves were obtained according to the equation reported in the
Experimental part. The penetration depth parameters F for
the spin-labeled lipids acting as a ‘‘molecular ruler’’28 and for
the peptides are reported in Table 2.
At a P : L ratio of 1 : 100, the TOAC label of AmpT3 is fully
water exposed with a penetration depth lower than that of
TempoPC, where the nitroxide is located in the lipid head-
group. The label in AmpT13 has a higher penetration depth,
positioned at the level of the 5th–7th carbon atom of the lipids,
just below the phosphate groups. At a 1 : 25 P : L ratio, the
penetration depth of both analogs increases significantly, with
Fig. 3 Ampullosporin conformation in methanol and in POPC SUV. (A) CD
spectra of ampullosporin A and its TOAC analogs in methanol. (B) CD
spectra of ampullosporin A in POPC SUV at P : L 1 : 100 and 1 : 25 (POPC
concentration is 10 mM).
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the label of AmpT3 located at the level of the 5th–7th carbon
atom of the lipids and that of AmpT13 close to the 10th carbon.
3.2.2 Peptide orientation and dynamics in bicelles. The
magnetic, orientational, and motional parameters of ampullos-
porin A were determined in isotropic (i.e. without macroscopic
alignment) and oriented bicelles at a P : L of 1 : 100 and at
308 K. The spectra and simulations of diamagnetically diluted
AmpT3 and AmpT13 are shown in Fig. 5. The spectra in
isotropic bicelles have been simulated using the MOMD
approach.32 The parameters we used for spectra simulations
are reported in Table 3. The EPR spectra recorded in isotropic
bicelles, with magnetic field parallel to the membrane normal n
(B0Jn, Fig. 5B and E), and with magnetic field perpendicular to
n (B0>n, Fig. 5C and F), are all diﬀerent, as expected for a
peptide adopting a well-defined orientation in the membrane.
The bicelles in the presence of Amp at a P : L of 1 : 100 are well
aligned as shown in the ESI.† However, a complete alignment
of the bicelles does not imply that membrane-bound peptides,
or parts of them, achieve the same degree of order, since the
heterogeneity of the secondary structure or the backbone
dynamics could lower their order. Indeed, while AmpT3 shows
well-aligned spectra (Fig. 5B is very diﬀerent from Fig. 5C),
AmpT13 is much more disordered (Fig. 5E is similar to Fig. 5F).
This aspect will be discussed below and in the Discussion
section.
We simulated the spectra of each analog in isotropic bicelles
and at B0Jn and B0>n with a single set of parameters. This
approach ensures a good reliability of the simulations. The
magnetic parameters of the TOAC label were taken from the
Fig. 4 Ampullosporin A penetration depth in liposomes. Power saturation data (dots) and the fitting curves (lines) for AmpT3 (top) and AmpT13 (bottom)
in POPC liposomes. The symbols indicate the diﬀerent sample conditions: black squares, sample purged with nitrogen; gray dots, sample in equilibrium
with air (oxygen); light gray triangles, sample with 50 mM NiEDDA and purged with nitrogen. The experiments were performed at room temperature
(298 K) at P : L 1 : 100 (left) and P : L 1 : 25 (right).
Table 2 Penetration depth parameter (F) of the reference spin labels
(SL)28 and of AmpT3 and AmpT13 in POPC liposomes obtained at room
temperature. The distance from the membrane surface (R, in nm) of the
two peptides is also reported. The F values reported have been obtained
as the average of the results of two experiments (see the ESI for the results
of the individual experiments)
SL F Peptide P : L F R/nm
TempoPC 0.1a AmpT3 P : L 1 : 100 1.5 0.08
5DPC 1.4b P : L 1 : 25 1.2 1.02
7DPC 1.2b
10DPC 2.1 AmpT13 P : L 1 : 100 0.65 0.85
12DPC 2.4 P : L 1 : 25 1.7 1.22
14DPC 3.0
a Repeated experiments with TempoPC showed a large variability in F,
but the value is always below 0.3; this value has been redetermined after
the publication of ref. 28. b An inversion in the linear trend was found
also in the original work.19
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literature,35 with the exception of the largest component of the
hyperfine coupling tensor (Azz) that was adjusted to better fit
the spectra. The Azz component is the most sensitive to the
polarity of the surroundings, with larger values observed for a
polar environment. The larger Azz value of AmpT3, compared to
that of AmpT13, suggests that in bicelles the former is more
water exposed than the latter. The oriented spectra of AmpT13
show a small contribution, amounting to less than 1% of the
total spins, arising from the free spin-label (the three sharp
lines in Fig. 5E and F).
The spectral simulations require the knowledge of the
orientation of the TOAC moieties relative to the principal
diﬀusion axis of the peptide. This information can be obtained
from the spectral fitting or, when available, estimated from the
crystal structure of the peptide. In this work, the Euler angles
(OD) relating the principal directions of the magnetic tensors
(g and A) of each TOAC label to the principal directions of the
diﬀusion tensor (D) were estimated from the crystal structure
of ampullosporin A.14 The estimate was made considering that
the TOAC piperidine label usually adopts a twisted boat con-
formation54 and that for helical peptides the main diﬀusion
axis corresponds to the average helical axis. Under these
assumptions, the spectral fitting provided the principal values
of the diﬀusion tensor, showing that the peptide undergoes an
anisotropic axial motion, with a much faster rotation about the
helical axis than perpendicular to it (DJ 4 D>).
The main advantage of oriented bicelles lies in the possibility
of determining the orientation of solutes in the membrane. From
the simulations we obtained that the ampullosporin A helix
adopts a transmembrane orientation in bicelles (C = 01  101)
corresponding to an average helical axis parallel to the membrane
normal. Additionally, we recorded the EPR spectra of AmpT3 at
P : L 1 : 25 (data not shown): these are identical to the spectra
reported in Fig. 5, confirming that in bicelles ampullosporin A
maintains a transmembrane orientation, at least to P : L 1 : 100.
The order parameter (S) of AmpT13 is lower than that of
AmpT3. This result suggests a greater conformation hetero-
geneity for the C-terminal part of the peptide in the membrane.
This feature was also observed in the crystal structure.14
3.2.3 Conformational study in membranes. We investigated
the secondary structure of ampullosporin A in bicelles at physio-
logical temperature by measuring the interspin distance between
the two TOAC labels of the doubly labeled peptide, AmpT3,13,
previously synthesized in our laboratory.12 The experiment was
performed also in SUV of POPC in frozen solution (150 K). The
spectra of AmpT3,13 (Fig. 6B in bicelles and Fig. 6D in SUV) were
analyzed by the convolution methodology,42 using the average of
the spectra of the singly labeled analogs AmpT3 and AmpT13
(‘‘Sum of Singles’’, Fig. 6A in bicelles and Fig. 6C in SUV) as
the non-broadened spectra. Spectra were recorded in isotropic
bicelles (i.e., not macroscopically oriented), or in frozen solution
of POPC SUV with glycerol added as a cryoprotectant. The
experiments in SUV were performed at low temperature since
at room temperature there was partial averaging of the dipolar
interaction that impaired the spectral analysis. The peptides were
diamagnetically diluted at 17% labeling percentage to ensure the
absence of broadening arising from intermolecular spin–spin
interactions. The convolution analysis gives the distance distribu-
tion curve shown in Fig. 6, bottom. The Gaussian distance
distribution curve in bicelles (rmax = 1.94 nm and half width at
half height Dhh = 0.06 nm) shows an average distance that is
about 0.2 nm larger than the one we previously obtained in
Fig. 5 Ampullosporin A motion and orientation in DMPC/DHPC bicelles.
EPR spectra are those of AmpT3 (A–C) and AmpT13 (D–F). Spectra are taken
in isotropic bicelles (A and D) and in oriented bicelles recorded with the
magnetic field parallel (B and E) and perpendicular (C and F) to themembrane
normal. Spectral simulations are shown in dashed lines. Temperature 308 K,
P : L 1 : 100, peptides diamagnetically diluted at 17% labeling percentage.
Table 3 Parameters used for the fitting of the spectra of AmpT3 and
AmpT13 in bicelles at all P : L ratios: g and hyperfine (A) tensors, diﬀusion
tensor (D), angles between the magnetic and the diﬀusion frame (OD),
angle between the diﬀusion frames and the membrane normal (C), order
parameter (S). Azz, D, C, and S were obtained from spectral fitting
ga Aa/mT
DJ/
106 s1
D>/
106 s1
OD
b
Cc Sa b g
AmpT3 x 2.0096 0.56 79 10 01 131 461 01 0.165
y 2.0064 0.56
z 2.0027 3.55
AmpT13 x 2.0096 0.56 79 10 01 301 901 01 0.09
y 2.0064 0.56
z 2.0027 3.35
a g and A tensor principal values are taken from ref. 35. The values of
the Azz hyperfine component depend strongly on the polarity of the
environment and have been varied to fit the spectra. b For an axial
diﬀusion tensor the angle a is irrelevant.32 c The error estimate isB101;
we show the dependence of the fitting on C in the ESI.
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methanol at 77 K (rmax = 1.73 nm and Dhh = 0.05 nm)
12 and
considerably larger than the one obtained in SUV (rmax =
1.56 nm and Dhh = 0.05 nm). The interspin distance in SUV is
remarkably similar to the one we estimated from the crystal
structure (B1.6 nm, obtained by modeling the TOAC residues
into the crystal structure and taking the inter-nitroxide distance9).
The distance distribution widths in all environments are comparably
narrow, supporting the view that almost the totality of the peptide
adopts a well-defined structure in each environment.
3.2.4 Peptide aggregation in bicelles. We investigated the
aggregation propensity of ampullosporin A in membranes as a
function of the P : L ratio using AmpT3. We studied only AmpT3
and not AmpT13 since in the latter the spin label is inserted in
a less structured region of the peptide, as seen from the lower
order parameter (Table 3). Therefore, AmpT13 is less likely
to be involved in a specific peptide–peptide interface. We
recorded the EPR spectra in isotropic bicelles at different P : L
ratios (1 : 100 and 1 : 25) and different labeling percentages
(AmpT3/Amp: 17%/83%, 33%/67%, and 67%/33%), and analyzed
the spectra for the presence of line broadening induced by
intermolecular dipolar spin–spin interactions. We observed no
line broadening at P : L 1 : 100 at all labeling percentages (data
not shown). Fig. 7, top, shows the spectra obtained at P :L 1 :25: no
line broadening was observed at 17% and 33% labeling ratios
(Fig. 7A and B), while a very minor broadening is present in the
spectrum at 67% labeling (Fig. 7C). This spectrum was examined
by the convolution methodology42 using the spectrum of AmpT3
at P : L 1 : 100 and 17% labeling as the non-broadened spectrum
(Fig. 6A). The simulation is shown in Fig. 7C (dashed line) and the
Gaussian interspin distance distribution curve in Fig. 7, bottom
(rmax = 2.6 nm and Dhh = 0.6 nm). The average distance is
compatible with the one expected for a homogeneous distribution
of transmembrane peptide monomers (B3 nm). This estimate
was made considering the average diameter for a peptide helix
(1.1 nm)55 and the area per DMPC lipid (B60 Å2).56 We conclude
that in bicelles ampullosporin A does not aggregate into stable,
well-defined structures up to P : L 1 : 25.
4. Discussion
In this work, we studied ampullosporin A in two diﬀerent
model membrane systems to explore diﬀerent aspects of the
Fig. 6 Ampullosporin A conformation in isotropic DMPC/DHPC bicelles,
308 K (A and B), and in POPC SUV, 150 K (C and D). Top, EPR spectra
resulting from the sum of the experimental spectra of AmpT3 and AmpT13
(A and C), and of AmpT3,13 (B and D). Simulations of AmpT3,13 are shown
in dashed/dotted lines. Bottom, distance distribution curves for AmpT3,13
in bicelles (B), in SUV (D) and, for comparison, in methanol at 77 K (E),
the latter obtained from analysis of the CW-EPR spectra.12 P : L 1 : 100,
peptides diamagnetically diluted at 17% labeling percentage.
Fig. 7 Ampullosporin A aggregation in isotropic DMPC/DHPC bicelles.
Top, experimental EPR spectra of AmpT3 diamagnetically diluted with Amp
at increasing labeling percentages: (A) 17% labeling, (B) 33% labeling,
(C) 67% labeling. The simulation obtained by the convolution procedure
is reported for spectrum (C) in a dashed line. Temperature 308 K, P : L
1 : 25. Bottom, distance distribution curve for spectrum C.
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peptide–membrane interaction. Small unilamellar vesicles of
POPC allowed us to determine the overall secondary structure
of the peptaibiotic using EPR and CD spectroscopies and the
insertion depth of spin-labeled analogs as a function of the P : L
ratio using EPR. We took advantage of the DMPC/DHPC bicelles to
obtain detailed information on the secondary structure, dynamics,
orientation and aggregation, using EPR. All experiments were
performed either at physiological temperature or at room tem-
perature, with membranes in solution in their liquid crystalline
(fluid) phase, with the exception of the interspin distance
determination in SUV, which was performed at 150 K.
The CD spectra show that ampullosporin A adopts a helical
structure in methanol with a predominance of the a-helix over
the 310-helix. The a-helical content further increases in SUV
(Fig. 3). Comparable results are obtained in frozen solution
using EPR for AmpT3,13: the average interspin distance decreases
from 1.73 nm methanol12 to 1.56 nm in SUV (Fig. 6). In bicelles,
the interspin distance obtained at physiological temperature is
longer (1.94 nm) and closer to the one expected for an ideal
310-helix (1.9 nm).
51–53 These results suggest that the peptide
adopts a slightly different conformation in the two membrane
systems, predominantly a-helical in SUV of POPC and more
elongated, likely with a higher 310-helical character, in DMPC
bicelles. Previously, also solid-state NMR data suggested that the
secondary structure of ampullosporin A in thin PC membranes
(di-C12:0-PC and di-C10:0-PC) encompasses a high degree of
310-helical structures.
17 A change in conformation depending
on the environment is not surprising since it is known that the
peptide secondary structure has an intrinsic flexibility, and the
energy difference between the two helical conformations is small
for Aib-containing peptides.14,53
The orientation adopted by the peptide helix relative to the
membrane surface as a function of the P : L ratio is diﬀerent
in the two membrane systems. The orientation in SUV was
determined from the penetration depth of the two singly
labeled analogs. To clarify the topology of the peptide in the
membrane, we calculated the distance from the membrane
surface (R) of the peptides (see the ESI† for details): the R
values, reported in Table 1, were then compared with the
experimental bilayer thickness of POPC (3.91 nm at 30 1C).56
The results are schematically summarized in Fig. 8.
At P :L 1 :100, both TOAC labels have a very low penetration
depth. The data are consistent with a parallel orientation of the
ampullosporin A helix (Fig. 8A) in which TOAC at position 3 is fully
exposed to the water phase while TOAC at position 13 lies just
below the polar headgroup region. This orientation is energetically
favorable since it exposes the hydrophilic sector (Fig. 1) towards the
water phase, while keeping the hydrophobic Trp residue buried in
the membrane. A parallel orientation is in agreement with the one
previously suggested for ampullosporin A on the basis of fluores-
cence quenching experiments (large unilamellar vesicles of egg PC,
pH 7.4, P :L r 140) and the calculation of the peptide ‘‘amphi-
pathic moment’’.16 Moreover, solid-state NMR spectra of POPC
deposited on cover glasses (pH 7.5) showed that ampullosporin A
lies parallel to the membrane surface at P :L 1 : 100, while the
orientation of the peptide is not well defined at P :L 1 : 10.17
At P : L 1 : 25, our saturation experiments gave a much higher
penetration depth for both labeling positions. This finding can
be explained either by a parallel insertion of the peptide deep in
the membrane core (Fig. 8B) or by a transmembrane insertion
(Fig. 8C). In the second hypothesis, the penetration depths
correspond to the TOAC3 residue being located below the polar
headgroup region in one membrane leaflet and the TOAC13
residue being located around the middle of the other leaflet.
We favor the latter hypothesis in which ampullosporin A changes
its orientation from parallel to transmembrane in a concentration-
dependent way: indeed, this is a common behavior for hydro-
phobic peptides, and has been associated with their antimicrobial
mechanism of action.57 In this transmembrane orientation the
peptide would bury the C-terminal part, while Trp1 remains
preferentially located just below the polar headgroup region. The
anchoring eﬀect of Trp residues when located at the polar–apolar
interface has been previously recognized.58 The preferential inser-
tion of the C-terminus found in this work is not a common feature
for peptaibiotics. Zervamicin, which has an N-terminal Trp residue
like ampullosporin A, has been suggested to bury either ends,
the N-terminus according to fluorescence/modelling data16 and
molecular dynamics,59 or the C-terminus according to an
EPR study.60 Antiamoebin, which has a Phe residue at the
N-terminus and a phenylalaninol at the C-terminus, has been
found to preferentially insert into the bilayer the fully hydro-
phobic N-terminal part of the peptide.16,61,62 Alamethicin, one
of the most studied peptaibiotics, is believed to first insert the
N-terminus, keeping the charged Glu residue at the C-terminus
towards the water phase.63
In bicelles, ampullosporin A adopts a transmembrane orien-
tation at P : L ratios 1 : 100 and higher. However, the order
parameters (S) of the TOAC residues, obtained from the spectral
simulations, are low. This finding indicates that the peptide is
not strongly anchored to the membrane surfaces as found
for alamethicin.22 The order parameter for the C-terminus is
Fig. 8 In-scale cartoon of the penetration depths of ampullosporin A
analogs in a POPC bilayer. The peptides are illustrated as ideal a-helices in
the ribbon representation. The nitrogen atoms of the TOAC labels are
shown as dots (purple in the online version). The Gln and Trp side chains
are shown explicitly in stick representation. The numbers represent the
distance from the membrane surface (R) of the TOAC nitrogen atoms.
Model (A) describes the peptide topology at P : L ratio 1 : 100. Models (B)
and (C) describe two possible interpretations of the topology at P : L ratio
1 : 25. In model (C), the penetration depth of AmpT13 is measured from the
bottom membrane leaflet.
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remarkably low, but, since we achieved a good spectral simulation
using a single diﬀusion tensor for both TOAC labels, we suggest
that the lower order parameter of TOAC13 arises from some
conformational heterogeneity of the C-terminus and not from
the much faster dynamics that would be observed in the presence
of significant helical fraying. Moreover, the narrow intramolecular
interspin distance distribution displayed by AmpT3,13 also con-
firms that the C-terminus remains folded (otherwise we would
have observed a much broader distribution).
The diﬀerences in the peptide structure and orientation between
SUV and bicelles could be tied to the diﬀerent hydrophobic
thicknesses of the two membranes. The hydrophobic thickness
is 2.88 nm for POPC and 2.57 nm for DMPC, at 30 1C,56 because
of the diﬀerent lengths and unsaturation degrees of the lipid
tails (16 : 0–18 : 1 for POPC; 14 : 0–14 : 0 for DMPC). Indeed, a
change from a parallel to a transmembrane orientation as a
function of the bilayer thickness was observed previously for
ampullosporin A in PC bilayers deposited on cover glasses.17 The
condition of perfect match between the length of the hydro-
phobic region of a transmembrane peptide and the membrane
hydrophobic thickness is energetically favorable. Any mismatch
in the two lengths (termed ‘‘hydrophobic mismatch’’) can be mini-
mized by local membrane deformations (thinning or expansion),
changes in peptide conformation and/or helical tilting.64–68 We
suggest that the stable transmembrane insertion in bicelles is a
result of the hydrophobic mismatch minimization that is reached
by the elongation of the helix from its mainly a-helical structure in
SUV to a prevalently 310 structure in bicelles. In the crystal
structure, as the distance between the a-carbons of the first and
the last amino acid is 2.2 nm, the peptide is 0.35 nm shorter than
the hydrophobic thickness of DMPC. The negative hydrophobic
mismatch that would be present if the peptide adopts in DMPC
the same structure found in the crystal is then strongly reduced
considering the elongation by 0.34 nm found in the AmpT3,13
analog in bicelles. In contrast, in POPC SUV the peptide is too
short to minimize the hydrophobic mismatch. Then, in the POPC
membrane ampullosporin A adopts its preferred a-helical confor-
mation and the parallel orientation is stabilized by the exposure of
the hydrophilic sector to the aqueous solution. Above a critical
concentration, the peptaibiotic can switch to a transmembrane
orientation, even if it does not fully span the bilayer.
A transmembrane orientation is usually tied to the mecha-
nism of action of hydrophobic peptides. It has been speculated
that the membrane depolarization induced by alamethicin and
ampullosporin A would depend on the same mechanism of
action, namely the formation of barrel-stave pores.2,4,13 However,
while this mechanism has been proven for alamethicin, which is
able to fully span the bacterial membranes, it is still unclear
whether it could be extended to shorter peptaibiotics like
ampullosporin A or trichogin GA IV.1 As for the former peptai-
biotic, we did not observe any aggregation in bicelles up to P : L
1 : 25; in contrast, alamethicin showed unequivocal signs of
aggregation at a P : L 1 : 50.22We can speculate that ampullosporin
A, in contrast to alamethicin, cannot strongly anchor to the
membrane surfaces (see the low order parameters discussed
earlier in the text) and is more prone to laterally diﬀuse in the
membrane, thus reducing the extent of the formation of stable
aggregates. Therefore, the membrane depolarization induced by
ampullosporin A might originate either from transient aggre-
gates and/or from stable pores formed only by a small fraction of
peptides. In fact, peptide aggregation might not even be needed
to explain the observed membrane depolarization, as molecular
dynamics studies have shown that even one or two peptides
are enough to produce membrane permeability through local
disruption of the membrane structure.69,70
5. Conclusions
We used CD and EPR spectroscopies to study the conformation,
orientation, dynamics and the aggregation propensity of
ampullosporin A and its spin-labeled analogs in zwitterionic
SUV and bicelles.
We found that the peptide orientation and the helical struc-
ture change in the two membrane systems. We rationalized this
behavior in terms of the minimization of the hydrophobic
mismatch in the two systems having diﬀerent thicknesses. In
methanol and in POPC SUV, where the peptide is too short to
fully span the bilayer, it adopts its preferred, mostly a-helical,
structure. In the thinner DMPC/DHPC bicelles, to minimize
the hydrophobic mismatch, the peptide structure elongates,
suggesting a prevailing 310-helical content. The structural diﬀer-
ences are mirrored in the orientation adopted by ampullosporin
A in the two systems. In vesicles, we suggest that the peptide
would change its orientation as a function of the P : L ratio: at
low peptide concentration it locates parallel to the membrane
surface, exposing its hydrophilic sector to the aqueous solution,
while at higher concentrations it adopts a transmembrane
orientation. In bicelles, ampullosporin A keeps a transmembrane
orientation at a P : L ratio 1 : 100 and higher, stabilized by the good
match between the peptide length and the bilayer thickness. In
addition, we detected no aggregation in bicelles because the
peptide was found to bemonomeric at a P :L ratio 1 : 25 and lower.
Overall, the comparison of the data obtained in the two
membrane-mimetic systems showed that ampullosporin A has
a rather flexible structure that readily adapts to the bilayer
thickness.
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